Aiming for safe, minimally invasive and reliable surgical treatment

Kobe City Medical Center General Hospital
Vice President
and Surgery and Transplant Surgery Director
Satoshi Kaihara

Many patients who require surgical operations visit our hospital, which is the main hospital in Kobe City. In our department, we are actively working on various things so that we can provide high-quality and safe medical care to these patients.

Careful treatment for each patient

Many of the diseases we treat are malignant diseases (cancer). Surgery for cancer requires radical surgery to remove not only the cancer itself but also the surrounding tissue, which places a heavy burden on the patient's body. In addition, it is impossible to escape the deterioration of organ function due to resection. Therefore, careful judgment is necessary to determine the necessity of surgery, and at our hospital, not only surgery but also all clinical departments involved in cancer treatment (Gastroenterology, Oncology, radiology, palliative medicine, pathology, etc.) Diagnosis Department), we have established a system that allows us to provide the most appropriate treatment according to the patient's situation. For patients who are judged to require surgery, after considering the postoperative QOL according to the background, symptoms, and progress of the disease (degree of progression), the surgical method is examined by a multidisciplinary team. A treatment plan is determined after consultation with the patient and their family. We understand that it is most important to obtain sufficient informed consent by repeating explanations gently and carefully before surgery. You can also get a second opinion if you want to hear another doctor 's opinion.

Advanced and safe cancer treatment incorporating the latest knowledge and technology

In recent years, as cancer research advances, its diagnosis and treatment methods, including surgery, are becoming more segmented, requiring doctor to have more specialized knowledge and skills. All of our surgical staff are experienced doctor who are Certified Physician /specialists/instructors or Gastroenterological Surgeon /instructors. In addition, as advanced specialist qualifications, we have 4 Technology Certified Physician Society of Endoscopic Surgery, 3 Instructor for Advanced Skills /specialists in hepatobiliary and pancreatic surgery, 1 Certified Physician from the Society of Transplant Surgery, and 1 specialist from the Society of Esophageal Society. . In recent years, the remarkable development of robotic surgery (DaVinci) has 8 qualified surgeons, and 4 of them are qualified as instructors. In this way, each of us makes use of his or her own specialized field to provide patients with advanced, safe, and best medical care. We also strive to maintain the highest level of treatment by actively participating in domestic and international academic conferences and absorbing the latest knowledge and technology.

Compared to conventional open surgery, laparoscopic surgery is characterized by less stress on the body and quicker recovery after surgery, but on the other hand, it is a surgery that requires advanced technology. In our department, laparoscopic surgery is widely adopted, mainly by endoscopic surgery society Technology Certified Physician are recognized as having advanced laparoscopic surgery skills. Not to mention cholelithiasis, almost all malignant diseases such as esophageal cancer, stomach cancer, colon cancer, liver cancer, pancreatic cancer, and emergency surgery such as inguinal hernia, appendectomy, gastroduodenal ulcer perforation, etc. going. In addition, the number of robotic surgeries has increased dramatically in recent years, and we are providing advanced medical care with less burden on the body (for details, please refer to "Clinic Results"). This reduces the burden on patients and greatly contributes to shortening the length of hospital stay.

On the other hand, even the most difficult surgeries, such as liver cancer and pancreatic cancer, which require more specialized knowledge, skills, and experience, are handled by highly experienced doctor who are qualified as Instructor for Advanced Skills /specialists in hepatobiliary and pancreatic surgery. I am undergoing many treatments. We also perform live liver transplantation, which is rare outside of university hospitals.

Practice of non-refusal medical care as a core hospital in Kobe City

Based on the awareness that our hospital is the last bastion of emergency medical care for Kobe City, we have adopted the slogan of never refusing medical care. In accordance with this policy, our department also has a system in which veteran staff doctor and young doctor are paired and on standby 24 hours a day, 365 days a year, regardless of day or night, and we perform a large number of emergency operations, about 300 cases a year. In addition, in the case of multiple injuries or complicated injuries, emergency surgery may be performed in cooperation with other clinical departments. I'm here

A total of 15 people, including 8 staff members and 7 post-doctoral residents, provide medical care. Our staff consists of experts in their respective fields.

Medical record

This page presents statistics on the number of surgeries performed in gastroenterological surgery.

Number of surgeries per year

The annual number of surgeries remained at 1,300-1,400 each year. However, in 2020, both planned and emergency surgeries decreased significantly due to restrictions on regular medical care due to the treatment of the new coronavirus infection, but have gradually recovered since then (see the next chapter for a breakdown).

Number of surgeries by organ

We show the number of surgeries according to main organ for these past five years. Similar to the trends in the number of surgeries overall, the number of surgeries for major diseases has decreased significantly due to restrictions on regular medical care due to the treatment of COVID-19, but each disease is recovering.

  2018 2019 2020 2021 2022
esophagus 28 25 22 21 20
gastroduodenum 129 135 95 63 71
colon 171 184 153 124 157
rectum 62 78 43 58 59
hepatobiliary 55 62 73 58 59
liver transplant 0 0 0 0 0
pancreas 50 63 51 48 51
gall bladder 212 175 155 173 164
appendix 116 133 84 62 95
hernia 138 133 100 126 110
Ileus 43 47 32 43 42

About laparoscopic surgery

Our hospital actively adopts laparoscopic surgery and robotic surgery as minimally invasive surgery, and the percentage of laparoscopic surgery is increasing every year. We have established a system to perform laparoscopic surgery safely and reliably, led by staff doctor who are certified as laparoscopic surgery Technology Certified Physician by the Society of Endoscopic Surgery. In addition, in robotic surgery, 4 supervisors of robotic surgery perform surgery under the guidance of 4 people.

The graph shows the percentage of minimally invasive surgery cases by laparoscopic/robot by organ. (1) Nearly all routine gastrointestinal surgeries are minimally invasive laparoscopic/robot surgeries, and (2) the percentage of liver and pancreas minimally invasive laparoscopic/robot surgeries is increasing.
In recent years, the number of robotic surgeries has also increased.

Hepato-Biliary-Pancreatic Highly Skilled Target Diseases

Surgery for malignant diseases (cancer) of the liver, pancreas, and biliary tract is a highly difficult operation. Therefore, Japanese Society of Hepato-Biliary-Pancreatic Surgery has created standards for certifying facilities with advanced equipment and technical standards and doctor with advanced surgical techniques for cancer surgery of the liver, pancreas, and biliary tract. As a result of examination based on these standards, our hospital has been certified as "Group A", which is the most difficult to acquire among "facilities certified for advanced hepato-biliary-pancreatic skills". In addition, we have 3 "hepato-biliary-pancreatic Instructor for Advanced Skills or specialists" enrolled, and these doctor are actively performing liver, pancreas, and biliary cancer surgery.
The breakdown of cases of liver resection and pancreatic resection is shown below.

Departmental statistics

Clinical Metrics Page

Main diseases/treatments

About the esophagus
The esophagus is a tubular gastrointestinal tract about 25 cm long that carries food from the throat to the stomach. Swallowed food flows into the stomach by gravity and the peristalsis of the esophagus. The throat is connected to the trachea, and the chest is surrounded by important organs such as the lungs, trachea, heart, aorta, and spine. , is also associated with the difficulty of treatment.
About esophageal cancer
I) Characteristics of esophageal cancer

The number of deaths from esophageal cancer in Japan ranks 6th among men and 13th among women, which is not so high. However, considering that it is a rare disease (lifetime risk of contracting 1 in 52 people, gastric cancer 1 in 9 people), it can be said that it is a highly malignant cancer.

Although many studies have been conducted on the development of esophageal cancer, the exact cause has not been elucidated. At present, environmental factors, especially alcohol consumption and smoking, are considered risk factors for esophageal cancer, although genetic factors are also important.

Early-stage esophageal cancer is asymptomatic and is often discovered during routine checkups. In advanced cancer, symptoms such as a feeling of being stuck in food and difficulty in swallowing appear. As the disease progresses, chest pain, loss of appetite, and weight loss also occur. It may be found with neck lymphadenopathy, cough, and hoarseness (hoarse voice). This is due to paralysis of the recurrent laryngeal nerve, which is responsible for vocalization, due to metastasis to the surrounding lymph nodes.

II) Progression and stage of esophageal cancer

Once cancer is found, tests will be needed to determine how far it has progressed. This is because treatment will vary depending on the severity of the disease.

Esophageal cancer develops from the mucous membrane of the esophagus and initially stays within the mucosa, but as it progresses, it gradually reaches the submucosa, muscle layer, and adventitia (a. wall invasion). Also, in the process of progressing, some cancer cells enter blood vessels and lymph vessels and fly to lymph nodes (b. lymph node metastasis) or to distant organs such as the liver and lungs (c. blood circulation). sex transfer).

a. Wall invasion depth

Esophageal cancer is classified into T1a (up to the muscularis mucosae), T1b (up to the submucosa), T2 (up to the muscle layer), T3 (up to the adventitia), and T4 (invasion into surrounding organs) according to its depth, as shown in the figure below. increase. For gastric cancer and colorectal cancer, shallow cancer (T1) to the submucosa is called "early cancer", and cancer that has spread to the muscle layer or deeper (T2-T4) is called "advanced cancer". However, even if esophageal cancer is as shallow as T1b, it is not uncommon (approximately 50%) to develop lymph node metastasis at an early stage. distinguishes it from good “early cancer”.

b. Lymph node metastasis

Esophageal cancer tends to spread to lymph nodes from an​ ​early stage. Therefore, it is necessary to carefully check the presence and extent of lymph node metastasis before treatment. Surgery requires extensive removal of lymph nodes.

c. Hematogenous metastasis

Hematogenous metastasis occurs when cancer cells enter the veins and spread to other organs. In this state, unlike lymph node metastasis, esophageal cancer must be considered a systemic disease.
Based on these three factors, the progression of esophageal cancer is determined (Stage 0-IVb).
Quoted from the 12th edition of the Rules for the Treatment of Esophageal Cancer
III) Treatment of esophageal cancer

Esophageal cancer is a disease with a very poor prognosis, and if left untreated, it progresses, leading to bleeding, obstruction, and ultimately systemic disease, which is life-threatening.
Treatment should be determined comprehensively based on the degree of progression and general condition. The Japan Esophageal Society has published the "Guidelines for Diagnosis and Treatment of Esophageal Cancer", and treatment policies are basically determined according to these guidelines, but this requires specialized knowledge, experience, and judgment. At our hospital, all patients who have been diagnosed with esophageal cancer are invited to participate in the "esophageal disease joint conference", which is held by doctor from all departments involved in the treatment of esophageal cancer, including Gastroenterology medicine, Radiation Oncology, radiotherapy, Oncology. I am considering treatment options. Stage 0 esophageal cancer can be cured by endoscopic treatment. The treatment of esophageal cancer of stage I to III is basically surgery. As with surgical treatment, chemoradiotherapy is highly effective and is expected to become more mainstream than surgery in the future. However, at present, the treatment results are considerably inferior to those of surgery, and surgery for residual or recurrent disease (called salvage surgery) places a great burden on the body. The basic policy is to perform surgery whenever possible.

Surgery for esophageal cancer
In thoracic esophageal cancer, the esophagus is surrounded by the lungs, trachea, heart, aorta, and spine. , is the common way to reach the esophagus in the middle of the body. Then, the esophageal lesion and the periesophageal and perigastric lymph nodes that may have metastasized are removed. All of the esophagus except the neck and 1/3 of the stomach will be removed. The operation is called a subtotal esophagectomy.

After removing the esophagus, the remaining stomach is stretched into a long, thin tube (called a gastric tube) that is lifted up and connected to the esophagus in the neck. Therefore, not only the thoracotomy, but also the abdomen (called laparotomy) and a small opening in the neck are required for the operation.

It is a very big operation that takes about 8 to 10 hours. Our hospital has introduced thoracoscopic surgery since 1998, and has accumulated experience in more than 200 cases. It is of course less stressful on the body than open-chest surgery, with smaller wounds and less impact on the lungs. I think that surgery is possible. Since 2018, robot-assisted surgery has been introduced, making it possible to perform more detailed surgery with less risk of complications. In addition, surgery to remove the esophagus from wounds in the neck and abdomen (mediastinoscopic esophageal surgery) without thoracotomy or manipulation of the thoracic cavity is also suitable for cases (low lung function, elderly people) as a surgery with less burden on the body. etc.).

Although it varies slightly depending on the surgical procedure, drinking water and oral intake are started about one week after the surgery. If all goes well, you can leave the hospital 2-3 weeks after the surgery.

complications of surgery

Esophageal surgery is said to be a major surgery, and it must be said that the risk of various problems (called complications) occurring during and after surgery is greater than in other surgeries. Due to the accumulation of medical technology, knowledge and experience, the number of patient deaths due to esophageal surgery has decreased significantly compared to the past. A 2011 national registry showed a complication rate of 41.9% and a postoperative mortality rate of 3.4% (National Clinical Database; NCD). Although this data is considerably better than the results of surgery in Europe and the United States, it is said that the risk is still very high compared to other surgeries [1]. The three major complications after surgery for esophageal cancer are pneumonia, recurrent laryngeal nerve paralysis, and suture failure.

1) Respiratory complications (pneumonia, 15%; NCD)

Since metastasis of esophageal cancer is likely to occur in the lymph nodes around the trachea in the mediastinum, it is necessary to clean the area (called lymph node dissection). This makes it difficult to take a big enough breath or cough up phlegm after surgery. Swallowing is also easily impaired, making it more likely to cause aspiration (difficulty in swallowing, causing food to flow into the respiratory tract). As a result, respiratory complications such as pneumonia (10%) and atelectasis may occur. If it is short-term, it can be treated by sucking sputum with a bronchial fiber, but if airway and respiratory management (sputum suction, artificial respiration, etc.) is prolonged, tracheotomy is required for long-term treatment. there is. Although it has decreased since the introduction of thoracoscopic surgery, it is still a life-threatening complication.

2) Recurrent laryngeal nerve palsy (about 20%; NCD)

The nerves that drive the vocal cords recurve the great vessels in the thoracic cavity (right-subclavian artery, left-aortic arch) and enter the vocal cords through the sides of the trachea. This lymph node around the recurrent laryngeal nerve is the most common site of lymph node metastasis of esophageal cancer and should be removed. Therefore, paralysis symptoms appear at a relatively high rate. If it is mild, it is called hoarseness and the voice is hoarse, but it may make it difficult to breathe or cause aspiration. Nerve function usually returns and improves within 6 months, but vocal cord surgery may be required if function is not restored.

3) Suture failure (13.3%; NCD)

Since the stomach is lifted up to the neck and anastomosed and reconstructed, blood flow tends to be poor near the tip, so saliva and gastric juice will leak if the joint is not firmly attached. This is called suture failure. If the leak is mild, wound care alone will heal. Prolonged fasting may be required. Gastric tube necrosis (2-3%) may occur when a large area of the gastric tube suffers from blood flow obstruction, and the gastric tube may rot, requiring emergency surgery. Mediastinitis is life threatening.

この他にも、乳び胸、術中・術後出血、創感染、敗血症、深部静脈血栓症などの合併症のリスクがあります。
当院では、手術を安心して受けていただくために、合併症の予防対策に特に力を入れており、全国的に見ても良好な治療成績を達成しています[2,3]。その結果、術後に退院するまでに要する日数が短縮しています。

Perioperative management

Even if you go to great lengths to undergo surgery, you will not be able to achieve your goal of "curing cancer" unless you can overcome complications. Of course, surgery centered on the surgeon and postoperative management are important, but preoperative oral care (dentist), respiratory rehabilitation (physiotherapist), intensive care from the early postoperative period (Anesthesiology), breathing and swallowing It is a disease that requires team medical care through multidisciplinary cooperation, such as rehabilitation (physical therapist), medication guidance (pharmacist), nutrition guidance (nutritionist), etc., and the function of the entire hospital is questioned.

About outpatient visits

In order to monitor your physical condition for a while after the operation, you will be asked to go to the outpatient clinic to detect cancer recurrence or metastasis at an early stage.

As the term "5-year survival rate" is often used, it is necessary to undergo long-term examinations until it can be determined that the cancer has been cured. Once every 3 to 6 months, we will check for recurrence due to lymph node metastasis or hematogenous metastasis, mainly through blood sampling and CT scans. Recurrences may be treated with surgery or radiotherapy. In addition, esophageal cancer is characterized by many “multiple cancers in the pharynx and larynx region”, and in order to detect this early, we have patients undergo an upper gastrointestinal endoscopy at least once a year.

Surgery results

According to the "National Esophageal Cancer Registry Survey Report" by the The Japan Esophageal Society, the 5-year survival rate for those who can be resected by surgery is 55.6%. Although treatment results have improved, it is undoubtedly a disease with a particularly poor prognosis among malignant tumors of the digestive system, and treatment is sometimes difficult.

Efforts to improve treatment outcomes are ongoing. For example, in a clinical trial called JCOG9907, results showed that "preoperative chemotherapy (FP therapy) + surgery" was effective for stage II and III esophageal cancer (5-year survival rate of 60.1%). ). Since then, “neoadjuvant chemotherapy + surgery” has become the standard treatment in Japan. At our hospital, we aim to further improve treatment results by performing DCF therapy, which has a higher response rate, as preoperative chemotherapy.
(Comprehensive Registry of Esophageal Cancer in Japan, 2012 Cited from The Japan Esophageal Society National Registry [4])

References:

  1. Takeuchi H, Miyata H, Ozawa S, Udagawa H, Osugi H, Matsubara H, Konno H, Seto Y, Kitagawa Y. Comparison of Short-Term Outcomes Between Open and Minimally Invasive Esophagectomy for Esophageal Cancer Using a Nationwide Database in Japan.Ann Surg Oncol 2017;24:1821-7
  2. Kobayashi H, Kondo M, Mizumoto M, Hashida H, Kaihara S, Hosotani R. Technique and surgical outcomes of mesenterization and intra-operative neural monitoring to reduce recurrent laryngeal nerve paralysis after thoracoscopic esophagectomy: A cohort study. Int J Surg 2018;56 :301-6.
  3. Kobayashi H, Kondo M, Kita R, Hashida H, Shiokawa K, Iwaki K, Kambe H, Mizuno R, Kawarabayashi T, Sumi T, Kaihara S, Hosotani R. Cause of recurrent laryngeal nerve paralysis following esophageal cancer surgery and preventive surgical technique along the left recurrent laryngeal nerve. Mini-invasive Surg 2020;30.
  4. Tachimori Y, Ozawa S, Numasaki H, Ishihara R, Matsubara H, Muro K, Oyama T, Toh Y, Udagawa H, Uno T, Registration Committee for Esophageal Cancer of the Japan Esophageal S. Comprehensive registry of esophageal cancer in Japan, 2012 Esophagus 2019;16:221-45.

shape and function of the stomach

The stomach is one of the organs that digests and absorbs food. is in The entrance of the stomach that borders the esophagus is called the cardia, and the exit of the stomach that leads to the duodenum is called the pylorus.
The main role is to temporarily store food, eat it in small portions until it becomes porridge, and send it out from the pylorus to the duodenum (small intestine) little by little. Surgery on the stomach reduces or eliminates these functions. A diet is necessary to compensate for this. (described later)

About stomach tumors
stomach cancer

I) Formation and progression of gastric cancer

Gastric cancer is the most common and well-known gastric tumor. Gastric cancer develops from the mucous membrane of the stomach and gradually penetrates deep into the submucosa, muscular layer, and subserous layer (wall invasion). Along the way, some cancer cells enter the lymphatic vessels and blood vessels in the wall of the stomach, fly along the lymphatic flow to lymph nodes, and fly along the bloodstream to distant organs such as the liver and lungs. To do. This is called metastasis, which is why gastric cancer is called a “malignant” tumor.

a. Wall invasion depth

The depth to which gastric cancer has reached is classified into T1 to T4 as shown in the figure below. The deeper the gastric cancer is, the more likely it is to metastasize. Generally, gastric cancer that is shallow to the submucosa (T1) is considered to be early gastric cancer with low metastasis potential, and gastric cancer deep in the muscle layer or deeper with a high possibility of metastasis. is treated as advanced gastric cancer. When gastric cancer breaks through the serosa and emerges outside the stomach (T3), cancer cells may spill out into the stomach and metastasize to the peritoneum (called peritoneal metastasis or dissemination). In addition, infiltration of the surrounding internal organs is called infiltration (T4), and other organs may need to be removed together with gastric cancer resection. You can't know these things unless you actually look inside your stomach, but you can make a certain amount of predictions with gastroscopes and CT scans before formulating a treatment policy.

T1

Cancer confined to the mucosa to submucosa (early gastric cancer)

T2

Cancer that has spread to the muscle layer

T3

Cancer that has protruded near the outside of the stomach

T4

Cancer outside the stomach or invading other internal organs or tissues

b.Relocation

Cancer metastasis can be roughly divided into three types: (1) lymph node metastasis, (2) hematogenous metastasis (liver, lung, etc.), and (3) peritoneal metastasis (dissemination). Gastric cancer is known to often develop lymph node metastasis from a relatively early stage. In addition, it is known that it often stays in metastases in the lymph nodes near the stomach for a while. For this reason, in the treatment of gastric cancer, the method of removing the lymph nodes around the stomach that may have metastasized together with the gastric lesion has been established as a standard surgery.
Lymph node metastasis is also important in determining the progress of gastric cancer. In other words, the progress of gastric cancer is determined by the depth of gastric cancer and the degree of lymph node metastasis (advancement, stage).

Ⅱ) Progression of gastric cancer (advancement, stage)

The progression of gastric cancer (called the degree of progress or stage) is currently classified into 6 stages, I, IIA, IIB, III, IVA, and IVB, in accordance with the regulations of the Japanese Gastric Cancer Association. will be The treatment method will be selected based on the results of gastroscopy, CT scan, etc., and the expected progress of your stomach cancer. In addition, the easiness of recovery of gastric cancer after treatment varies depending on the progress.

III) Treatment of gastric cancer

The table below is based on the gastric cancer treatment guidelines (revised in January 2018) by the Japan Gastric Cancer Society. Currently, treatment methods that are widely used and considered appropriate are listed as routine medical care, depending on the progress of gastric cancer.

Treatment methods for gastric cancer include (1) endoscopic treatment (mucosal resection with a gastrocamera), (2) surgery, (3) chemotherapy (anticancer drugs), and (4) radiotherapy. Early-stage cancer that remains in the mucosa is often targeted for endoscopic treatment, but even if it is an early-stage cancer, there is a possibility that it has metastasized to the lymph nodes, or other advanced cancer. Surgery is considered the most effective treatment. Surgery is a method of removing the stomach and the lymph nodes around the stomach together, but as explained in the later section, if the stomach can be partially left (pyloric gastrectomy or cardia gastrectomy). There is also a case where the entire stomach is removed (total gastrectomy). In addition, if the cancer grows and connects to another organ, it may be necessary to remove that organ as well (combined resection).

However, if there is metastasis to more distant organs or lymph nodes (stage IVB), it cannot be removed by surgery, so chemotherapy is the main treatment. Even in this case, palliative surgery may be performed to improve symptoms, such as when the stomach is blocked by a tumor or bleeding from the tumor continues.

  • *The range of lymph nodes to be resected differs depending on the stage of cancer progression.
  • ⁑For advanced cancers that have a high recurrence rate even with surgery and adjuvant chemotherapy, we also provide multidisciplinary treatment that combines preoperative chemotherapy and surgery.
  • ⁂Even in stage IV, there are cases where a normal gastrectomy, not a palliative surgery, is performed after chemotherapy.

In addition, a pathological examination is performed in which the resected gastric cancer is examined in detail under a microscope to confirm the correct stage. In this case, unlike the stage classification before surgery, it is further classified into 8 stages such as IA, IB, IIA, IIB, IIIA, IIIB, IIIC, and IV. Results are usually available 2-3 weeks after surgery, so we will explain the results at the first outpatient visit after you leave the hospital. Depending on the stage of the pathological examination results, adjuvant chemotherapy (anticancer drug treatment given for a limited period to prevent recurrence) may be recommended after surgery.

In addition to this, there are examinations (examination laparoscopy) that look into the stomach with a laparoscope to check whether the cancer has spread outside the stomach and whether there is peritoneal dissemination, and before surgery By using anti-cancer drugs (preoperative chemotherapy), we also actively perform multidisciplinary treatments that aim to improve curability (completely cure cancer) as much as possible.

In addition to the treatments recommended in the gastric cancer treatment guidelines, there are a wide variety of treatment methods for gastric cancer. When performing surgery, there are different approaches such as robot-assisted surgery, laparoscopic surgery, and open surgery. Based on the individual patient's physical condition, cancer progression, etc., we will propose the best treatment options for the patient, including clinical trials that are not listed in the guidelines. I am trying to get it. At our hospital, we regularly hold joint conferences with the Department of Gastroenterology of Oncology, Department of Radiological Imaging, Diagnostic Clinical Pathology, and Surgery for gastrointestinal diseases. We provide daily medical care, so please do not hesitate to consult us regarding treatment methods other than diagnosis and surgery.

About Stomach Cancer Surgery

I) Patient-friendly, minimally invasive surgery Laparoscopic surgery, robot-assisted surgery

Laparoscopic surgery involves inflating the stomach (intra-abdominal cavity) with carbon dioxide gas, inserting a camera (laparoscopic) through the navel, and inserting cylinders with a diameter of about 1 cm into 4-5 points of the abdomen. It is a surgery performed by inserting and removing surgical instruments from. Robot-assisted surgery is an extension of this.

Recently, most gastric cancer surgeries are laparoscopic or robotic. Depending on the patient's medical condition, a normal laparotomy may be performed, so please feel free to contact the doctor.

Laparoscopic surgery not only causes less trauma to the patient, but also enables delicate surgery with less bleeding due to the magnifying effect.

II) Scope of gastrectomy Pyloral side gastrectomy, total gastrectomy, cardial side gastrectomy

Surgery for stomach cancer consists of removing the stomach and removing the surrounding lymph nodes. The area to be resected depends on the location and progress of the cancer. In order to focus on the QOL (quality of life) of postoperative patients, we take various measures such as avoiding total gastrectomy as much as possible.

a. Pyloral gastrectomy

If the cancer exists on the exit (pylorus) side of the central part of the stomach, about 2/3 to 3/4 of the exit side of the stomach including the pylorus is resected, and the stomach on the entrance (cardia) side is removed. You can leave This is called a pyloric gastrectomy. By directly connecting the remaining stomach to the duodenum, or by lifting the small intestine and connecting it to the stomach, food and digestive juices pass through.

b.Total gastrectomy

If the cancer has spread near the cardia, surgery to remove the entire stomach may be necessary. Since the stomach is completely gone, a passageway is created by connecting the esophagus and the lifted small intestine.

c. Cardiac gastrectomy

In the case of early-stage cancer near the cardia of the stomach, we perform a surgery called cardia gastrectomy to avoid total gastrectomy. Since more than half of the stomach remains, postoperative weight loss and nutritional status are said to be less than after total gastrectomy.

The scope of gastrectomy is determined not only by the location and spread of the cancer, but also by comprehensively judging the degree of progression of the cancer, the age of the patient, and physical strength. We may propose other surgical methods, or change the resection range and surgical method depending on the situation during the operation.

Efforts related to surgery

When you are told that you have stomach cancer or are told that you need surgery, you may have various concerns and questions. We would like to introduce the efforts we are making for patients who actually undergo surgery.

I) Oral care

If it is decided to undergo surgery, we hand out a referral letter to all patients and ask them to see a dentist. Keeping the oral cavity clean is very important from the viewpoint of preventing complications such as postoperative pneumonia. Not only that, chewing is also important after gastrectomy, so we work with many practitioners to treat caries (cavities), extract teeth, and make dentures (dentures) before surgery. going.

II) Nutrition guidance, ONS

Gastrectomy can lead to various post-gastrectomy complications. The function of the stomach is to store the food you eat, break it down into small pieces by peristalsis, disinfect it with gastric acid, digest it, and send it to the intestinal tract. Symptoms appear when these functions are lost as the stomach becomes smaller or disappears. Specifically, first, the amount of food that can be eaten at one time is reduced. Then, it becomes easy to have diarrhea because the digestive absorption capacity decreases. In addition, since food directly enters the small intestine, symptoms such as dumping syndrome, such as bloating and pain in the stomach early after eating, cold sweats due to hypoglycemia about 2 hours after eating, and blackness in front of the eyes. And so on. These symptoms often improve gradually over a period of months, but they cannot be completely removed. Body weight may temporarily decrease from a few percent to 10% or more after surgery. It will gradually increase again, but even if the stomach cancer is cured, it will not return to the original weight. Diet therapy is important for improving these symptoms, minimizing weight loss, and maintaining physical fitness.

At our hospital, a registered Registered Dietitian provides nutritional guidance for diet therapy twice during hospitalization (at the time of admission and before discharge), and also after discharge as an outpatient. Specifically, based on split meals, which is a method of reducing the amount of meals at one time and increasing the number of meals, it explains in detail how to eat efficiently and precautions. At the outpatient clinic, we also evaluate whether the diet is going smoothly at home and whether the necessary nutrients are being taken. Some people ask about eating out and alcohol consumption. In addition, ONS (Oral Nutrition Supplementation) is used to actively compensate for nutritional deficiencies by having patients drink enteral nutritional supplements and concentrated liquid diets in addition to their normal diet. We are making various efforts from inpatient to outpatient so that the nutritional status of children can be improved as much as possible.

I will explain according to the above document.

In addition, our hospital is a facility member of the "Stomach Surgery and Postoperative Disorder Research Group". In order to help patients lead a comfortable daily life after gastrectomy, we use the booklets and printouts created by the study group, as well as the PGSAS app provided by the study group. We strive to give you a deeper understanding of the current state of your life.

Post-surgery evaluation table for gastric cancer using the PGSAS app. By entering information such as the contents of the questionnaire filled out by the patient and the surgical procedure, it is possible to visually understand the actual condition of post-gastrectomy disorders at that time.

Ⅲ) Clinical Path, Gastric Cancer Community Collaboration Path

When undergoing gastric cancer surgery, I think there are various questions about what the specific course will be after being hospitalized. A rough schedule that shows when such medical procedures will be performed is called a clinical path. At our hospital, we use the same clinical path for almost all surgical procedures for gastric cancer patients.

By introducing the clinical path, there is an advantage that everyone can easily understand the flow of examinations and treatments after hospitalization and surgery, like a schedule table. For us doctor professionals, it is possible not only to standardize gastric cancer treatment by objectively judging whether it is progressing according to the path, Registered Dietitian, etc.) can aim to further improve the quality of medical care through information sharing. I will give it to you and explain it when you go through the hospitalization procedure.

See the clinical path

We aim to be hospitalized on the day before surgery and to be discharged about a week after surgery.

The usual clinical path only includes the contents from hospitalization to surgery and discharge. In our department, we have introduced a schedule for outpatient visits after discharge, such as examination schedules and hospital visit schedules, and we call it the "Stomach Cancer Regional Collaboration Path". Although we mainly target patients with early-stage stomach cancer, we work closely with many general practitioners to ensure that patients can continue to visit our hospitals with peace of mind even after they are discharged from the hospital.

When you undergo actual gastric cancer surgery, we will talk about it according to the explanatory document. We ask that you fully understand the reasons for choosing surgery as a treatment method, the specific surgical method, and the postoperative risks (complications, etc.), and then consent after you are satisfied.

Click here for Gastric Cancer Surgery Instructions

This is the preoperative explanatory document currently in use. I will explain according to this document.

About complications

Early complications after surgery include bleeding, suture failure (the joint between the stomach and the intestine does not stick well), pancreatic fistula, and anastomotic stenosis (temporary obstruction of the joint due to edema, etc.). It can happen.

また、胃の術後の後遺症としてダンピング症候群(胃の貯留能の低下、消失等が原因で起こる様々な症状)や逆流性食道炎、胃内容排出遅延、腸閉塞、胆石症等が起こってしまうことがあります。

In the surgical treatment process, in most cases, the clinical path is used for treatment.

If all goes well, you will be able to leave the hospital approximately 7 to 10 days after the surgery. In the meantime, we will work with a registered dietitian to provide nutritional guidance twice during hospitalization, and instruct you on how to eat if your stomach becomes small or disappears.

About outpatient visits

For early gastric cancer, the possibility of recurrence is low, so outpatient visits are about once every six months to one year. It is an outpatient visit according to the gastric cancer community cooperation pass.

For advanced cancer, adjuvant therapy is often recommended. Regarding anti-cancer drug treatment, our hospital cooperates with the Oncology, so during the anti-cancer drug treatment, the baton will be passed to the Oncology once, but once the anti-cancer drug treatment is completed, we will go to the hospital for surgery every 3 to 6 months. I will.

For both early gastric cancer and advanced gastric cancer, we will ask you to go to the outpatient clinic for about 5 years after surgery, but if there is no recurrence, we will basically ask you to continue to see a doctor in the area.

Number of surgeries in our department

The number of gastric cancer surgeries in our department ranges from 80 to over 100 per year. Among them, the proportion of minimally invasive surgery such as laparoscopic surgery and robotic surgery is increasing year by year, reaching 95% in 2022. In order to provide more body-friendly and high-quality surgeries, treatment is performed mainly by staff of multiple Technology Certified Physician and robotic surgery support proctors.

Gastric submucosal tumor

Most of them become tumors called gastrointestinal mesenchymal tumors (GIST: abbreviation for Gastrointestinal Stromal Tumor). Unlike stomach cancer, it often arises from the stomach wall (muscle) rather than from the stomach mucosa. There is almost no lymph node metastasis, but when it becomes large, the possibility of metastasis to the liver and peritoneal dissemination increases.

Method of treatment

Unlike gastric cancer, there is no need to remove the lymph nodes, so the surgical method is completely different. Laparoscopic surgery is performed for small tumors (less than 5 cm). In particular, tumors that have grown inside the stomach cannot be located by ordinary laparoscopic surgery, and excision of the normal stomach wall causes deformation and narrowing of the stomach. You may. For such cases, we perform LECS surgery (LECS: Laparoscopy & Endoscopy Cooperative Surgery), which is performed jointly with endoscopic (gastric camera) surgery and laparoscopic surgery. It will be a collaborative operation between Gastroenterology and surgery.

About colorectal cancer
Colorectal cancer is cancer that develops in the large intestine (colon, rectum, and anus), which is about 2 meters long.
Colorectal cancer arises from the cells of the mucous membrane of the large intestine, and there are some that arise from the malignant transformation of a part of a benign tumor called adenoma, and others that arise directly from the normal mucosa. The progress is slow, but if left untreated, the enlarged cancer blocks the lumen of the large intestine, causing intestinal obstruction, bleeding from the tumor, and metastasis to other organs such as the liver and lungs. It is expected to be life threatening. Treatment is needed to get rid of the cancer and avoid such dangers.
<Structure of colon wall and depth of cancer invasion>

Treatment for colorectal cancer includes surgery, anticancer drugs, and radiation, but surgery is the main treatment.

The principle of treatment is to remove the cancer cleanly without leaving any residue. If the cancer is confined to the mucosa only, or if there is only a small amount of infiltration in the submucosa, the possibility of lymph node metastasis is extremely low and endoscopic treatment is possible. If there is infiltration deep into the submucosal layer or deeper, there is a certain probability of lymph node metastasis (around 10% in early-stage SM cancer), so the surrounding lymph nodes should also be removed as a preventive measure. need arises. Surgery is required for that.
<Lymph node metastasis>

Types of surgery include (1) ileocecal resection, (2) right hemicolectomy, (3) transverse colectomy, (4) left hemicolectomy, (5) sigmoid resection, (6) rectal resection, rectal amputation (colostomy), etc. It varies depending on the localization of The main surgical methods are open surgery, which has been conventionally performed, and laparoscopic surgery, in which the large intestine is resected by making five small incisions of 5 mm to 1 cm in size on the abdomen.

In 2019, 218 colorectal cancer patients underwent surgery for colorectal cancer in our department. Of these, 179 (82%) were performed by laparoscopic surgery, and the annual number of colorectal cancer surgeries is top class among neighboring prefectures.

At our hospital, we are actively working on laparoscopic surgery in colorectal cancer surgery. In particular, we are working to provide high-quality surgical treatment that is more gentle on the body, led by multiple staff members who are Technology Certified Physician laparoscopic surgery. I'm in.
In addition, the elderly and obese are not excluded from laparoscopic surgery, and laparoscopic surgery is performed with caution for adhesions as much as possible for those who have a history of laparotomy. Even patients with poor general condition (heart, lung, liver, kidney function) are indicated if they can tolerate general anesthesia.

About robot-assisted rectal surgery

The large intestine is roughly divided into the colon and the rectum based on the difference in structure and position of the organ. Robotic-assisted colectomy and rectal resection is a robotic-assisted laparoscopic colectomy and rectal resection. Currently, we are mainly using a surgery support robot called "Da Vinci" developed in the United States, but we plan to introduce cutting-edge equipment, including recently developed domestic robot equipment.

On Robot-Assisted (Da Vinci) Surgery in Surgery

Compared to conventional open surgery, robot-assisted surgery has the same advantages as conventional laparoscopic surgery, such as smaller incisions, less pain, faster postoperative recovery, and less bleeding during surgery. I'm here. It should be noted that the greatest feature of robotic equipment is the support of robotic forceps that can bend intricately. It also has the advantage of enabling precise manipulation and enabling surgical techniques that are difficult to achieve with laparoscopic surgery. Therefore, in addition to the same advantages as conventional laparotomy and laparoscopic surgery, "more delicate and precise surgery" becomes possible.

Delicate and precise surgery can be expected to reduce damage to surrounding organs and improve curability. Especially in the case of the rectum, by carefully preserving the close pelvic plexus (nerves responsible for urination and sexual function) through delicate manipulation, postoperative urinary and sexual functions can be maintained and early recovery can be expected. , It is possible to perform surgery with “less aftereffects and gentle on the body”. Also, rectal cancer is generally associated with an artificial anus, and the closer the cancer is to the anus, the more likely it will become an artificial anus. In robotic surgery, by making full use of the characteristics of the robot, which is good at precise movements even in a narrow pelvis, it is possible to operate deep into the pelvis, making it possible for more patients to preserve the anus. Achieving functional preservation of the anus, etc., is thought to be beneficial in improving postoperative quality of life for patients.

For these reasons, we have proactively adopted robotic surgery for colorectal cancer ahead of others. And recently, we are actively introducing robotic surgery for colon cancer.

Progress after surgery

The hospitalization period after surgery is about one week, but the situation varies depending on the location of the cancer, the degree of progression, and the state of the abdomen (adhesions and obesity). We try to explain to each patient and family so that they can receive it with sufficient understanding. In addition, we have introduced the latest postoperative recovery strengthening program and strive for early recovery. Surgery naturally causes great damage to the body. The goal is to minimize the damage caused by the surgery as much as possible so that the patient can recover to the pre-operative state of health as soon as possible. To that end, not only doctor and nurses, but also pharmacists, physical therapists, nutritionists, social workers, medical office workers, and other staff involved with patients are involved as a team.

Risks and complications associated with surgery include bleeding, infection, and suture failure, which may require drainage surgery and colostomy. It is said to be a complication in about 1.5% of colon cancer surgeries. After-effects associated with rectal surgery include neuropathy (dysuria, defecation disorder, and sexual dysfunction). We take preventative measures to avoid complications as much as possible, and if they do occur, we will discover them as soon as possible and respond and treat them.

In colon surgery (especially rectal surgery), a colostomy may be created. Sometimes it's temporary, sometimes it's permanent. If a colostomy is created, the nurse will provide careful guidance on how to care for the colostomy. We have several certified nurses who specialize in colostomy care, and we also provide long-term follow-up after discharge (stoma outpatient).

About anticancer drug treatment

Treatment other than surgery includes anticancer drug treatment. It depends on the progress (stage) of the cancer. There have been remarkable advances in anticancer drug treatment for colorectal cancer, and certain effects can be expected.

Even if the disease has progressed a little and metastasis to the liver or lungs is recognized, if the condition is operable, it may be completely cured by surgery. If cancer is discovered after metastasis, which is difficult to completely remove, is treated with anticancer drugs in addition to surgery. In addition, for rectal cancer, anticancer drug treatment may be given before surgery to make the disease smaller before surgery. Anticancer drugs may be used to prevent recurrence after surgery.

Even if the cancer recurs after surgery, if it is found early, it may be completely cured by resection, but in most cases, anticancer drug therapy is the main treatment. Anticancer drug treatment is performed in cooperation with Oncology at our hospital. Prior to anticancer drug treatment, genetic testing is performed to determine if it is effective, and a central venous reservoir is placed to facilitate anticancer drug treatment. In this way, surgical techniques and anticancer drug treatments for colorectal cancer (colon cancer and rectal cancer) are progressing day by day. It is necessary to develop a comprehensive treatment strategy that includes cancer drug treatment. At our hospital, we have introduced a clinical system that goes beyond the boundaries of clinical departments to determine better treatment strategies for both Oncology and related clinical departments.

There are various treatments for liver cancer, each with its own characteristics. Therefore, in order to select a treatment method, it is necessary to first understand the liver to some extent. Let's work together to find the best treatment.
Liver anatomy and function
The liver is an organ located in the upper right abdomen, surrounded by the ribs on the cranial half.
The liver is a highly vascularized organ made up of three types of blood vessels, the portal vein, hepatic artery, and hepatic vein, and the bile duct, which carries bile.
Based on these vessels, they are divided into two lobes, the left lobe and the right lobe. The left and right lobes are further divided into four segments, the lateral segment, the medial segment, the anterior segment, the posterior segment, and eight subsegments (S1 to S1). 8).

The liver has many functions, such as storing nutrients, making proteins, breaking down drugs and poisons, and making bile, which is a digestive juice. Therefore, in order to evaluate the function of the liver, it is necessary to combine these various functions comprehensively, and when treating the liver, a safe treatment method is selected based on the Child-Pugh classification below.

Child-Pugh Classification
This is a method to evaluate the function of the liver using five items. The total score is then used to divide cirrhosis from early stage to late stage.

test value, etc. score
1point 2 points 3 points
bilirubin level 1~2 2~3 >3
albumin value >3.5 2.8~3.5 <2.8
ascites none Mild Moderate degree
encephalopathy none 1~2 3~4
prothrombin time >80 50~80 <50
liver tumor

Various tumors, including benign and malignant, occur in the liver, and many tumors are targets for surgery. Liver cancer includes primary liver cancer, which originates from the liver itself, and metastatic liver cancer, in which cancer from other organs metastasizes to the liver.

  1. Most primary liver cancers are hepatocellular carcinomas, and others include intrahepatic cholangiocarcinoma.
  2. Metastatic liver cancer causes liver metastasis not only from gastric cancer such as gastric cancer and colon cancer, but also from lung cancer and breast cancer. The treatment policy varies depending on the type of cancer, but in the case of metastatic liver cancer from colorectal cancer, there is a possibility that it can be completely cured by resecting the liver metastasis, so surgery is aggressively performed in conjunction with chemotherapy.
Treatment of primary liver cancer

Treatment methods for hepatocellular carcinoma include surgery (hepatectomy), radiofrequency ablation therapy, embolization therapy, arterial injection therapy, drug therapy, and Gastroenterology section) and liver transplantation (see section on liver transplantation for details).

Which of these treatments is most appropriate depends on the individual patient's circumstances. Therefore, guidelines as a treatment policy for liver cancer have been proposed as "liver treatment guidelines", and treatment is performed according to these guidelines.

In the case of intrahepatic cholangiocarcinoma, surgical indications and surgical methods are selected in consideration of the site and size of the tumor, presence or absence of lymph node metastasis, presence or absence of bile duct invasion, and presence or absence of intrahepatic metastasis.

liver resection
resection range
The scope of liver resection is determined based on the concept of "preserving liver function and leaving no cancer". Specifically, it is classified into several types based on tumor localization and liver function.

Depending on the surgical procedure, the surgical procedure can be performed in about 3 hours, or it may take more than 10 hours.

resection method
In addition to open surgery, liver resection methods include laparoscopic and robot-assisted minimally invasive surgery.

Compared to conventional open surgery, minimally invasive surgery results in smaller wounds, so there are advantages such as faster postoperative recovery and less bleeding. limits minimally invasive surgery. Currently, approximately 70% of liver resections are performed using minimally invasive surgery.

Simulation/Navigation
By constructing a 3D image based on images taken before surgery, it is possible to set the resection range and surgical method, estimate the degree of difficulty of surgery and the expected remaining liver capacity, and select the optimal surgical method that is neither excessive nor deficient. Decide In addition, intraoperative ICG fluorescence imaging is used to visualize the tumor and the liver region to be resected in real time for navigation during liver resection.
Postoperative course

After the operation, you can start eating from the second day.
Although there are individual differences, you can return to society in about a month after the operation.

Complications after hepatectomy include bleeding, bile leakage, ascites, pleural effusion, and liver failure.

After surgery for liver cancer, there is a possibility that the remaining liver will recur.

In our department, we provide outpatient follow-up for those who have received liver transplants and those who have become donors for living-donor liver transplants. We also offer consultations on liver transplantation. Below is a brief description of the general aspects of liver transplantation.

1. What is living donor liver transplantation?

Liver transplantation is a treatment that transplants a liver donated by another person to a person with serious liver disease who cannot be cured by medical treatment. Live liver transplantation is a surgical procedure in which a part of the liver is removed from a healthy person and transplanted, while brain-dead liver transplantation is transplantation from a brain-dead donor. Living donor liver transplantation was performed for the first time in the world in 1988, and more than 10,000 living donor liver transplantations have been performed in Japan since 1989. On the other hand, brain-dead liver transplantation was performed for the first time in Japan in 1999, and more than 700 cases have been performed so far. Recently, there are 300 to 400 living-donor liver transplants and 60 to 90 brain-dead liver transplants each year.

Liver transplantation is targeted for patients with poor prognosis due to severe liver disease or severely impaired QOL. Various liver diseases are indicated, but transplant surgery is generally performed for the following diseases.

<Target disease>
  • Decompensated liver cirrhosis (hepatitis viral, secondary biliary, liver cancer complications, etc.)
  • Congenital liver/biliary diseases such as congenital biliary atresia and congenital metabolic disorders
  • Primary biliary cholangitis, Budd-Chiari syndrome, primary sclerosing cholangitis, etc.

However, not everyone with the above diseases can receive a liver transplant. Since liver transplantation is a physically demanding treatment, the age of the transplant recipient (recipient) is generally considered to be up to 70 years old, and the age of the living donor to be up to 65 years old (depending on the facility). .

2. Content of surgery

In transplant surgery, the organ donor's (donor's) liver (whole or part) is first removed. Whole liver in brain-dead donors, part of liver in living donors (outer segment (approximately 1/4 of total liver), left lobe of liver (approximately 1/3), right lobe of liver (approximately 1/2 to 2/3)) extract the The size of the liver to be transplanted depends on the size of the recipient's liver and the size of the donor's liver.

The recipient's liver is completely removed and the donor's liver is transplanted. When the blood vessels of the transplanted liver and the recipient's blood vessels are all connected and blood flow resumes, the transplanted liver begins to function. Next, the bile duct of the transplanted liver and the recipient's bile duct (or intestine) are sewn together to recreate the bile flow path, and the abdominal wound is closed to complete the transplant surgery. Generally, it takes 6-8 hours for living donor surgery and 10-12 hours for recipient surgery.

3. Risks and Complications of Transplant Surgery

Liver transplantation is a major surgery with many risks, and the surgery is not without risk of death. Surgery is performed by doctor with extensive experience in liver surgery, but if the patient's preoperative condition is poor, the risk of surgery increases accordingly.
Complications of surgery include bleeding, blockage of connected blood vessels, bile leakage, bile duct stenosis, and intestinal obstruction. In addition, there are various risks such as rejection, infection, and renal failure that requires dialysis.
Several immunosuppressants are administered immediately after surgery. Immunosuppressants are necessary to prevent rejection, but care must be taken because they also lower the natural immunity, making infections more likely to occur. In addition, treatment may be necessary for hypertension and diabetes as a side effect of the drug itself.
Rejection includes acute rejection and chronic rejection, but in both cases treatment with immunosuppressants is required. If treatment is unsuccessful, the transplanted liver will eventually fail, leading to liver failure. Therefore, it is very important to continue taking immunosuppressants to prevent rejection.

Four. General postoperative course

The recipient will be placed in the intensive care unit for a while after the operation, then continue treatment in a general ward, and if there are no particular problems, they will be discharged in 1 to 2 months. During hospitalization, blood tests and ultrasonography are performed many times, and if there are any problems, tests such as CT, liver biopsy, cholangiography, and gastroscopy are considered.
Living donors are generally hospitalized for about 1 to 2 weeks, and then return to normal life after receiving treatment at home.
After being discharged from the hospital, you will visit the hospital regularly. Recipients need to continue to visit the hospital to take immunosuppressants for the rest of their lives. Living donors also go to the hospital for a while after surgery to check their physical condition.

Five. Liver transplant results

The 5-year survival rate (percentage of those who survive 5 years after transplantation) of those who have undergone liver transplantation is said to be about 70-80% for adults and about 80-90% for children. There is no difference in living-donor liver transplantation. However, the success rate varies depending on the type of disease and conditions before surgery.
Living donor safety is the most important requirement for living-donor liver transplantation. Most of the donors have recovered enough to return to their daily lives, but there have been more than 10 cases of donor death in living-donor liver transplantation worldwide, including one case in Japan.

6. Liver Transplant Benefits

Perhaps the greatest benefit of liver transplantation is that patients who would soon die without a transplant may be able to return to a normal life with this treatment. However, the history of liver transplantation is still short, and it is not yet clear how long this condition can be maintained after transplantation.

About the biliary tract
The bile duct is the path through which the bile produced in the liver flows to the duodenum, and consists of the bile duct and the gallbladder. The bile duct begins as a thin branch in the liver, and many branches join together to finally form a single bile duct that passes through the pancreas and opens into the papilla of the duodenum. The bile ducts are divided into intrahepatic bile ducts, hilar bile ducts, distal bile ducts, gallbladder, and duodenal papilla (Fig. 1). The gallbladder is a pear-shaped organ that temporarily stores bile. Bile is a yellow-brown digestive juice produced by the liver that aids in the digestion of fats.
Figure 1
Diseases of the biliary tract ①Biliary tract cancer

Biliary tract cancer is divided into ``cholangiocarcinoma'' and ``gallbladder cancer'' depending on the site of origin, and cholangiocarcinoma is divided into intrahepatic cholangiocarcinoma, perihilar region cholangiocarcinoma, distal cholangiocarcinoma, and duodenal papilla cancer (hepatic cancer). For intra-cholangiocarcinoma, see Liver disease). Biliary tract cancer is difficult to detect at an early stage because subjective symptoms are difficult to detect, but as the disease progresses, jaundice (yellowing of the skin and the whites of the eyes) appears due to the narrowing of the bile ducts and obstruction of bile flow. Cancer also spreads by invading and metastasizing to the liver, lymph nodes, and other organs.

Besides surgery, there are chemotherapy (anti-cancer drug treatment) and radiotherapy as treatment methods, but surgery is the only treatment that can hope for a cure.

surgery

Surgical methods for biliary tract cancer vary depending on where the cancer occurs and the extent of resection varies depending on the degree of progression. The duration of the operation varies depending on the type of operation, but the short one can take several hours, and the long one can take more than 10 hours.

Hilar cholangiocarcinoma requires liver resection along with the bile duct [Fig.2].
Figure 2
Distal bile duct cancer and duodenal papilla cancer require pancreatoduodenectomy to remove the pancreatic head and duodenum together with the bile duct [Fig.3]
Figure 3
In the case of extensive cholangiocarcinoma extending from the hepatic hilum region to the distal bile duct, combined hepatectomy and pancreaticoduodenectomy should be performed along with the bile duct.

In the case of gallbladder cancer, cholecystectomy is sufficient in the early stages, but if the cancer has progressed and spread to adjacent liver, bile ducts, lymph nodes, etc., the scope of resection will be wider, and not only the gallbladder will be removed. Resection including the liver, bile ducts, and lymph nodes is required [Figure 4].
Figure 4
Pre-surgery preparation
At our hospital, after a thorough evaluation of the condition of the disease in Gastroenterology, we perform surgery aimed at radical resection while maintaining safety (Fig. 5).
Figure 5

If there is jaundice, a procedure called biliary drainage is performed before surgery to remove jaundice because it affects the safety of surgery. The main method is to insert a duct into the bile duct using an endoscope (endoscopic drainage).
When extensive liver resection is necessary, the blood vessel (portal vein) of the resected side of the liver is stuffed with a catheter (portal vein embolization) before surgery to prevent postoperative liver failure, and the left side of the liver becomes enlarged. Surgery may be performed after encouraging regeneration.

Progress after surgery

If the postoperative course goes smoothly, the patient can be discharged from the hospital in about 2 to 3 weeks.
After you leave the hospital, you will have regular visits to the hospital to check for recurrence through blood tests and CT scans. In addition, depending on the condition of the disease, chemotherapy (anticancer drug treatment) may be performed in cooperation with the internal medicine department.

Diseases of the biliary tract ② Cholelithiasis and other benign diseases

The formation of stones in the biliary tract is called cholelithiasis, and the most common is cholecystolithiasis, in which stones form in the gallbladder. It may be asymptomatic and incidentally discovered by abdominal ultrasound or CT, but it may also cause symptoms such as gallstone attack, cholecystitis, or gall bladder stones that flow into the bile ducts and become bile duct stones.
As symptoms, right hypochondral pain and right back pain that occur after eating or at night are relatively common, but they may also be perceived as stomach pain or low back pain, and the location and degree of pain vary. Usually, asymptomatic gallbladder stones do not require surgery, but if symptoms of gallbladder stones (cholelithiasis, cholecystitis, bile duct stones) occur even once, surgery is recommended.
In addition to gallbladder stones, surgery may be considered for gallbladder polyps and adenomyomatosis of the gallbladder. Surgery is recommended when there is a possibility of cancer, such as gallbladder polyps larger than 1 cm.

surgery
For benign diseases such as cholecystolithiasis, the gallbladder is removed by laparoscopic surgery (laparoscopic cholecystectomy) [Figure 6].
Figure 6

Three or four holes are made in the abdomen and a laparoscope or forceps are inserted to remove the gallbladder. Recovery after surgery is faster because the incisions are smaller than in open surgery. However, for patients who have had upper abdominal surgery before or who have severe gallbladder inflammation, laparoscopic surgery may be difficult and open surgery may be performed.

Progress after surgery

Normally, in the case of laparoscopic cholecystectomy, the patient is hospitalized on the day of surgery and discharged the next day (2 days and 1 night). Open surgery requires hospitalization for about a week. In most cases, there are no sequelae after removal of the gallbladder. Digestion of fat may be reduced and diarrhea may occur, but this will subside over time.

1) Pancreas
The pancreas is an organ behind the stomach and in front of the spine that has two main functions.
First, it makes a digestive juice called pancreatic juice and secretes it into the duodenum. Pancreatic juice breaks down carbohydrates, proteins, and lipids, and plays a major role in the digestion and absorption of food.
Second, it secretes hormones such as insulin and glucagon into the blood. These are hormones that regulate the concentration of glucose (blood sugar) in the blood, and it is known that abnormalities in the secretory function of these hormones lead to diabetes. Therefore, diabetes can be exacerbated if the pancreas is removed.
2) Pancreatic disease
Pancreatic cancer (invasive pancreatic ductal carcinoma)

A cancer that originates in the pancreatic duct and spreads to the surrounding area. It is divided into “pancreatic head cancer”, “pancreatic body cancer” and “pancreatic tail cancer” depending on the location. Of these, pancreatic head cancer is in contact with the duodenum and bile duct, and since it is close to the liver, it affects these organs as well.

pancreatic cystic tumor

Large and small bag-like tumors called “cysts” are caused by tumors that develop from the cells that produce mucus in the pancreas.

Intraductal papillary mucinous neoplasm (IPMN) There are various types of adenocarcinoma, from benign adenoma to malignant adenocarcinoma, which gradually changes from benign to malignant. If the size is large or if it grows gradually, it is more likely that it has become malignant.
Pancreatic neuroendocrine tumor (P-NET) A tumor that arises from cells in the pancreas that produce hormones such as insulin. Excessive production of hormones may or may not cause symptoms. It has been increasing in recent years, and there is a risk of malignancy.
Mucin-Producing Pancreatic Tumor (MCN) Mostly seen in women in their 40s and 50s. Although it is not common, it is said that there is a risk of malignancy, and if a diagnosis is made, surgical treatment is required.
Serous cystic neoplasm (SCN) It is a relatively large cystic tumor that occurs more often in middle-aged women. It is a rare condition that is likely benign and malignant, but surgical treatment is recommended when it increases in size.
3) Treatment of pancreatic cancer
Treatment options for pancreatic cancer

Treatment of pancreatic cancer includes surgery, nonsurgical treatments, and supportive care.

surgery Part or all of the pancreas is removed. In addition, depending on the condition, nearby organs such as the stomach, biliary tract, duodenum, spleen, and lymph nodes may also be removed. Pancreaticoduodenectomy / Body and Tail Pancreatic Resection / Total Pancreatectomy / Other Surgery / Palliative Surgery (Bypass Surgery)
Treatment other than surgery There are mainly chemotherapy with anticancer drugs and radiotherapy. Chemotherapy/chemoradiotherapy/radiotherapy/other antitumor therapies
supportive care It is a treatment that supplements the original treatment. For pancreatic cancer, there are preoperative treatment for jaundice, postoperative treatment for complications, and treatment for relieving cancer symptoms. Biliary drainage / duodenal stent / treatment of complications and side effects / palliative therapy / counseling
Classification of pancreatic cancer

Pancreatic cancer is divided into three categories, resectable pancreatic cancer, borderline resectable pancreatic cancer, and unresectable pancreatic cancer, based on whether or not surgery (radical resection) can be performed for pancreatic cancer.

resectable pancreatic cancer Cancer has not spread to other organs or invaded blood vessels around the pancreas
Borderline Pancreatic Cancer Cancer that has invaded the blood vessels around the pancreas but is resectable, or cancer that has shrunk with chemotherapy and may be resectable
unresectable pancreatic cancer Cancer that has spread throughout the body and has metastasized to other organs, or has extensively invaded blood vessels around the pancreas

Pancreatic cancer may be completely cured by complete removal of cancer cells (= radical resection) by surgical resection. Therefore, whether or not resection is possible is an important point in treatment selection.

If the cancer has metastasized to organs far from the pancreas, lymph nodes, or the peritoneum, or if it has invaded large blood vessels adjacent to the pancreas, complete resection becomes impossible, and chemotherapy or radiotherapy is selected. I will go.

According to the latest guidelines, preoperative chemotherapy increases the possibility of a radical cure, so it is recommended that anticancer drugs be aggressively administered before surgery even for resectable pancreatic cancer. In the case of borderline pancreatic cancer, anticancer drug therapy or radiation therapy may be performed before surgery to shrink the cancer that has invaded the blood vessels around the pancreas and make it resectable.

Surgery for pancreatic cancer

The extent of resection in pancreatic cancer surgery varies depending on where the cancer occurs and how advanced it is.

① Pancreaticoduodenectomy

This is a surgical procedure performed for cancer that occurs in the pancreatic head. The pancreatic head, duodenum, lower bile duct, gallbladder, and surrounding lymph nodes are all removed.
If the cancer has infiltrated strongly around, the portal vein, which is an important blood vessel, can be partially resected and reconstructed (=portal vein joint resection), or the nerve plexus around the superior mesenteric artery can be resected. Enlargement surgery is performed.
In this surgery, reconstructive surgery is performed on the gastrointestinal tract, which connects the pancreas, biliary tract, and stomach to the jejunum, recreating routes for pancreatic juice, bile, and food to flow.

② Body and tail pancreatic resection

This is a surgical procedure performed for cancer that has occurred in the body or tail of the pancreas. Leaving the head of the pancreas, the body and tail of the pancreas are excised together with the spleen and surrounding lymph nodes. The reason for removing the spleen is that the blood vessels related to the spleen are located on the dorsal side of the body and tail of the pancreas, and there is a high possibility that metastasis has occurred there. This surgery does not require reconstruction of the gastrointestinal tract.

<Laparoscopic pancreatic body and tail resection>

Pancreatic mucinous cystic tumors tend to occur in relatively young women, and at our hospital, we actively perform laparoscopic surgery and robot-assisted surgery for benign or borderline malignant disease as minimally invasive surgery with a small surgical wound. I'm here. Since the scar is small, it has excellent cosmesis, and by reducing the burden on the body, it leads to early recovery after surgery. In addition, for some pancreatic cancers, laparoscopic surgery and robot-assisted surgery are performed by selecting cases while considering the progression of the cancer.

③ Other surgical procedures

When pancreatic cancer or IPMN exist in the wide range of the pancreas, we may resect the whole pancreas (= total pancreatectomy). In this case, insulin cannot be secreted at all, so it is essential to self-inject insulin after surgery.

When cancer cannot be resected because it has spread to other organs or infiltrated the surrounding area, and when the bile duct or duodenum is blocked by cancer, surgery to create a passageway to send bile and food to the small intestine (= bypass surgery). Recently, medical devices such as biliary stents and duodenal stents have been developed, and there are many cases of treatment without surgery.

About preoperative chemotherapy

Preoperative treatment for pancreatic cancer has become standard, and we perform preoperative chemotherapy for resectable pancreatic cancer and resectable borderline pancreatic cancer. The advantage of preoperative chemotherapy is that the rate of radical resection can be improved when the tumor becomes smaller, and the sensitivity to chemotherapy can be determined.

About adjuvant therapy

After surgery, if the cancer is diagnosed as stage I or higher, there is a possibility of recurrence, and adjuvant chemotherapy with anticancer agents is recommended. This can be expected to prevent cancer recurrence and prolong the time until recurrence.

Complications early after surgery

Complications that can occur relatively early after surgery include:

① pancreatic juice leakage

Complications specific to pancreatic surgery. Pancreatic juice containing digestive enzymes secreted from the pancreas leaks into the abdomen from the part where the pancreas and the small intestine are connected in "pancreatoduodenectomy" and the stump of the pancreas in "body and tail pancreatic resection". That's it. Pancreatic juice has the function of dissolving food, but in the stomach and intestines, the mucous membrane protects it, so it does not dissolve your own tissue. However, when the pancreatic juice leaks into the abdomen, it dissolves as if it were digesting the surrounding tissue, and peritonitis may occur at the same time. Bleeding may occur if the blood vessel is ruptured. Pancreatic juice leaks Even if pancreatic juice leaks, if you can guide the pancreatic juice to go out without accumulating in the abdominal cavity (= drainage), in most cases, the pancreatic juice will heal naturally. Depending on the degree of pancreatic juice leakage, long-term treatment may be required from 2 weeks to 1 month for healing.

② Bleeding

There are many arteries and veins around the pancreas, and bleeding may occur from the surgically manipulated site after surgery. Bleeding may also occur as a complication of pancreatic leakage. It can be treated with blood transfusion, but arterial bleeding due to pancreatic juice leakage is stopped by intravascular catheterization.

③ Suture failure

In the case of pancreatoduodenectomy, in addition to the pancreas and small intestine, it is necessary to connect the bile duct to the small intestine, and the stomach to the small intestine. In this case, drainage is performed in the same way as pancreatic juice leakage and treated.

④ Infection

Depending on the site and degree, such as wound infection and intraabdominal abscess, treatment and antibiotic therapy are performed.

⑤ Others

Deep vein thrombosis, pulmonary embolism, chylous ascites, heart/pulmonary/cerebrovascular complications, etc.

After-effects after pancreatic resection

After resection of the pancreas, various long-term sequelae may occur.

(1) Decreased food intake, malnutrition, dumping syndrome, weight loss, etc.

It is expected to improve after a certain period of time after surgery.

② Exacerbation of diabetes

Even if you do not have diabetes to begin with, pancreatic resection may reduce insulin secretion and lead to diabetes, which may require oral treatment such as self-injection of insulin. Patients with pre-existing diabetes may also experience poor postoperative diabetes control. In such cases, treatment will be provided in cooperation with the Department of Diabetes/ Endocrinology at our hospital.

③ Diarrhea

When the pancreas is removed, the secretion of pancreatic juice, which is a digestive juice, is reduced, so digestion of fat may not go well and diarrhea may occur easily, which may result in fatty liver. It is treated by oral administration of digestive enzymes as a substitute for pancreatic juice.

In addition, it is known that excision of the nerve plexus around the superior mesenteric artery for resection of pancreatic cancer causes postprandial diarrhea. It depends on the progress of the cancer, but we prevent it by performing surgery that preserves the nerve plexus as much as possible, but there is a possibility that some symptoms will occur.

4) Course from admission to discharge

You will usually be admitted to the hospital the day before your surgery. You can drink water and tea, including rehabilitation to move your body from the first day after surgery. On the 5th day after the operation, a CT imaging test will be performed. If there are no particular problems, eating will begin. . If there are no complications, patients are often discharged from the hospital 2 to 3 weeks after surgery, but if complications such as pancreatic juice leakage occur, the hospitalization period will be extended.

An important point for life after surgery is to actively move your body. Practicing standing and walking will help you recover better, and sleeping too long not only weakens your muscles but also increases the risk of complications.

The 2-3 days after surgery are the most painful times. Immediately before the operation, you will be given painkillers through a tube inserted through your back to relieve pain. Rehabilitation while relieving pain, such as regular pain relief drips, will lead to a good postoperative course.

5) Outpatient visits

Depending on the degree of progression, postoperative chemotherapy is recommended to prevent recurrence, and treatment is performed on an outpatient basis in cooperation with Gastroenterology and Oncology. Outpatient visits are usually required for 5 years after surgery, and regular blood tests and CT imaging (or abdominal ultrasound, MRI, or PET scan) are done to evaluate for recurrence.

1) What is an inguinal hernia?

An inguinal hernia is a swelling at the base of the foot.

An inguinal hernia is a swelling at the base of the foot. A disease in which the muscle wall at the base of the thigh (groin) weakens and a hole opens, through which the intestines and fat in the abdomen are wrapped in a membrane called the peritoneum and protrude like a bag. That's what I mean. The term “hernia” refers to a protruding condition. Since the intestine often comes out, it is also commonly called "Daccho".

2) Causes and symptoms of inguinal hernia

Inguinal hernia, also known as a childhood disease, has slightly different causes in children and adults. In children, it is congenital, but in adults, it is thought that it often occurs due to the weakening of body tissues with age. In addition to age, the burden on the wall of the stomach, such as carrying heavy objects and standing for long periods of time, accumulates on the wall of the stomach, and the muscle wall that supports it becomes partially weakened and gradually becomes like a hole. Intestines and fat come out from there. Depending on where it comes out, it is called an inguinal hernia (groin) or femoral hernia (lower thigh).

This is a surgical procedure performed for cancer that has occurred in the body or tail of the pancreas. Leaving the head of the pancreas, the body and tail of the pancreas are excised together with the spleen and surrounding lymph nodes. The reason for removing the spleen is that the blood vessels related to the spleen are located on the dorsal side of the body and tail of the pancreas, and there is a high possibility that metastasis has occurred there. This surgery does not require reconstruction of the gastrointestinal tract.
3) Inguinal hernia surgery

Surgery is required to fix a hernia. It cannot be cured with medicine. There is also a belt called a hernia band (hernia band) that holds down the hernia, but it is not a fundamental treatment.

Surgery uses an artificial stiffener (mesh) to close the hernia hole and strengthen the weakened abdominal wall. There are various methods of detailed surgery, but in our hospital, we generally perform surgery in two ways. You can choose either an incision in the groin or a laparoscopic method. Whether to use the groin incision method or laparoscopic surgery depends on the patient's physical condition.

In the groin incision method, surgery is usually performed under spinal anesthesia (half anesthesia). In some cases, it may be performed under general anesthesia or local anesthesia. A 5 cm incision is made in the groin (depending on the thickness of the abdomen), and the fat and muscle are separated to expose the hernia bag and hole. (Mesh plug method, Liechtenstein method, Kugel method, etc.).

Laparoscopic surgery is performed under general anesthesia. A hole of about 1 cm is made in the navel and 3 places on both sides, and a tube called a port is passed through it, and carbon dioxide gas is injected to expand the stomach. A camera is inserted to observe the hernia hole from inside the stomach, the peritoneum around the hernia is peeled off, the mesh is spread to cover the hernia hole, fixed with a dissolvable pin, and finally the peeled peritoneum is placed over the peritoneum. suture.

The operation time is 1 hour to 1.5 hours for the inguinal incision method and 1.5 hours to 2 hours for the laparoscopic surgery. Add time for anesthesia. People with large hernias, those who have had hernias for many years, those who are obese, those who have recurrent hernias, and those with hernias on both sides will take longer.

Hospitalization period and postoperative course

In the case of inguinal hernia surgery, you will come directly to the operating room on the morning of the surgery, and after a pre-operative examination by the doctor in charge, you will enter the operating room. After surgery, you will be admitted to the ward.

If you have pain in the wound after surgery, we have prepared painkillers to take, so please do not hold back. Over time, the pain will gradually get better. The part of the hernia that was originally swollen may swell for a while, but the swelling will gradually subside over time.

If things go smoothly, you can leave the hospital the day after the surgery (hospitalization for 2 days and 1 night). After you leave the hospital, you will be asked to visit the outpatient clinic once (1-2 weeks later) for a check-up. The wound is sewn with dissolvable sutures, so there is no need to remove the sutures.

For about 2 to 3 weeks after discharge, please refrain from activities that put a lot of force on your stomach, such as strenuous sports or carrying heavy objects. Depending on the condition of the hernia at the time of surgery, you can return to your normal life in about 1-2 months.

4) Surgical complications

Complications are problems that can occur as a result of surgery. We are always careful not to cause complications during surgery, but unfortunately we cannot eliminate complications. Please understand that there is a small but certain probability of complications in any surgery. The main complications that can occur with inguinal hernia surgery are listed below.

① Postoperative bleeding

The surgery is completed after confirming that there is no bleeding, but sometimes postoperative bleeding or hematoma may occur in the wound. In rare cases, blood transfusion or reoperation for hemostasis may be required.

② Infection

Surgical wounds can become infected and suppurate. In this case, the wound may open, drain pus, and need cleaning. Also, if the mesh becomes infected, the infection may not subside unless the mesh is removed by reoperation.

③ Water accumulates

After surgery, the original hernia space may fill with water and swell as if it were a hernia. It is called a serous seed, but in most cases it will gradually disappear over time. If it doesn't go away easily, you may need to pierce it with a needle to drain the water.

④ Postoperative pain

There will be pain from the wound for a while after the operation, but it will gradually ease over time. Although rare, chronic pain and numbness may remain.

⑤ Hernia recurrence

The hernia may come from a different place than the one reinforced with the mesh, resulting in a similar inguinal hernia condition as before. It is said that recurrence occurs in about a few percent, although reports vary somewhat. Surgery is usually required for treatment. In some cases, the hernia may appear on the side opposite to the one that was operated on.

⑥ Allergies

Some people are allergic to the antibiotics and anesthetics used during surgery. If you are known to be allergic to certain drugs, please consult your doctor beforehand.

⑦Others

麻酔の合併症、静脈血栓塞栓症、心臓や肺の合併症など他にも起こりうる合併症はありおますが、このような合併症が発生した場合には、最善と思われる処置を迅速に講じます。

(Note) With permission from Medicon Co., Ltd., the figures are excerpts from the company's website and explanatory documents for patients.

Our Emergency and Critical Care Center accepts patients of various ages and people with diseases as much as possible and provides emergency medical care. In order to be able to respond immediately to emergency abdominal diseases that require emergency surgery, we have a system in which a full-time surgeon is always on duty every day, including holidays. In addition, we also perform laparoscopic surgery to reduce the burden on patients as much as possible while considering safety and urgency in emergency surgery for emergency diseases.
1) About the system of emergency medical treatment in our department

Our hospital has the philosophy of "providing highly advanced medical care and emergency medical care", and while treating patients of various ages and diseases on a daily basis, at the same time, we accept as many emergency patients as possible, so that citizens can always feel safe. We aim to provide the best medical care possible. In accordance with this philosophy, our department focuses not only on highly advanced medical care for each organ disease listed above, but also on enhancing emergency medical care.

The emergency department of our hospital accepts about 36,000 patients a year, many of whom have acute abdominal diseases, and depending on the severity of their symptoms and condition, special treatment is required. Medical examination, emergency surgery, and semi-emergency surgery (surgery to be performed early after symptoms have stabilized) are necessary. In preparation for such cases, our department always has at least two full-time surgeons on duty and one on standby, and has a system that allows emergency surgery to be performed as quickly as possible 24 hours a day, 365 days a year.

Our department performs an average of 1,300 to 1,400 operations per year, of which approximately 30% (300 to 400) are emergency operations. In addition, even in an environment where surgeries are restricted due to corona measures, the proportion of emergency surgeries has not changed, and we continue to strive to fulfill our responsibilities. We also aim to minimize the burden on patients during emergency surgery, and actively perform highly advanced medical care with minimally invasive procedures such as laparoscopic surgery.

2) Role of our department for emergency abdominal care in an aging society

Currently, Japan is one of the countries facing an unprecedented aging society. For this reason, the percentage of elderly people among patients who visit emergency departments is increasing year by year. In general, the characteristics of the elderly are as follows: 1) The pathology is not simple (complex) because there are many underlying diseases (pre-existing diseases) and a wide range of diseases, 2) Symptoms are vague and difficult to understand, 3) Consciousness disturbance and heart failure These points also apply to elderly patients presenting to the emergency department, such as the tendency to have comorbid symptoms. Furthermore, due to the nature of our hospital, which has focused on emergency medical care for many years under the philosophy mentioned above, there are many regular patients with various acute diseases such as heart failure and stroke, which correspond to 3). is also one of the characteristics of our school.

Therefore, among the patients who come to us with acute abdominal diseases, there are cases where consciousness disturbance and cardiac (circulatory) failure are lurking, and conversely, there are cases where various pathological conditions are complicatedly entwined. There are more than a few cases of acute abdominal disease triggered by a decrease in blood pressure. In addition, there are cases in which “cancer” is discovered for the first time while treating such patients. In emergency medical care for such complicated medical conditions, highly specialized medical care and judgment are required quickly, such as "What is the essential cause of the medical condition?" and "Which treatment should be prioritized?" Our department strives to provide prompt and appropriate life-saving treatment to such patients in cooperation with emergency departments and specialists in each department. In addition, in order to increase the survival rate of elderly patients whose general condition has deteriorated, we have introduced laparoscopic surgery, which minimizes the physical burden on the patient, even when emergency surgery is performed. We provide advanced and minimally invasive treatments.

3) Major abdominal emergency diseases

Examples of abdominal emergencies that require emergency surgery include:

acute cholecystitis

It is a disease in which the gallbladder is acutely inflamed due to gallstones. If the inflammation is severe, the gallbladder may become necrotic or perforated (rotten or torn), allowing bacteria to spread throughout the body, which can sometimes be life-threatening. Symptoms include fever and pain in the pit of the stomach, and some people complain of fatigue and loss of appetite.
It is treated with antibiotics, or a tube is inserted through the skin into the gallbladder to drain the pus out of the body. When it is determined that emergency surgery is necessary, laparoscopic surgery is performed if possible, and the rate of laparoscopic surgery in 2019/2020 was 89%.

Acute appendicitis

This disease is commonly referred to as "Mocho's inflammation". Medically, it refers to a condition in which the thin tail-like part of the appendix attached to the cecum becomes inflamed. Pus may accumulate in the appendix, and in severe cases, it may rupture and the pus may spread throughout the abdomen, leading to peritonitis of the entire abdomen. In some cases, the initial symptoms are pain in the pit of the stomach and around the navel, which may be diagnosed as gastroenteritis, but as the disease progresses, fever and pain in the lower right abdomen are seen.
If the degree of inflammation is mild, it can be cured with antibiotics, but there are cases where it repeats after that. In some cases, repeated appendicitis makes surgery difficult, and we recommend emergency surgery if it is considered safer and more reliably treatable at the time of the visit. Laparoscopic surgery is basically performed instead of open surgery, and in recent years 2016-2020, almost 100% of surgeries are performed by laparoscopic surgery.

*Recently, with the aim of reducing postoperative complications, even in cases of severe appendicitis, antibiotics and treatment to drain pus are used to calm the inflammation and avoid emergency surgery. We also perform laparoscopic surgery again.

bowel obstruction

It is a disease in which the intestine becomes blocked. Symptoms include bloating, abdominal pain, nausea and vomiting. In many cases, during the wound healing process after abdominal surgery, a phenomenon called "adhesion" occurs, in which the intestine and the surgical wound stick together, or the intestines stick to each other, resulting in accidental twisting or bending of the intestines. is the cause. In the early stages, treatment begins with fasting and intravenous drips. Sometimes it is treated by inserting a tube through the nose to expel food and digestive juices from the intestine.
If there is no improvement with the above treatments, or if the torsion is so strong that the blood circulation is poor and the intestine itself rots, an emergency operation is performed. In recent years, laparoscopic surgery has been adopted for such pathological conditions if it is possible.

*Intestinal obstruction may occur due to colorectal cancer, and treatment may be performed jointly with Gastroenterology.

Gastrointestinal perforation

Peritonitis is a disease in which food and feces spread through the stomach and intestines. It is accompanied by quite severe abdominal pain, and sometimes circulatory failure (shock) may occur. Most of them require emergency surgery, but the treatment method and progress vary greatly depending on the location of the hole.

If there is a hole in the stomach or duodenum caused by an ulcer, it is often a relatively mild condition that can be treated without surgery or can be improved simply by suturing the torn part.

On the other hand, if the large intestine is ruptured, it is easy to fall into bacteremia, which spreads bacteria throughout the body from peritonitis caused by stool, or septicemia, which weakens the whole body. For this reason, an artificial anus may be created in an emergency operation, the deterioration of the general condition may be prolonged, requiring treatment in an intensive care unit, and in the worst case, unfortunately, life may not be saved.

*Cancer can also cause a hole in the intestine.

Intra-abdominal organ injury due to trauma

In our hospital, patients with trauma due to accidents are also brought in by ambulance. In particular, severe cases are treated in cooperation with various medical departments centering on the emergency department. In terms of treatment, we do our best to save lives by combining not only surgery but also treatment (by doctor) in which a tube called a catheter is inserted into the blood vessel to clog the blood vessel and stop the bleeding.

Other diseases

In addition to the above, there are various abdominal emergencies such as incarcerated inguinal hernia (see the explanation of inguinal hernia for details) and colonic diverticulitis. Not only the disease but also the patient's age and general condition are different, so for each patient, we explained the disease, the appropriate treatment for it, possible complications, etc. and had them understand. Above all, I try to provide tailor-made treatment.

On Robot-Assisted (Da Vinci) Surgery in Surgery

As a Robotic Surgery Center, all departments work together to actively perform surgery. For more information on robot-assisted surgery, please visit the Robotic Surgery Center website.
Robotic Surgery Center
Robot-assisted (da Vinci) surgery in surgery

At our hospital, gastric cancer was covered by insurance from June 2018, and esophageal cancer and rectal cancer from October 2018. Recently, it has also been introduced for normal colorectal cancer, pancreatic cancer, and liver cancer, and the indications and cases are increasing year by year.

As of May 2023, our department has 5 robot-assisted surgery proctors certified by the Japan Endoscopic Surgery Society (1 esophagus, 1 stomach, 2 rectum, 1 pancreas). . This is to certify proctors who have acquired standard skills as operators of robot-assisted endoscopic surgery and who can guide others in robot-assisted surgery smoothly and safely. is the required qualification.

We not only aim for a complete cure of cancer, but also provide patients with a better life after surgery. We also actively perform surgery that emphasizes postoperative QOL (quality of life) in order to take advantage of the characteristics of robotic surgery, such as rectal surgery that preserves function.

If you have any questions related to da Vinci surgery for each organ or disease, please feel free to contact the outpatient surgery department. We have specialists such as proctors for each organ, so we will respond appropriately.

As of May 2023, nearly 350 patients have already undergone da Vinci surgery in surgery.

As of May 2023

stomach cancer

about 130 cases

rectal cancer

about 120 cases

enteral cancer

about 10 cases

Esophageal cancer

about 80 cases

pancreatic cancer

about 15 cases

About inguinal hernia treatment unique to our hospital

About the treatment at our hospital for pain after inguinal hernia surgery

What is chronic pain after inguinal hernia surgery?

In recent years, ``inguinal hernia postoperative chronic pain (CPIP)'' has become known as one of the postoperative complications of inguinal hernia surgery. I'm here.

Generally, the pain after inguinal hernia surgery peaks within 1 to 2 weeks after surgery and gradually improves. In some cases, the pain may continue for one to two weeks, but in most cases, the pain can be controlled by taking analgesics, and the pain will reduce over time and eventually disappear. To do. However, the pain may not subside even three months after inguinal hernia surgery, and the pain may interfere with daily life. This condition is diagnosed as `` chronic pain after inguinal hernia surgery'' (CPIP). Pain in the thighs and testicles that was not present before inguinal hernia surgery, as well as pain during sexual intercourse, are considered to be a type of CPIP.

Frequency of chronic pain after inguinal hernia surgery

CPIP is a disease that has been reported mainly in Europe and America since around 2000, and many research reports have been published since then. The frequency varies depending on the degree of pain, but according to a report published in Sweden in 2018, a questionnaire survey of 22,917 patients who underwent inguinal hernia surgery found that 15% after anterior incision, 18% after laparoscopic surgery patients, Pain that interferes with daily life even one year after surgery There was (Br J Surg 2018; 105: 106–112). In addition, a study conducted by 577 facilities in Germany, Austria, and Switzerland, also reported in 2018, found that Laparoscopic hernia radical surgery Of the 20,040 patients who underwent 9.5% 1,900 people Pain during exercise 1 year after surgery had. Also, Patients who require treatment 520 people, total 2.6% (Surg Endosc. 2018;32:1971-1983). Once patients suffer from CPIP, they become exhausted due to the mental stress caused by the pain, and are unable to carry out their daily lives. Against this background, CPIP is widely recognized overseas, not only by medical professionals but also by patients undergoing surgery, as the most unpleasant postoperative complication of inguinal hernia surgery.
On the other hand, it has been reported that the incidence of this disease is lower in Japan than in other countries, but the exact frequency is currently under investigation. In any case, it is a disease that is still relatively unfamiliar to medical professionals in Japan.

Causes and types of chronic pain after inguinal hernia surgery

Currently, the standard surgical method for inguinal hernia surgery is radical surgery using mesh, so most patients who develop CPIP are patients who have undergone surgery using mesh. On the other hand, there are some patients who underwent surgery without mesh insertion and developed CPIP. Additionally, laparoscopic surgery has been reported to have less postoperative pain and a lower incidence of CPIP, but as mentioned above, some patients develop CPIP after laparoscopic surgery. In other words, it is important to be aware that CPIP is a postoperative complication that can occur with any surgical technique.
There are three types of CPIP pain. 1) neuropathic pain, 2) somatic pain, and 3) testicular pain.

Neuropathic pain

There are three pain-sensing nerves running in the groin and two in the pelvic cavity. The hardening of tissue due to wound healing after surgery is called scarring, and the pain that occurs when these nerves become involved during the scarring process is called neuropathic pain. It is also known that the mesh used in hernia surgery shrinks over time. This neuropathic pain can also occur when nerves are pulled into the compressed mesh, causing compression or pulling of the nerves. Neuropathic pain is the cause of many cases of CPIP that do not respond to treatment with drugs or injections.

②Somatic pain

On the other hand, the inserted mesh may contract surrounding tissues, especially muscles, which may interfere with the flexible movement of the groin and pelvis, causing discomfort or pain, or the mesh may twist or twist within the pelvis. This can cause the area to become like a hard lump, which may cause discomfort and pain. This kind of pain is called somatic pain. Although not many patients develop pain that becomes a problem in daily life, once CPIP develops, outpatient treatment becomes difficult.

③Testicle pain

The mesh is placed right next to the vas deferens, where sperm are transported. When the mesh adheres to the vas deferens, the mesh compresses or strains the nerves that run alongside the vas deferens, causing testicular pain. The mesh may sink into the vas deferens itself and erode, causing testicular pain. Outpatient treatment is also extremely difficult in these cases.

Diagnosis and treatment of chronic pain after inguinal hernia surgery, and its results

"Pain" is not something that can be seen by a third party, nor can it be evaluated by blood tests or X-rays. As a result, many patients are troubled by the fact that their condition is often not understood by those around them. Not understanding their pain and not receiving appropriate treatment leads to cumulative mental stress and some people develop depression. In order to provide effective treatment for CPIP, it is most important to know exactly what is causing the pain, and it is important to diagnose the ``type of pain'' mentioned earlier.

There is no established treatment method for CPIP, and there are no specific descriptions of treatment in any domestic or international guidelines. Therefore, treatment of CPIP is extremely difficult.
At our hospital, we actively treat patients suffering from "chronic pain after inguinal hernia surgery." It is necessary to diagnose the type and degree of pain through step-by-step examinations and treatment, so you may need to visit the hospital many times. Please refer to the treatment algorithm for chronic pain after inguinal hernia surgery created by our department.

Diagnosed with chronic pain after inguinal hernia surgery as of October 2023 83 people Patients were treated according to this algorithm. Patients who were able to be treated without surgery 29 people However, 54 patients required surgery. In other words, while it is possible to alleviate pain with treatment using algorithms for refractory CPIP, it is also true that there are many patients who require surgery.
Surgical treatment for CPIP is different from general surgery and has not been established. Therefore, the surgical method is carefully considered, taking into account the patient's symptoms, the details of the previous surgery, and the site where the mesh will be placed.
Generally, surgery involves a certain degree of risk, and sometimes fatal complications such as bleeding, myocardial infarction, cerebral infarction, and pulmonary embolism may occur. In addition, CPIP surgery requires removing the mesh and, in the case of neuropathic pain, identifying and removing the causative nerve, making it an extremely difficult surgery. Furthermore, regarding CPIP surgery, Risks resulting from surgery' should also be considered. in particular," Even with surgery, the pain may not be relieved as expected."" Possibility of experiencing new pain that was not present before surgery"" Possibility of inguinal hernia recurrence” and so on. Therefore, we do not perform simple surgeries. We make decisions only after careful consideration of suitability and after taking time to consult with patients and their families.
As a result of a questionnaire survey conducted on patients who underwent surgery, 90 and above of patients said “very or generally satisfied”, but to put it the other way around, Not 100% of patients are satisfied.Therefore, we perform surgery with the full understanding that ``surgery does not necessarily relieve pain.''

If you continue to experience pain 3-6 months after inguinal hernia surgery, please contact us.
If you have any questions regarding this condition, please contact the "Hernia Outpatient Clinic" every Thursday afternoon.

In inguinal hernia surgery (surgery for prolapse), artificial reinforcing material (called mesh) made of polypropylene or polyester is commonly used, and guidelines recommend the use of mesh. Before 1990-2000, when there was no mesh, hernias were healed by suturing the patient's own tissue, but because the recurrence rate was as high as 10-35%, the use of mesh, an artificial reinforcing material, was recommended. There is a historical background that led to this.

However, is it really a good idea to insert a mesh, which is a foreign object that will never go away, into the body to treat a benign disease called a hernia?

In recent years, groin pain after hernia surgery using mesh (chronic (mansei) pain (Toutu)・Pain during sexual intercourse has been widely discussed in the media and on social networks. A detailed analysis by a specialized department has shown that there is no difference in the rate of chronic pain whether a mesh is inserted or not.Import (hot water) Vas deferens (Seikan)) have been reported to have a negative effect on In a report published in 2018, a questionnaire survey of 22,917 patients who underwent inguinal hernia surgery in Sweden found that 15% of patients underwent anterior incisional surgery using mesh, while 15% of patients underwent laparoscopic surgery. After surgery, 18% of patients report that they still have pain that interferes with their daily life even one year after surgery (Br J Surg 2018; 105: 106–112). Against this background, BBC News, the British national broadcaster, has featured on hernia mesh complications, especially chronic pain, on three separate occasions. https://www.bbc.co.uk/search?q=Hernia+mesh&seqId=df20bf20-56a2-11ee-a0ab-558b52201976&d=SEARCH_PS), overseas Surgery without mesh It is also true that this is being gradually reconsidered.

At our hospital, we have treated many patients who developed chronic pain after hernia surgery using mesh. There are many patients for whom treatment with drugs or injections is ineffective, and the mesh has to be removed surgically.
It has been about 20 years since mesh was actually used, but no one knows how the inserted mesh will affect the human body over the years. The raw materials that make up the mesh are also unknown. There are also reports that the mesh erodes into internal organs (vas deferens, bladder, and intestinal tract) over time (Ann Surg. 2018;267:569-575.). Among the patients who have undergone surgery for chronic pain at our hospital, many have had the mesh removed because of pain more than 10 years after the mesh was inserted.
At our hospital, we also perform inguinal hernia surgery using mesh in accordance with the guidelines. Surgery without mesh We also perform tissue repair methods (called tissue repair methods), which patients can choose from. There are various methods for tissue repair, but the one we use at our hospital is Shouldice method This method has a low incidence of postoperative recurrence and chronic pain, and is the most excellent surgical method among tissue repair methods. The recurrence rate after the Shouldice method is reported to be 1.15% by Shouldice Clinic, the birthplace of the Shouldice method, and if the surgery is performed according to the original method, the results can be equal to or far superior to surgery using mesh. Masu. At our hospital, we have introduced a critical path for all patients who undergo inguinal hernia surgery, and the hospital stay for surgery that does not use mesh is 2 nights and 3 days. Movement restrictions are exactly the same as laparoscopic surgery and mesh surgery.

On the other hand, the Shouldice method is a complicated surgery that is difficult to reproduce, so there are no facilities in Japan that use it.
Narita, doctor at our hospital, visited Shouldice Hospital in Ontario, Canada, the birthplace of the Shouldice method, and participated in 15 surgeries over three days, giving detailed instructions to staff surgeons on surgical techniques. I had it done. Since then, we have carefully performed tissue repair using the Shouldice method in consultation with the patient. The tissue repair method using the Shouldice method is already approved by insurance medical treatment, so there is no problem in actually performing it. Please note that patients who have undergone radical surgery for prostate cancer or patients with a femoral hernia cannot undergo this surgery. Surgery for recurrence of inguinal hernia may also not be indicated.

If you are undergoing inguinal hernia surgery and wish to have the surgery done without mesh, please contact our outpatient surgery department.
If you have any questions regarding this condition, please contact the "Hernia Outpatient Clinic" every Thursday afternoon.

clinical research

Our department conducts clinical research to solve various clinical questions. Observational studies are conducted without direct consent and with this revelation. In addition, intervention studies and observational studies that have been reviewed and approved by the hospital's clinical research ethics committee are conducted after obtaining the individual patient's consent.

In addition, in our department, we actively report the knowledge obtained through these activities in domestic and international conference presentations and papers.

Major clinical studies (including observational and intervention studies)

Research subject name Person in charge of our hospital Explanatory text
(PDF)
Nationwide survey on the pathology, treatment, and prognosis of obturator hernia Masahiro Narita PDF
Accuracy and problems of preoperative diagnosis in cases of gallbladder cancer and suspected gallbladder cancer at our hospital Hiroshi Toriguchi PDF
Multi-institutional retrospective cohort study of incidental gallbladder cancer Masahiro Narita PDF
Significance of minimally invasive surgery in gastric cancer conversion surgery Shotaro Matsuda PDF
Reexamination of treatment results after introduction of new chemotherapy in Conversion Surgery for unresectable locally advanced pancreatic cancer Hiroshi Toriguchi PDF
Robot-assisted inferior caudal pancreatectomy at our hospital: innovations and changes from introduction to present Hiroshi Toriguchi PDF
Current status and problems of surgical treatment of hepatocellular carcinoma for elderly patients aged 80 years or older at our hospital Hiroshi Toriguchi PDF
Experience using surgical staple line reinforcement in bulk treatment of Gleason's sheath during laparoscopic liver resection Hiroshi Toriguchi PDF
Examination of surgical treatment results for colorectal cancer at Kyoto University surgery-related facilities Yuki Hashida PDF
Current status and challenges of treatment outcomes for resectable colorectal cancer liver metastases at our hospital Hiroshi Toriguchi PDF
Examination of recurrence and prognosis after liver transplantation for non-alcoholic steatohepatitis (NASHNASH) liver cirrhosis Kenji Uryuhara PDF
Clinicopathological features of cholangiocarcinoma and their clinical significance Yoshifumi Kitamura PDF
Is highly difficult laparoscopic liver resection at our hospital beneficial to patients? Hiroshi Toriguchi PDF
Introduction and short-term results of robot-assisted colectomy in a community hospital Yuki Hashida PDF
Verification of the usefulness of cross-institutional laparoscopic inguinal hernia radical surgical guidance for young surgeons Tatsuya Koyama PDF
A study of malignant neoplastic lesions of the appendix in our hospital Shotaro Matsuda PDF
An attempt to eliminate suture failure in rectal DST anastomosis Yuki Hashida PDF
Treatment results for colorectal neuroendocrine tumors Yuki Hashida PDF
Examination of appendiceal malignancy from the perspective of TNM classification Yuki Hashida PDF
Introduction of robot-assisted rectal surgery in local hospitals and training of surgeons based on short-term results Yuki Hashida PDF
Current status and problems of laparoscopic surgery for gallbladder cancer in our hospital Hiroshi Toriguchi PDF
A comparative study to clarify the pros and cons of resection for peritoneal wash cytology-positive pancreatic cancer Yoshifumi Kitamura PDF
Current status and results of preoperative chemotherapy for resectable pancreatic cancer in our hospital Yasuki Kihara PDF
Efforts to prevent suturing failure by intracavitary reinforcing sutures in DST reconstruction after rectal resection Yuki Hashida PDF
Ingenuity of robot-assisted lower esophageal surgery aiming for zero recurrent laryngeal nerve paralysis Hiroyuki Kobayashi PDF
Constructing a multicenter database of endoscopic surgery Yuki Hashida PDF
Preoperative evaluation ensuring curability and safety in bismuth type III/IV cholangiocarcinoma surgery Yoshifumi Kitamura PDF
Did robot-assisted surgery reduce postoperative complications in esophageal cancer? Hiroyuki Kobayashi PDF
Results of intracavitary anastomosis in laparoscopic colectomy at our hospital Yuuya Kaneda PDF
A single-arm confirmatory trial of less-intensive surveillance for recurrent low-risk colorectal cancer Yuki Hashida  
Clinical performance of TNT for rectal cancer in a single institution Yuki Hashida PDF
Ingenuity of surgical method selection and perioperative management for elderly gastric cancer Masato Kondo PDF
Efficacy and tolerability of postoperative adjuvant chemotherapy for colorectal cancer in the elderly Yuki Hashida PDF
A retrospective exploratory pooled analysis of the efficacy of postoperative adjuvant chemotherapy for stage II and III rectal cancer by progression stage Yuki Hashida PDF
Association between adverse events and prognosis in postoperative adjuvant chemotherapy for colorectal cancer Yuki Hashida PDF
Current status of thoracoscopic and mediastinoscopic surgery for esophageal cancer in our hospital Hiroyuki Kobayashi PDF
Laparoscopic appendectomy for acute appendicitis during pregnancy Yuki Hashida PDF
Analysis of clinicopathological factors that shorten recurrence-free survival after surgery for duodenal papilla cancer: a multicenter retrospective cohort study Yoshifumi Kitamura PDF
A retrospective study on the outcome of gastrojejunal bypass surgery in the elderly Satoshi Kaihara PDF
Examination of risk factors for the development of gastric varices in long-term patients after spleen-preserving caudal pancreatectomy -Domestic multicenter joint study- Satoshi Kaihara PDF
Constructing a multicenter database of endoscopic surgery Yuki Hashida PDF
Nationwide fact-finding survey of the high-risk group for liver cancer recurrence after liver transplantation Satoshi Kaihara PDF
Surgery and treatment information database project in the National Clinical Database (NCD) Satoshi Kaihara PDF
Examination of preoperative factors for differentiating xanthogranulomatous cholecystitis from gallbladder cancer Satoshi Kaihara PDF
Results and progress after introduction of robotic gastrectomy in a general public hospital Masato Kondo PDF
Usefulness of reinforcing sutures in DST anastomosis in laparoscopic rectal surgery for rectal cancer
Intracorporeal Reinforcing Sutures Reduce Anastomotic Leakage in Double-Stapling Anastomosis for Laparoscopic Rectal Surgery
Yuki Hashida PDF
Prevention of suture failure by reinforcing sutures in DST reconstruction after laparoscopic rectal resection Yuki Hashida PDF
GIST (Gastrointestinal Stromal Tumor) malignancy and drug resistance
multicenter joint research
Masato Kondo PDF
Usefulness of reinforcing sutures to prevent suture failure in laparoscopic rectal resection Yuki Hashida PDF
A study on the safety of introduction of robot-assisted gastrectomy Masato Kondo PDF
Follow-up study of treatment after complete resection for recurrent high-risk gastrointestinal stromal tumors (STAR ReGISTry) Masato Kondo PDF
Multicenter study on the significance of CRS/HIPEC for peritoneal dissemination Satoshi Kaihara PDF
Examination of usefulness and validity of minimally invasive surgery for remnant stomach cancer Satoshi Kaihara PDF
Appropriate colorectal cancer liver metastasis resection based on the presence or absence of RAS gene mutation Kentaro Iwaki PDF
Laparoscopic rectal fixation for rectal prolapse (modified Wells) Yuki Hashida PDF
Reconsideration of surgical method for non-functioning pancreatic neuroendocrine tumor Hiroyuki Kanbe PDF
Does extended gastric tube with intravenous glucagon reduce postoperative esophageal carcinoma suture failure? Takuma Kawarabayashi PDF
Is preoperative EUS useful for evaluating tumor size in pancreatic cancer? Ryosuke Kita PDF
Usefulness of intraoperative glucagon administration during esophageal cancer reconstruction Ryosuke Kita PDF
A multicenter retrospective observational study on the effect of preoperative glycemic control on postoperative outcome in gastrointestinal malignant tumor surgery for type 2 diabetes patients Masato Kondo PDF
Introduction and short-term results of robot-assisted rectal surgery in a city hospital Yuki Hashida PDF
Laparoscopic left-sided colectomy focusing on medial approach for splenic flexure colon cancer Yuki Hashida PDF
Usefulness of laparoscopic surgery for colon cancer in very elderly people Yuki Hashida PDF
A multicenter retrospective observational study on the effect of gastrointestinal reconstruction after distal gastrectomy on the course of diabetes in gastric cancer patients with type 2 diabetes Masato Kondo PDF
Usefulness of laparoscopic colorectal surgery for very elderly colorectal cancer Yuki Hashida PDF
Surgery Registry for Gastric Cancer at Kyoto University Surgical Facilities Hiroyuki Kobayashi PDF
Effect of RAS gene mutation on local recurrence of liver metastasis after resection of colorectal cancer Kentaro Iwaki PDF
Examination of surgical treatment results for colorectal cancer at Kyoto University surgery-related facilities Yuki Hashida PDF
Examination of medium- and long-term results after total pancreatectomy Kentaro Iwaki PDF
Stylization of robot-assisted surgery for rectal cancer Yuki Hashida PDF
Constructing a multicenter database of endoscopic surgery Yuki Hashida  
Verification of the safety of gastrointestinal surgery in patients taking antithrombotic drugs (antiplatelet drugs/anticoagulant drugs) Kenji Uryuhara PDF
Introduction of robot-assisted rectal resection and initial treatment outcomes Yuki Hashida PDF
Which cases do not require neoadjuvant therapy in the category of resectable pancreatic cancer? A retrospective study at a facility prior to surgery Yoshifumi Kitamura PDF
Indications and limitations of laparoscopic surgery for strangulated ileus Hiroyuki Kanbe PDF
Study on clinicopathological factors and prognosis in surgically resected cases of duodenal cancer (multicenter observational study) Yoshifumi Kitamura PDF
Introduction and results of robotic gastric cancer surgery in city hospitals Masato Kondo PDF
Phase II clinical trial of preoperative XELOX plus bevacizumab (BV) therapy for patients with resectable colorectal cancer metastasis to the liver    
Questionnaire on the reality of metachronous multiple carcinomas after gastrectomy    
Surgery Registry for Gastric Cancer at Kyoto University Surgical Facilities    
Multicenter retrospective observational study of esophagojejunostomy in total laparoscopic gastrectomy    
Multicenter joint research on GIST malignancy and drug resistance    
Results of robot-assisted gastric cancer surgery in our hospital E    
Usefulness of reinforcing sutures to prevent suture failure in laparoscopic rectal resection    
Efficacy of laparoscopic surgery for hepatocellular carcinoma with liver cirrhosis    
Efficacy of laparoscopic surgery for rectal prolapse from the viewpoint of pathophysiology Yuki Hashida PDF
Treatment strategy for colorectal cancer liver metastasis (collaboration with Oncology, observational study)    
Effects of preoperative chemotherapy on advanced gastric cancer (collaboration with Oncology, observational study)    
Laparoscopic surgery for StageIB gastric cancer (observational study)    
Effectiveness of colostomy wound management protocol (observational study)    
Stump treatment in pancreatic body and tail resection (observational study)    
Gallbladder cancer resection protocol and results (observational study)    
Indications for lateral rectal ablation (observational study)    
Preoperative chemotherapy for advanced rectal cancer (collaboration with Oncology, observational study)    
Indications and Outcomes of Elective Appendectomy for Perforated Appendicitis (Observational Study)    
Evaluation of nutritional status after surgery for gastric cancer (observational study)    
Verification of safety of laparoscopic liver resection (multicenter observational study)    
Development of prognostic nomogram after gastrectomy in elderly gastric cancer patients (multicenter observational study)    

Academic presentations and papers

Academic presentations and papers

  1. Hashida, Y., Iwaki, K., Kambe, H., Mizuno, R., Shiokawa, K., Matsubara, T., Kita, R., Masui, H., Mizumoto, M., Kitamura, Y., Kondo, M., Uriuhara, K., Kobayashi, H., Kaihara, S.: Colon nerve Treatment results for endocrine tumors. The 15th Annual Meeting of the The Japanese Gastroenterological Association, Saga, 2019.2.1-3
  2. Hashida, Y.: Laparoscopic surgery for parastomal hernia treatment. The 36th Annual Meeting of the Japanese Society of Ostomy and Urination Rehabilitation, Osaka, 2019.2.22-23
  3. Motoko Mizumoto, Naoto Urano, Satoshi Kaihara: Joint laparoscopic endoscopic surgery for cardiac submucosal tumor in our hospital. The 91st Annual Meeting of the Japanese Society of Gastric Cancer, Numazu, 2019.2.27-3.1
  4. Hiroyuki Kobayashi, Masato Kondo, Ryosuke Kita, Hideyuki Masui, Hiroki Hashida, Takaaki Matsubara, Keiichi Shiokawa, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Motoko Mizumoto, Kenji Uryuhara, Koji Kitamura, Satoshi Kaihara: Ichinaka Introduction of robot-assisted lower esophageal surgery in hospitals. The 119th Annual Meeting of the Japan Surgical Society, Osaka, April 18-20, 2019
  5. Hashida, H., Mizuno, R., Kanbe, H., Iwaki, K., Shiokawa, K., Mizumoto, M., Kitamura, Y., Kondo, M., Kobayashi, H., Uryuhara, K., Hosoya, R., Kaihara, S.: DST in laparoscopic rectal resection Prevention of suture insufficiency by reinforcing sutures in reconstruction. The 119th Annual Meeting of the Japan Surgical Society, Osaka, April 18-20, 2019
  6. Hiroyuki Kambe, Yoshifumi Kitamura, Kentaro Iwaki, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Masato Kondo, Hiroki Hashida, Hiroyuki Kobayashi, Kentsugu Uriubara, Satoshi Kaihara: Effect of preoperative biliary drainage in pancreatoduodenectomy patients and its impact on postoperative complications. The 119th Japan Surgical Society, Osaka, 2019.4.18-20
  7. K. Iwaki, S. Kaihara, H. Kanbe, R. Mizuno, K. Shiokawa, M. Mizumoto, Y. Kitamura, M. Kondo, Y. Hashida, H. Kobayashi, K. Uryuhara: Effectiveness of laparoscopic surgery for hepatocellular carcinoma with liver cirrhosis sex. The 119th Annual Meeting of the Japan Surgical Society, Osaka, April 18-20, 2019
  8. Yoshifumi Kitamura, Satoshi Kaihara, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Kenji Uryuhara, Hiroyuki Kobayashi, Yutaka Hashida Tsuyoshi, Ryo Hosoya: Stylized simulation and results by cholangiographic CT fusion imaging in perihilar region cancer. The 119th Annual Meeting of the Japan Surgical Society, Osaka, April 18-20, 2019
  9. Keiichi Shiokawa, Kenji Uryuhara, Kentaro Iwaki, Ryosuke Mizuno, Hiroyuki Kanbe, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Masato Kondo, Yuki Hashida, Hiroyuki Kobayashi, Satoshi Kaibara, Ryo Hosoya: Our hospital Investigation of treatment outcomes and prognostic factors for encouraging perforation of the lower gastrointestinal tract. The 119th Annual Meeting of the Japan Surgical Society, Osaka, April 18-20, 2019
  10. Kentaro Iwaki, Satoshi Kaihara, Yoshifumi Kitamura: The impact of laparoscopic surgery for hepatocellular carcinoma with liver cirrhosis. ILLS 2019 Tokyo,Tokyo,2019.5.9-11
  11. Kambe H, Kitamura Y, Shiokawa K, Matsubara T, Uriuhara K: A case of fossa hernia in the sigmoid colon that avoided intestinal resection due to early diagnosis. The 17th Annual Meeting of the Japanese Hernia Society, Yokkaichi, May 24-25, 2019
  12. Hiroyuki Kobayashi, Masato Kondo, Ryosuke Kita, Hideyuki Masui, Takaaki Matsubara, Keiichi Shiokawa, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Satoshi Kaihara: Introduction and problems of robot-assisted lower esophageal surgery at our hospital. The 73rd Annual Meeting of the The Japan Esophageal Society, Fukuoka, June 6-7, 2019
  13. Masato Kondo, Satoshi Kaihara:Introduction and results as a safe operative procedure for robotic gastrectomy. EAES 2019, Sevilla, 2019.6.12-15
  14. Ryosuke Mizuno, Masato Kondo, Hiroyuki Kanbe, Kentaro Iwaki, Keiishi Shiokawa, Takaaki Matsubara, Hideyuki Masui, Ryosuke Kita, Motoko Mizumoto, Koji Kitamura, Hiroki Hashida, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara, Ryo Hosotani:Comparison of standard IPOM and IPOM plus in our hospital. EAES 2019, Sevilla, 2019.6.12-15
  15. Satoshi Kaihara, Yoshifumi Kitamura, Kenji Uryuhara, Keiichi Shiokawa, Yuki Hashida, Kentaro Iwaki: Central Sectionectomy for Hilar Cholangiocarcinoma; Application of the Hanging Method in Parenchymal Dissection. The 31st Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Takamatsu, 2019.6.13-15
  16. Kentaro Iwaki, Satoshi Kaihara, Hideyuki Masui, Yoshifumi Kitamura, Kenji Uryuhara: A novel preoperative remnant liver functional evaluation using 99mTcGSA-SPECT and KICG for safe hepatectomy. The 31st Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Takamatsu, June 13-15, 2019
  17. Yoshifumi Kitamura, Satoshi Kaihara, Kentaro Iwaki, Kenji Uryuhara: Importance of regional lymph node dissection for pancreatobiliary subtype of ampullary carcinoma. Investigation of recurrent sites after curative resection. The 31st Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Takamatsu, 2019.6.13-15
  18. Kaihara S, Kitamura Y, Uryuhara K, Iwaki K, Kanbe H, Mizuno R, Shiokawa K, Matsubara T, Kita R, Masui H: Surgical techniques in tubulectomy. The 74th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokyo, July 17-19, 2019
  19. Hiroyuki Kobayashi, Masato Kondo, Ryosuke Kita, Hideyuki Masui, Takaaki Matsubara, Keiichi Shiokawa, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Satoshi Kaihara: Introduction and problems of robot-assisted lower esophageal surgery at our hospital. The 74th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokyo, July 17-19, 2019
  20. Hiroyuki Kambe, Koji Kitamura, Ryosuke Mizuno, Kentaro Iwaki, Keiichi Shiokawa, Takaaki Matsubara, Hideyuki Masui, Ryosuke Kita, Motoko Mizumoto, Masato Kondo, Hiroyuki Kobayashi, Hiroki Hashida, Kenji Uryuhara, Satoshi Kaihara: Clinical investigation of resected primary duodenal carcinoma. The 74th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Tokyo, July 17-19, 2019
  21. Motoko Mizumoto, Ryosuke Mizuno, Hiroyuki Kanbe, Kentaro Iwaki, Keiichi Shiokawa, Takaaki Matsubara, Hideyuki Masui, Ryosuke Kita, Satoshi Kaihara, Ryo Hosotani: Clinical experience of primary small bowel cancer in our hospital. The 74th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokyo, July 17-19, 2019
  22. “Emergency operation for diverticulitis from the view of pre-operative CT imaging, 74th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Tokyo, 2019.7.17-19
  23. Masato Kondo, Kentaro Iwaki, Ryosuke Mizuno, Hiroyuki Kanbe, Keiichi Shiokawa, Motoko Mizumoto, Yoshifumi Kitamura, Hiroyuki Kobayashi, Hiroki Hashida, Satoshi Kaihara: Introduction and results of robotic gastrointestinal surgery in general city hospitals. The 74th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokyo, July 17-19, 2019
  24. Hashida, Y., Iwaki, K., Kanbe, H., Mizuno, R., Mizumoto, M., Kitamura, Y., Kondo, M., Uryuhara, K., Kobayashi, H., Kaihara, S.: Laparoscopic surgery for rectal prolapse from the viewpoint of pathology. The 74th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokyo, July 17-19, 2019
  25. Keiichi Shiokawa, Kenji Uryuhara, Kentaro Iwaki, Ryosuke Mizuno, Hiroyuki Kanbe, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Masato Kondo, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara: Our hospital for T2 gallbladder cancer Examination of treatment protocol. The 74th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokyo, 2019.7.17-19
  26. Kentaro Iwaki, Satoshi Kaihara, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida, Hiroyuki Kobayashi, Kenji Uryuhara: The replaced RHA preserving technique for the plexus of pancreatic head dissection. The 74th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokyo, July 17-19, 2019
  27. Kitamura, Y., Kaihara, S., Iwaki, K., Kanbe, H., Mizuno, R., Shiokawa, K., Matsubara, T., Kita, R., Masui, H., Uryuhara, K.: Preoperative 3D-CT fusion image aim for R0 resection in hilar cholangiocarcinoma. The 74th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokyo, 2019.7.17-19
  28. Kenji Uriuhara, Satoshi Kaihara: Current status and issues of post-liver transplant patient follow-up at our hospital. The 55th Annual Meeting of the The Japan Society for Transplantation, Hiroshima, 2019.10.10-12
  29. Hiroki Hashida, Masato Kondo, Motoko Mizumoto, Hiroyuki Kobayashi, Satoshi Kaihara: Stylization of laparoscopic surgery centered on the medial approach for transverse colon cancer. The 74th Annual Meeting of the Japanese Society of Coloproctology, Tokyo, 2019.10.11-12
  30. Hashida, H., Mizuno, R., Kanbe, H., Shiokawa, K., Mizumoto, M., Kondo, M., Kobayashi, H., Kaihara, S.: Laparoscopic surgery for colon cancer in very elderly people. The 57th Annual Meeting of the Japan Society of Clinical Oncology of Oncology, Fukuoka, 2019.10.24-26
  31. Hiroyuki Kobayashi, Masato Kondo, Ryosuke Kita, Hideyuki Masui, Takaaki Matsubara, Keiichi Shiokawa, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Satoshi Kaihara:Impact of Intravenous Injection of Glucagon on Anastomotic Leakage in Esophagectomy. 27-31
  32. Koji Kitamura, Satoshi Kaihara, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Kenji Uryuhara, Hiroyuki Kobayashi:Usefulness of three-dimensional computed tomography simulation for safe laparoscopic liver anatomical resection. ACS 2019, San Francisco, October 27-31, 2019
  33. Masato Kondo, Hiroyuki Kobayashi, Takuma Kawarabayashi, Suehiko Sumi, Hiroyuki Kanbe, Kentaro Iwaki, Ryosuke Mizuno, Keiichi Shiokawa, Satoshi Kaihara: An automatic suturer with a tissue reinforcing material for simpler and stronger anastomosis make use of. 49th Gastric Surgery Postoperative Disorders Study Group, Kagoshima, 2019.10.31-11.1
  34. Takuma Kawarabayashi, Yoshifumi Kitamura, Suehiko Sumi, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Motoko Mizumoto, Masato Kondo, Yuki Hashida, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara: After pancreatoduodenectomy A case of long-term actinomycosis pancreatitis. The 81st Annual Meeting of the Japanese Society of Clinical Surgery, Kochi, 2019.11.14-16
  35. Suehiko Sumi, Satoshi Kaihara, Takuma Kawarabayashi, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida, Hiroyuki Kobayashi, Kenji Uriuhara: Unresectable pancreatic head A case in which complete excision was achieved by conversion surgery for a local cancer. The 81st Annual Meeting of the Japanese Society of Clinical Surgery, Kochi, 2019.11.14-16
  36. Hiroyuki Kobayashi, Masato Kondo, Keiichi Shiokawa, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Takuma Kawarabayashi, Toshihiko Sumi, Motoko Mizumoto, Hiroki Hashida, Satoshi Kaihara: Recurrent laryngeal nerve palsy from experience of neuromonitoring Superior mediastinum dissection procedure. The 32nd Annual Meeting of the Japan Society for endoscopic Surgery, Yokohama, December 5-7, 2019
  37. Motoko Mizumoto, Takuma Kawarabayashi, Toshihiko Sumi, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara: Cardia in our hospital Outcomes of LECS. The 32nd Annual Meeting of the Japan Society for endoscopic Surgery, Yokohama, 2019.12.5-7
  38. Kanbe H, Kitamura Y, Kawarabayashi T, Sumi Sumi, Iwaki K, Mizuno R, Shiokawa K, Mizumoto M, Kondo Y, Hashida Y, Kobayashi H, Uryuhara K, Kaibara S: Strangulation ileus Indications and limitations of laparoscopic surgery. The 32nd Annual Meeting of the Japan Society for endoscopic Surgery, Yokohama, December 5-7, 2019
  39. Hashida, H., Kondo, M., Kobayashi, H., Kawarabayashi, T., Sumi, Sumi, K. Iwaki, Kamibe, H., Mizuno, R., Kitamura, Y., Mizumoto, M., Uryuhara, K., Kaihara, S.: Introduction of robot-assisted rectal surgery and early results. The 32nd Annual Meeting of the Japan Society for endoscopic Surgery, Yokohama, 2019.12.5-7
  40. K. Iwaki, M. Kondo, T. Kawarabayashi, S. Sumi, H. Kanbe, R. Mizuno, M. Mizumoto, Y. Kitamura, Y. Hashida, H. Kobayashi, K. Uryuhara, S. Kaihara: Laparoscopic surgery in the elderly Gastrectomy has a high frequency of complications, but the medium-term results are favorable. The 32nd Annual Meeting of the Japan Society for endoscopic Surgery, Yokohama, December 5-7, 2019
  41. Mizuno R, Hashida Y, Kawarabayashi T, Sumi Sumi, Iwaki K, Kanbe H, Shiokawa K, Mizumoto M, Kitamura Y, Kondo M, Kobayashi H, Uryuhara K, Kaibara S: Laparoscopy Efforts to prevent suture failure in lower rectal DST anastomosis. The 32nd Annual Meeting of the Japan Society for endoscopic Surgery, Yokohama, December 5-8, 2019
  42. Sumihiko Sumi, K. Uryuhara, T. Kawarabayashi, H. Kanbe, R. Mizuno, M. Mizumoto, Y. Kitamura, M. Kondo, Y. Hashida, H. Kobayashi, K. Uryuhara, S. Kaihara: Laparoscopy in our hospital Results and complications of inguinal hernia repair (TAPP method). The 32nd Annual Meeting of the Japan Society for endoscopic Surgery, Yokohama, December 5-7, 2019
  43. Masato Kondo, Takuma Kawarabayashi, Suehiko Washimi, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Motoko Mizumoto, Yoshifumi Kitamura, Kenji Uryuhara, Hiroyuki Kobayashi, Hiroki Hashida, Satoshi Kaihara: Robotic gastric cancer surgery at a city hospital introduction and performance of The 32nd Annual Meeting of the Japanese Society for Endoscopic Surgery, Yokohama, December 5-7, 2019
  44. Yoshifumi Kitamura, Satoshi Kaihara, Takuma Kawarabayashi, Suehiko Sumi, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Motoko Mizumoto, Masato Kondo, Kenji Uryuhara, Hiroyuki Kobayashi, Hiroki Hashida, Ryo Hosoya : ”Utilization of image-assisted surgery and surgical techniques in laparoscopic liver S7 and S8 tumor resection”. The 32nd Annual Meeting of the Japan Society for endoscopic Surgery, Yokohama, December 5-7, 2019
  45. Masato Kondo, Hironaga Satake, Motoko Mizumoto, Takanori Watanabe, Norimitsu Tanaka, Kenro Hirata, Hiroaki Tanioka, Yoshihiro Okita, Takahisa Kyogoku, Mitsutoshi Tatsumi, Koreatsu Matoba, Shinichi Adachi, Satoshi Kaihara, Hisateru Yasui, Akihito Tsuji: Multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX P Ⅱ ). ASCO-GI 2020, San Francisco, 2020.1.23-25
  46. Hashida, H., Sumi, S., Kawarabayashi, T., Mizuno, R., Kanbe, H., Iwaki, K., Shiokawa, K., Mizumoto, M., Kondo, M., Kobayashi, H., Kaihara, S.: Laparoscopic surgery for colorectal cancer in very elderly people. Usefulness. The 16th Annual Meeting of the The Japanese Gastroenterological Association, Himeji, February 7-8, 2020

  1. Kobayashi, H., Kita, R., Masui, H., Kitano, S., Kumada, Y., Matsubara, T., Shiokawa, K., Uryuhara, K., Hashida, Y., Kondo, M., Kitamura, Y., Mizumoto, S., Kaibara, S., Hosoya, R.: Chest cavity Ingenuity of a safe upper mediastinum dissection technique in endoscopic esophageal cancer surgery. The 118th Annual Meeting of the Japan Surgical Society, Tokyo, 2018.4.5-
  2. Yuki Hashida, Keiichi Shiokawa, Takaaki Matsubara, Yukiko Kumada, Shoichi Kitano, Hideyuki Masui, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Kenji Uryuhara, Ryo Hosoya, Satoshi Kaihara: Crohn's disease Usefulness of anti-TNF-a antibody and surgical treatment for pneumothorax. The 118th Annual Meeting Japan Surgical Society, Tokyo, April 5-7, 2018
  3. Masato Kondo, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yoshifumi Kitamura, Motoko Mizumoto, Kenji Uryuhara, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya: Altitude Progression Results of review laparoscopy and preoperative chemotherapy for gastric cancer. The 118th Annual Meeting of the Japan Surgical Society, Tokyo, April 5-7, 2018
  4. Motoko Mizumoto, Keiichi Shiokawa, Takaaki Matsubara, Yukiko Kumada, Shoichi Kitano, Hideyuki Masui, Ryosuke Kita, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara, Ryo Hosoya: Our hospital Investigation of postoperative disorders due to reconstructive methods of laparoscopic gastrectomy in The 118th Annual Meeting Japan Surgical Society, Tokyo, April 5-7, 2018
  5. R. Kita, K. Shiokawa, T. Matsubara, Y. Kumada, S. Kitano, H. Masui, M. Mizumoto, Y. Kitamura, Hiroyuki Kobayashi, H. Kobayashi, K. Uryuhara, Y. Hashida, S. Kaibara, R. Hosoya: Laparoscopy Introduction of lower systematic hepatectomy - to maintain quality comparable to that of open surgery -. The 118th Annual Meeting Japan Surgical Society, Tokyo, April 5-7, 2018
  6. Kitano, S., Shiokawa, K., Matsubara, T., Kumada, Y., Kitano, S., Masui, H., Kita, R., Kaihara, S., Hosoya, R.: Results of short-term surgery for lower rectal cancer using TaTME at our hospital. The 118th Annual Meeting of the Japan Surgical Society, Tokyo, April 5-7, 2018
  7. Yukiko Kumada, Masato Kondo, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Satoshi Kaibara, Ryo Hosoya: Oral nutrition supplementation in gastrectomy patients. The 118th Annual Meeting of the Japan Surgical Society, Tokyo, April 5-7, 2018
  8. Keiichi Shiokawa, Kenji Uryuhara, Takaaki Matsubara, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Yuki Hashida, Hiroyuki Kobayashi, Satoshi Kaibara, Ryo Hosoya: Comparative analysis of surgical strategy for acute cholecystitis. The 118th Annual Meeting of the Japan Surgical Society, Tokyo, April 5-7, 2018
  9. Ryosuke Mizuno, Yuki Hashida, Kentaro Iwaki, Hiroyuki Kanbe, Keiichi Shiokawa, Takaaki Matsubara, Hideyuki Masui, Ryosuke Kita, Motoko Koji Kitamura, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara, Ryo Hosoya : Efficacy of preoperative chemotherapy for locally advanced rectal cancer. The 118th Annual Meeting Japan Surgical Society, Tokyo, April 5-7, 2018
  10. Sumi Sumi, Kitano S, Uryuhara K, Kaihara S, Kobayashi H, Hashida Y, Kondo M, Kitamura Y, Mizumoto M, Kita R, Masui H: A study of incarcerated obturator hernia cases in our hospital. The 118th Annual Meeting of the Japan Surgical Society, Tokyo, April 5-7, 2018
  11. Shunta Takahashi, Hiroyuki Kobayashi, Ryosuke Kita, Hideyuki Masui, Shoichi Kitano, Yukiko Kumada, Takaaki Matsubara, Keiichi Shiokawa, Kenji Uryuhara, Yuki Hashida, Masato Kondo, Yoshifumi Kitamura, Motoko Mizumoto, Satoshi Kaihara, Ryo Hosoya : A case of small intestinal submucosal aneurysm that was difficult to diagnose preoperatively. The 118th Annual Meeting of the Japan Surgical Society, Tokyo, April 5-7, 2018
  12. Kobayashi H, Kondo M, Mizumoto M, Kita R, Masui H, Kitano S, Kumata Y, Matsubara T, Shiokawa K, Uryuhara K, Hashida H, Kitamura K, Hosotani R, Kaihara S: Mesenterization and Intra-Operative Neural Monitoring to Reduce the Recurrent Laryngeal Nerve Paralysis after Thoracoscopic esophagectomy in Prone Position. SAGES,Seattle,2018.4.11-14
  13. Kentaro Iwaki, Shintaro Yagi, Tomomi Morita, Gen Yamamoto, Yuki Masano, Ken Fukumitsu, Kazuyuki Nagai, Takashi Ito, Jun Yoshizawa, Naoko Kamo, Koichiro Hata, Kojiro Taura, Hideaki Okajima, Toshimi Kaido, Uemoto Shinji: Risk factor analysis for massive ascites after living-donor liver transplantation. The 36th Japan Liver Transplant Society, Tokyo, May 25-26, 2018
  14. Kaihara S, Kitamura K, Uryuuhara K: Tape Guided Parenchymal Dissection Applying Hanging Method for Safe and Secure Anatomical Hepatectomy. JGSSLS2018, Graz, 2018.5.26-27
  15. Kitamura K, Kaihara S, Uryuuhara K: 3D-CT simulation and laparoscopic procedure for safe anatomical liver resection. JGSSLS2018, Graz, 2018.5.26-27
  16. Kaihara S, Kitamura K, Uryuhara K, Kita R, Masui H, Hashida H, Hosotani R: Strategies on the treatment of colorectal liver metastasis. 9
  17. Kitamura K, Kaihara S, Kita R, Masui H, Uryuhara K, Hashida H, Hosotani R: Our procedure and results for anatomical liver resection less than segmentectomy based on the Glissonean branches. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery, Yokohama, 2018.6.7-9
  18. Kita R, Kaihara S, Masui H, Kitamura K, Uryuuhara K, Hosotani R: Evaluation of the safety and validity of hepatectomy for elderly people. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery, Yokohama, 2018.6.7- 9
  19. Masui H, Kaihara S, Shiokawa K, Matsubara H, Kita R, Mizumoto M, Kitamura K, Kondo M, Hashida H, Kobayashi H, Uryuuhara K, Hosotani R: Evaluation of the new guidelines of IPMN- from the viewpoint of surgical validity -. The 30th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery, Yokohama, 2018.6.7-9
  20. Iwaki K, Yagi S, Iida T, Masano Y, Tajima T, Okumura S, Yamamoto G, Kamo N, Kaido T, Uemoto S: Case report of extensive isolated spontaneous celiac trunk dissection after liver transplantation. Hepato-Biliary-Pancreatic Surgery, Yokohama, 2018.6.7-9
  21. Hiroyuki Kobayashi, Masato Kondo, Motoko Mizumoto, Kenji Uryuhara, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yoshifumi Kitamura, Hiroki Hashida, Satoshi Kaibara, Ryo Hosoya A case of esophageal rupture who underwent thoracoscopic perforation suturing and mediastinal drainage. The 72nd Annual Meeting of the The Japan Esophageal Society, Utsunomiya, 2018.6.28-29
  22. Kaihara S, Hosoya R: Mid- and long-term results after total pancreatectomy. The 49th Annual Meeting of the Japan Pancreas Society, Wakayama, 2018.6.29-30
  23. Keiichi Shiokawa, Kenji Uriuhara: A case study of incarcerated obturator hernia in our hospital. The 16th Annual Meeting of the Japan Hernia Society, Sapporo, 2018.6.29-30
  24. Uriuhara, K.: Current state of inguinal hernia surgery guidance at our hospital. The 16th Annual Meeting of the Japan Hernia Society, Sapporo, 2018.6.29-30
  25. Kaihara, S., Kitamura, Y., Uryuhara, K., Shiokawa, K., Matsubara, T., Kitano, S., Kumada, Y., Kita, R., Masui, H., Hosoya, R.: Functional residuals by 3D image analysis by fusing Asialocinti and CT. Examination of the effectiveness of hepatic reserve evaluation. The 73rd Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  26. Kobayashi, H., Kita, R., Masui, H., Kitano, S., Kumada, Y., Matsubara, T., Shiokawa, K., Kondo, M., Kaibara, S., Hosoya, R.: Thoracoscopic mediastinal approach for esophageal cancer with zero complications. The 73rd Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  27. Hashida H., Shiokawa K., Matsubara T., Kita R., Masui H., Mizumoto M., Kondo M., Kobayashi H., Hosoya R., Kaihara S. Short-term results and efficacy of lower rectal surgery with TaTME. The 73rd Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  28. Masato Kondo, Keiichi Shiokawa, Takaaki Matsubara, Yukiko Kumada, Shoichi Kitano, Hideyuki Masui, Ryosuke Kita, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya: CME for advanced transverse colon cancer with a complete medial approach. Conscious laparoscopic surgery. The 73rd Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  29. Yoshifumi Kitamura, Satoshi Kaihara, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Kenji Uryuhara: Our procedure of superior mesenteric artery surrounding dissection for pancreatic head cancer. The 73rd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  30. Motoko Mizumoto, Naoto Arano, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara, Ryo Hosoya: Transformed laparoscopic endoscopic cooperative surgery for gastric submucosal tumor. The 73rd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  31. Kitano, S., Kondo, M., Shiokawa, K., Matsubara, T., Kumada, Y., Mizumoto, M., Kobayashi, H., Kaibara, S., Hosoya, R.: A study of clinicopathological characteristics in patients undergoing additional resection after ESD. The 73rd Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  32. Yukiko Kumada, Satoshi Kaihara, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Hideyuki Masui, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Ryo Hosoya: Surgical results of liver resection in the elderly over 80 years old , Examination of long-term prognosis. The 73rd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  33. Kita R, Kaihara S, Masui H, Kitamura K, Uryuuhara K, Hosotani R: Strategy for pancreaticojejunostomy ~ reducing the pancreatic fistula ~.
  34. Masui H, Uryuuhara K, Shiokawa K, Matsubara T, Kumata Y, Kitano S, Kita R, Mizumoto M, Kaihara S, Hosotani R: Standardization of distal pancreatectomy for prevention of pancreatic fistula. The 73rd General Meeting of the Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  35. Keiichi Shiokawa, Hiroyuki Kobayashi, Kentaro Iwaki, Hiroyuki Kanbe, Takaaki Matsubara, Hideyuki Masui, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida, Kenji Uryuhara, Satoshi Kaibara, Ryo Hosoya: Our hospital treatment strategy for colorectal cancer ileus. The 73rd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  36. Ryosuke Mizuno, Yuki Hashida, Kentaro Iwaki, Hiroyuki Kanbe, Keiichi Shiokawa, Takaaki Matsubara, Hideyuki Masui, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara, Ryo Hosoya : Standardization of laparoscopic abdominal incisional hernia repair. The 73rd Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Kagoshima, 2018.7.11-13
  37. Kobayashi H, Kondo M, Mizumoto M, Kita R, Masui H, Kitano S, Kumata Y, Matsubara T, Shiokawa K, Kaihara S, Hosotani R: Mesentery-oriented Lymph Nodes Dissection and Intra-operative Neural Monitoring to Reduce the Postoperative Recurrent Laryngeal Nerve Paralysis in Esophagectomy. ISDE, Vienna, 2018.9.16-19
  38. Masui H, Kobayashi H, Kondo M, Kaihara S, Hosotani R: laparoscopic trans-hiatal repair for Boerhaave's syndrome: A case report. ISDE, Vienna, 2018.9.16-19
  39. Motoko Mizumoto, Noriko Kato, Ryoya Doi, Akiko Sano, Miwa Hasegawa, Satoshi Kaihara: Examination of the safety of path adaptation to encouragement requiring preoperative decompression. Clinical Path Society, Hakodate, 2018.10.12-13
  40. Kondo M: Introduction and results as a safe operative procedure for robotic gastrectomy. Asian summit on robotic surgery, Singapore, October 18-21, 2018
  41. Hiroki Hashida, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Kentsugu Uriubara, Ryo Hosoya, Satoshi Kaihara: Laparoscopic surgery for colorectal cancer in very elderly patients. The 16th The Japanese Society of Gastroenterological Surgery Congress, Kobe, 2018.11.1-11.4
  42. Hiroki Hashida, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara: Very old Usefulness of Laparoscopic Surgery for Patients with Colorectal Cancer. The 73rd Annual Meeting of the Japanese Society of Coloproctology, Tokyo, 2018.11.9-11.10
  43. Hashida H: Laparoscopic Repair with Sandwich Technique for Parastomal Hernia. ELSA, Kuala Lumpur, 2018.11.15-17
  44. Mizumoto M, Shimeno N, Hashida H, Kaihara S: Evaluation of laparoscopic and endoscopic cooperative surgery for gastric submucosal tumor of cardia. ELSA, Kuala Lumpur, 2018.11.15-17
  45. Mizuno R, Kitamura Y, Iwaki K, Kambe H, Shiokawa K, Matsubara T, Masui H, Kita R, Mizumoto M, Masato Kondo, Kobayashi H, Uriubara K, Hashida H, Kaibara S, Hosoya R: NOMI (nonocclusive mesenteric ischemia) cases in our hospital. The 46th Annual Meeting of the Japanese Association for Emergency Medicine, Yokohama, 2018.11.19-20
  46. Kentaro Iwaki, Satoshi Kaihara, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Motoko Koji Kitamura, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Kenji Uryuhara: Differentiation from hepatocellular carcinoma 2 cases of resection of giant hepatocellular adenoma for which it was difficult to resect. The 80th Annual Meeting of the Japanese Society of Clinical Surgery, Tokyo, 2018.11.22-24
  47. Hiroyuki Kambe, Satoshi Kaihara, Kentaro Iwaki, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Hideyuki Masui, Ryosuke Kita, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Kenji Uryuhara, Hiroki Hashida: Pancreatic Adenosquamous Cell Carcinoma A case of synchronous double cancer of bladder cancer. The 80th Annual Meeting of the Japanese Society of Clinical Surgery, Tokyo, 2018.11.22-24
  48. Hiroyuki Kobayashi, Masato Kondo, Motoko Mizumoto, Ryosuke Kita, Hideyuki Masui, Takaaki Matsubara, Keiichi Shiokawa, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Kenji Uryuhara, Hiroki Hashida, Yoshifumi Kitamura, Satoshi Kaihara: Chest cavity Mesentery-oriented lymph node dissection in endoscopic esophageal cancer. The 31st Annual Meeting of the Endoscopic Surgery Society, Fukuoka, December 6-8, 2018
  49. Hiroki Hashida, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Koji Kitamura Shiokawa, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Kenji Uryuhara, Hiroyuki Kobayashi, Satoshi Kaihara: Spleen flexion Laparoscopic left-sided colectomy with a four-way approach to the partial colon. The 31st Annual Meeting of the Endoscopic Surgery Society, Fukuoka, December 6-8, 2018
  50. Masato Kondo, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Hideyuki Masui, Ryosuke Kita, Satoshi Kaihara: Laparoscopic caudal pancreatic resection with emphasis on functional preservation for benign and borderline malignant pancreatic disease technique. The 31st Annual Meeting of the Endoscopic Surgery Society, Fukuoka, December 6-8, 2018
  51. Yoshifumi Kitamura, Satoshi Kaihara, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Masato Kondo, Kenji Uryuhara, Hiroyuki Kobayashi, Hirotsugu Hashida, Ryo Hosoya : Results of laparoscopic partial hepatectomy in our hospital. The 31st Annual Meeting of the Endoscopic Surgery Society, Fukuoka, December 6-8, 2018
  52. M. Mizumoto, R. Mizuno, H. Kambe, K. Iwaki, K. Shiokawa, T. Matsubara, H. Masui, R. Kita, Y. Kitamura, Masato Kondo, H. Hashida, H. Kobayashi, K. Uriubara, S. Kaihara, R. Hosoya: Selection of surgical methods for gastric submucosal tumor at our hospital. The 31st Annual Meeting of the Japanese Society for Endoscopic Surgery, Fukuoka, Dec. 6-8, 2018.
  53. Kita R, Iwaki K, Kambe H, Mizuno R, Shiokawa K, Matsubara T, Masui H, Mizumoto M, Kitamura Y, Masato Kondo, Kobayashi H, Uriubara K, Hashida H, Kaihara S, Hosoya R: Short-term outcomes after TaTME introduction for lower rectal cancer. The 31st Annual Meeting of the Japanese Society for Endoscopic Surgery, Fukuoka, Dec. 6-8, 2018.
  54. Hideyuki Masui, Yuki Hashida, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Kenji Uryuhara, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya : Endoscopic surgery for advanced cancer of the descending colon. The 31st Annual Meeting of the Endoscopic Surgery Society, Fukuoka, December 6-8, 2018
  55. Keiichi Shiokawa, Masato Kondo, Kentaro Iwaki, Hiroyuki Kanbe, Ryosuke Mizuno, Takaaki Matsubara, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Hiroki Hashida, Kenji Uryuhara, Hiroyuki Kobayashi, Satoshi Kaibara, Ryo Hosoya: Our hospital Investigation of decompression method for ileus in colon cancer. The 31st Annual Meeting of the Endoscopic Surgery Society, Fukuoka, December 6-8, 2018
  56. Kentaro Iwaki, Masato Kondo, Hiroyuki Kanbe, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Koji Kitamura, Yoshifumi Kitamura, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara: Endoscopy for Complicated appendicitis Surgery. 31st Endoscopic Surgery Society, Fukuoka, 2018.12.6-8
  57. Hiroyuki Kanbe, Yuki Hashida, Kentaro Iwaki, Ryosuke Mizuno, Keiichi Shiokawa, Takaaki Matsubara, Ryosuke Kita, Hideyuki Masui, Satoshi Kaihara: A new trend in laparoscopic abdominal hernia repair. The 31st Annual Meeting of the Endoscopic Surgery Society, Fukuoka, December 6-8, 2018
  58. Ryosuke Mizuno, Kenji Uryuhara, Kentaro Iwaki, Hiroyuki Kanbe, Keiichi Shiokawa, Takaaki Matsubara, Hideyuki Masui, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Hiroki Hashida, Satoshi Kaihara, Hosoya Ryo: Selection and results of TAPP/TEPP surgery emphasizing inguinal anatomy. The 31st Annual Meeting of the Endoscopic Surgery Society, Fukuoka, December 6-8, 2018
  59. Hashida, Y., Iwaki, K., Kanbe, H., Mizuno, R., Shiokawa, K., Matsubara, T., Kita, R., Masui, H., Mizumoto, M., Kitamura, Y., Kondo, M., Koji Kitamura, K., Kobayashi, H., Kaihara, S.: Colorectal nerve Treatment results for endocrine tumors. 15th Annual Meeting of the Japanese Gastroenterological Association, Saga, 2019.2.1-03
  60. Hashida, Y.: Laparoscopic surgery for parastomal hernia treatment. The 36th Annual Meeting of the Japanese Society of Ostomy and Urination Rehabilitation, Osaka, 2019.2.22-23

  1. Kaihara S, Iwamura S, Matsubara T, Kumata Y, Kitano S, Kita R, Masui H, Mizumoto M, Uryuhara K: Preoperative assessment of remnant liver function in major hepatectomy after portal vein embolization using 99mTc-GSA scintigraphy / 3D-CT fused imaging. AHPBA (American Hepatobiliary Pancreas), Miami, 2017.3.29-4.2
  2. Kondo, M., Mizumoto, M., Iwamura, N., Kita, R., Masui, H., Kitano, S., Kumada, Y., Matsubara, T., Kaibara, S., Hosoya, R.: Prevention of suture insufficiency after surgery for esophageal cancer by lengthening the gastric tube with intravenous glucagon injection. The 117th Surgical Society, Yokohama, 2017.4.27-29
  3. Matsubara, T., Omori, A., Kumada, Y., Kitano, S., Masui, H., Kita, R., Iwamura, N., Mizumoto, M., Kondo, M., Hiroyuki Kobayashi, H., Hosoya, R., Kaihara, S.: Education of laparoscopic colorectal surgery at city hospitals efforts. The 117th Surgical Society, Yokohama, 2017.4.27-29
  4. Satoshi Kaihara, Keiichi Shiokawa, Takaaki Matsubara, Yukiko Kumada, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Masato Kondo, Kenji Uryuhara, Hiroyuki Kobayashi, Hiroki Hashida, Ryo Hosoya: Pancreatic head with portal vein invasion Results of combined resection of the portal vein in normal pancreatic cancer resection. The 117th Surgical Society, Yokohama, 2017.4.27-29
  5. Arano N, Matsubara T, Kumada Y, Kitano S, Masui H, Kita R, Kitamura Y, Kondo M, Hashida Y, Kobayashi H, Hiroyuki Kobayashi, Kaibara S, Hosoya R: Laparoscopy in our hospital Joint endoscopic surgery. The 117th Annual Meeting of the Surgical Society, Yokohama, April 27-29, 2017
  6. Kaihara S., Shiokawa K., Matsubara T., Kitano S., Yukiko Kumada, R. Kita, H. Masui, M. Mizumoto, Y. Kitamura, M. Masato Kondo, Y. Hashida, H. Kobayashi, K. Uryuhara, R. Hosoya: Pancreatoduodenum Investigation of the intraoperative/postoperative influence of preoperative conditions in resection. The 117th Surgical Society, Yokohama, 2017.4.27-29
  7. Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaibara, Ryo Hosoya: Treatment strategy after resection of colorectal cancer liver metastasis - Postoperative adjuvant chemotherapy -. The 117th Surgical Society, Yokohama, 2017.4.27-29
  8. Masato Kondo, Keiichi Shiokawa, Takaaki Matsubara, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Yuki Hashida, Kenji Uryuhara, Hiroyuki Kobayashi, Satoshi Kaibara, Ryo Hosoya: Preoperative SOX therapy performed A study of surgical cases of locally advanced gastric cancer. The 117th Annual Meeting of the Surgical Society, Yokohama, 2017.4.27-29-144-
  9. Hashida, H., Shiokawa, K., Matsubara, T., Kitano, S., Kita, R., Masui, H., Mizumoto, M., Kitamura, Y., Kondo, M., Kenji Uryuhara, K., Kobayashi, H., Kaibara, S., Hosoya, R.: Treatment of colorectal endocrine tumors. Outcomes of surgical treatment at our hospital. The 117th Surgical Society, Yokohama, 2017.4.27-29
  10. Masato Kondo, Keiichi Shiokawa, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Kenji Uryuhara, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaibara, Ryo Hosoya: Abscess formation in our hospital Approach of interval appendectomy for appendicitis. The 117th Surgical Society, Yokohama, 2017.4.27-29
  11. Matsubara T., Kumada Y., Kitano S., Masui H., Kita R., Iwamura N., Mizumoto M., Kitamura Y., Hiroki Hashida, Kobayashi H., Uryuhara K., Kaibara S., Hosoya R.: Ovary and A case in which a tumor was found in the pancreas at the same time. The 117th Surgical Society, Yokohama, 2017.4.27-29
  12. Uryuhara K, Kitamura K, Iwamura S, Kita R, Masui H, Hashida H, Hosotani R. Hepatectomy for Large HCC -strategies and technical tips for secure operation-. The 29th Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Yokohama, June 7-10, 2017
  13. Kaihara S, Kita R, Masui H, Uryuhara K, Hashida H, Hosotani R: Reliable and safe procedure of anatomical resection of segment VIII for HCC. The 29th Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Yokohama, June 7-10, 2017
  14. Kaihara S, Masui H, Kitamura K, Hosotani R: Evaluation of treatment outcome to incidental gallbladder cancer. The 29th Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Yokohama, June 7-10, 2017
  15. Kaihara S: Pancreatic neuroendocrine tumors: A single institution's experience with surgically treated patients. The 29th Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Yokohama, June 7-10, 2017
  16. Kenji Uryuhara, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Yuki Hashida, Hiroyuki Kobayashi, Satoshi Kaibara, Ryo Hosoya: Groin Treatment strategy for incarcerated partial hernia. The 15th Annual Meeting of the Japanese Hernia Society, Tokyo, 2017.6.2-3
  17. Satake H, Tanioka H, Miyake Y, Yoshioka S, Watanabe T, Matsuura M, Kyogoku T, Inukai M, Kotake T, Okita Y, Hatachi Y, Yasui H, Kotaka M, Kato T, Kaihara S, Tsuji A: Hepatectomy followed by adjuvant chemotherapy with capacitabine plus oxaliplatin for three months for colorectal cancer liver metastases: A multi-center phase 2 study. 2017 ASCO Annual Meeting,Chicago,2017.6.2-6
  18. Kaihara S, Kondo M: Therapeutic strategy for acute appendicitis with an appendicular abscess or mass. EAES 2017, Frankfurt, 2017.6.14-17
  19. Kita R, Masui H: Liver Parenchymal Dissection with Pre-coagulation Dissection Technique for Laparoscopic Hepatectomy. EAES 2017, Frankfurt, 2017.6.14-17
  20. Kaihara S: A safe technique for laparoscopic distal pancreatectomy with spleen preservation. EAES 2017, Frankfurt, June 14-17, 2017
  21. Motoko Mizumoto, Masato Kondo, Kenji Uryuhara, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yoshifumi Kitamura, Satoshi Kaibara, Ryo Hosoya: esophageal mesenteric transformation and Intra - Stylization of thoracoscopic esophagectomy by operative nerve monitoring. The 71st Annual Meeting of the The Japan Esophageal Society, Karuizawa, 2017.6.15-16
  22. Masui H., Kita R., Kondo M., Kobayashi H., Kaihara S., Hosoya R.: A study of surgically treated esophageal perforation and spontaneous esophageal rupture. The 71st Annual Meeting of the The Japan Esophageal Society, Karuizawa, 2017.6.15-16
  23. Hiroyuki Kobayashi, Motoko Mizumoto, Satoshi Kaihara, Ryo Hosoya: A study on the relationship between preoperative nutrition and immune status and postoperative complications. The 71st Annual Meeting of the The Japan Esophageal Society, Karuizawa, 2017.6.15-16
  24. Kaihara, S., Shiokawa, K., Matsubara, T., Kumada, Y., Kita, R., Masui, H., Mizumoto, M., Kitamura, Y., Kondo, M., Hashida, Y., Uryuhara, K., Hiroki Hashida, H., Hosoya, R.: Triggered by abdominal pain due to tumor rupture An example of SPNs discovered in The 48th Annual Meeting of the Japan Pancreatic Society, Kyoto, July 14-15, 2017
  25. Motoko Mizumoto, Nobua Iwamura, Ryosuke Kita, Hideyuki Masui, Shoichi Kitano, Yukiko Kumada, Ayaka Omori, Takaaki Matsubara, Satoshi Kaihara: Preventive effect of recurrent laryngeal nerve paralysis after surgery for esophageal cancer by intra-operative nerve monitoring. 72nd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kanazawa, 2017.7.20-22
  26. Satoshi Kaihara, Ayaka Omori, Takaaki Matsubara, Yukiko Kumada, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Nobuya Iwamura, Ryo Hosoya: Liver reserve evaluation by 99mTc-GSA scintigraphy and VINCENT fusion image in right lobe liver resection. The 72nd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kanazawa, 2017.7.20-22
  27. Kenji Uryuhara, Yoshifumi Kitamura, Takaaki Matsubara, Yukiko Kumada, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Nobua Iwamura, Ryo Hosoya: Treatment Strategies for Colorectal Liver Metastasis: The Analysis of Risk Factor and the Management. 72nd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kanazawa, 2017.7.20-22
  28. Matsubara T., Kitano S., Kumada Y., Kita R., Masui H., Iwamura N., Kaibara S., Hosoya R.: Postoperative management of patients with acute generalized peritonitis in cooperation with emergency department and surgeons. 72nd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kanazawa, 2017.7.20-22
  29. Satoshi Kaihara, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida, Kenji Uryuhara, Hiroyuki Kobayashi, Ryo Hosoya: Before surgery for resectable pancreatic cancer treatment strategy. 72nd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kanazawa, 2017.7.20-22
  30. Yuki Hashida, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaibara, Ryo Hosoya: A clinical study of surgical resection for patients over 80 years of age with colorectal cancer. 72nd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kanazawa, 2017.7.20-22
  31. Satoshi Kaihara, Keiichi Shiokawa, Takaaki Matsubara, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida Hashida, Kenji Uryuhara, Hiroyuki Kobayashi, Ryo Hosoya: The strategies for the reduction of the bile leakage after the hepatectomy in our hospital. 72nd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kanazawa, 2017.7.20-22
  32. Hiroyuki Kobayashi, Ayaka Omori, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Ryo Hosoya, Satoshi Kaihara: Examination of treatment strategy for colorectal cancer ileus patients at our hospital. 72nd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kanazawa, 2017.7.20-22
  33. Keiichi Shiokawa, Takaaki Matsubara, Yukiko Kumada, Shoichi Kitano, Hideyuki Masui, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroki Hiroki Hashida, Hiroyuki Kobayashi, Kenji Uriuhara, Satoshi Kaihara, Ryo Hosoya: Contamination surgery Towards eradication of wound SSI. 72nd Annual Meeting of the Japanese Society of Gastroenterological Surgery, Kanazawa, 2017.7.20-22
  34. Satoshi Kaihara: Postoperative long-term follow-up of living-donor liver transplant donors at our hospital. The 53rd Annual Meeting of the The Japan Society for Transplantation, Asahikawa, 2017.9.7-9
  35. Urano, N., Inokuma, T., Kaihara, S.: Joint laparoscopic-endoscopic surgery for luminal-growing gastric submucosal tumor with Delle in our hospital. The 107th Annual Meeting of the Kinki Branch of the The Japanese Society of Gastroenterology, Osaka, 2017.9.23
  36. Takaaki Matsubara, Yukiko Kumada, Shoichi Kitano, Hideyuki Masui, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Kenji Uryuhara, Ryo Hosoya, Satoshi Kaihara: Limitations of surgical treatment for colorectal neuroendocrine tumors Outlook. 15th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Fukuoka, 2017.10.12-15
  37. Yuki Hashida, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaibara, Ryo Hosoya: Treatment of left-sided colorectal cancer ileus in our hospital strategy. 15th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Fukuoka, 2017.10.12-15
  38. Motoko Mizumoto, Ayaka Omori, Takaaki Matsubara, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Nobua Iwamura, Satoshi Kaihara, Ryo Hosoya: Examination of recurrent factors of gastrointestinal GIST in our hospital. 15th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Fukuoka, 2017.10.12-15
  39. Kondo M, Mizumoto M, Kita R, Masui H, Kitano S, Kumata Y, Matsubara T, Shiokawa K, Kaihara S, Hosotani R: Prevention of Recurrent Laryngeal Nerve Paralysis after Esophagectomy by Intra-operative Nerve Monitoring. ACS, San Diego, 2017.10.22-26
  40. Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Hideyuki Masui, Ryosuke Kita, Satoshi Kaihara, Ryo Hosoya: Safe use of electric scalpel in laparoscopic surgery. Gastric cancer postoperative disorders study group, Tokyo, 2017.11.3-4
  41. Masato Kondo, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Hiroyuki Kobayashi, Hiroki Hashida, Satoshi Kaibara, Ryo Hosoya: Post-gastric surgery patients Efforts on oral nutrition supplementation. Gastric Cancer Postoperative Disorder Research Group, Tokyo, 2017.11.3-4
  42. Kita R., Shiokawa K., Kobayashi H., Hosoya R., Kaihara S.: A case of laparoscopic abdominal perineal resection (TAMIS-APR) for malignant melanoma in the anal rectum. The 72nd Annual Meeting of the Society of Coloproctology, Fukuoka, 2017.11.10-11
  43. Shiokawa K, Matsubara T, Kumata Y, Kitano S, Kita R, Masui H, Mizumoto M, Kondo M, Kobayashi H, Hosotani R, Kaihara S: Laparoscopic Posterior Rectopexy for Complete Rectal Prolapse. ACRES2017, Taipei, 2017.11.24-26
  44. Kaihara S: Complete intrathoracic reconstruction for lower esophageal cancer under the prone position. ACRES2017, Taipei, 2017.11.24-26
  45. Shimeno N, Shiokawa K, Matsubara T, Kumata Y, Kitano S, Masui H, Kita R, Kondo M, Hashida H, Kaihara S. Laparoscopic endoscopic cooperative surgery for gastric submucosal tumor. ACRES2017, Taipei, 2017.11.24-26
  46. Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida, Kenji Uryuhara, Hiroyuki Kobayashi, Ryo Hosoya: Laparoscopy in our hospital Introduced lower systematic liver resection and results. The 30th Annual Meeting of the Japanese Society for Endoscopic Surgery, Kyoto, December 7-9, 2017
  47. Masato Kondo, Motoko Mizumoto, Ryosuke Kita, Hideyuki Masui, Shoichi Kitano, Yukiko Kumada, Takaaki Matsubara, Keiichi Shiokawa, Kenji Uryuhara, Yuuki Hashida, Yoshifumi Kitamura, Satoshi Kaibara, Ryo Hosoya: Esophagus without recurrent laryngeal nerve palsy Ingenuity of mediastinal dissection technique above cancer. The 30th Annual Meeting of the Japanese Society for Endoscopic Surgery, Kyoto, December 7-9, 2017
  48. Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Kenji Uryuhara, Hiroyuki Kobayashi, Ryo Hosoya, Satoshi Kaihara: Laparoscopy for parastomal hernia Lower repair. The 30th Annual Meeting of the Japanese Society for Endoscopic Surgery, Kyoto, December 7-9, 2017
  49. Kita, R., Masui, H., Kitano, S., Kumada, Y., Mizumoto, M., Kitamura, Y., Kobayashi, H., Uriuhara, K., Hashida, Y., Kaihara, S., Hosoya, R.: Based on a complete medial approach to advanced transverse colon cancer D3 dissection of the sandwich. The 30th Annual Meeting of the Japan Society for endoscopic Surgery, Kyoto, December 7-9, 2017
  50. Kaihara S., Shiokawa K., Matsubara T., Kitano S., Kumada Yukiko, Kita R., Masui H., Mizumoto M., Kondo M., Uryuhara K., Kobayashi H., Hashida H., Hosoya R.: Laparoscopy at our hospital Image-assisted utilization method in inferior systematic hepatectomy. The 30th Annual Meeting of the Japan Society for endoscopic Surgery, Kyoto, December 7-9, 2017
  51. Keiichi Shiokawa, Takaaki Matsubara, Yukiko Kumada, Shoichi Kitano, Hideyuki Masui, Ryosuke Kita, Yoshifumi Kitamura, Masato Kondo, Hiroki Hashida, Hiroyuki Kobayashi, Kentsugu Uriubara, Satoshi Kaihara, Ryo Hosoya: Devices of laparoscopic endoscopic joint surgery for gastric submucosal tumor at our hospital. The 30th Japan Society for endoscopic Surgery, Kyoto, 2017.12.7-9
  52. Yoshifumi Kitamura, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Yukiko Kumada, Hideyuki Masui, Motoko Mizumoto, Masato Kondo, Yuki Hashida, Kenji Uryuhara, Hiroyuki Kobayashi, Satoshi Kaibara, Ryo Hosoya: Simultaneous liver metastasis from colorectal cancer A study on short-term outcomes in resected cases. The 30th Annual Meeting of the Japanese Society for Endoscopic Surgery, Kyoto, December 7-9, 2017
  53. Kaihara S., Shiokawa K., Matsubara T., Kitano S., Kumada Y., Kita R., Mizumoto M., Kitamura Y., Kondo M., Kobayashi H., Hashida Y., Uriuhara K., Hosoya R.: Laparoscopic liver resection Investigation of the usefulness of the difficulty scoring system in surgery. The 30th Annual Meeting of the Japan Society for endoscopic Surgery, Kyoto, December 7-9, 2017
  54. Hashida, Y., Shiokawa, K., Matsubara, T., Kumada, Y., Kita, R., Masui, H., Mizumoto, M., Kitamura, Y., Kondo, M., Uryuhara, K., Kobayashi, H., Kaibara, S., Hosoya, R.: Acute appendicitis during pregnancy Nine patients underwent laparoscopic appendectomy. The 30th Annual Meeting of the Japan Society for endoscopic Surgery, Kyoto, December 7-9, 2017
  55. Yuki Hashida, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Motoko Mizumoto, Yoshifumi Kitamura, Masato Kondo, Kenji Uryuhara, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya: Laparoscopy in our hospital Surgical results of posterior fixation of the lower rectum. The 30th Annual Meeting of the Japan Society for endoscopic Surgery, Kyoto, December 7-9, 2017
  56. Uriuhara, K., Kobayashi, H., Hashida, Y., Kondo, M., Kitamura, Y., Mizumoto, M., Kita, R., Masui, H., Kitano, S., Kumada, Y., Shiokawa, K., Hosoya, R., Kaibara, S.: Inguinal area and obturator foramen A study on the selection of surgical procedures for emergency surgery for incarcerated hernias. The 30th Annual Meeting of the Japan Society for endoscopic Surgery, Kyoto, December 7-9, 2017
  57. Uryuhara K, Matsubara T, Kitano S, Kitano Y, Kumada Y, Kita R, Masui H, Mizumoto M, Kitamura Y, Kondo M, Hashida Y, Kobayashi H, Kaibara S, Hosoya R: Acute cholecystitis in our hospital. Examination of surgical procedures and treatment options. The 30th Annual Meeting of the Japan Society for endoscopic Surgery, Kyoto, December 7-9, 2017
  58. Motoko Mizumoto: Comparison of postoperative injury after laparoscopic pyloric gastrectomy in our hospital. The 90th Annual Meeting of the Japanese Gastric Cancer Society, Yokohama, 2018.3.7-9
  59. Masato Kondo: Neoadjuvant chemotherapy using G-SOX for locally advanced gastric cancer. The 90th Annual Meeting of the Japanese Gastric Cancer Society, Yokohama, 2018.3.7-9

  1. Kaihara, S. et al.: Current status and countermeasures for extrahepatic bile duct cancer surgery at our hospital. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  2. Kenji Uriuhara, et al.: Treatment status of recurrence of hepatitis C after liver transplantation at our hospital and experience with new antiviral drugs. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  3. Hiroyuki Kobayashi, et al.: Usefulness of the NIM-response system for left upper mediastinal lymph node dissection for esophageal cancer. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  4. Hashida, H. et al.: Surgical treatment and perioperative anti-TNF-α antibody treatment for Crohn's disease. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  5. Junji Komori, et al.: Challenge to liver and organ creation by stem cell transplantation. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  6. Masato Kondo, et al.: Preoperative SOX therapy for locally advanced gastric cancer. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  7. Motoko Mizumoto, et al.: Ingenuity of joint laparoscopic-endoscopic surgery for gastric submucosal tumor with Delle. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  8. Yusuke Sakamoto, et al.: A study of surgical procedures for T2 gallbladder cancer in our hospital. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  9. Kita R., et al.: Examination of usefulness of wound management protocol. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  10. Masui H., et al.: Results of liver resection in the elderly. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  11. Kitano, S. et al.: Techniques and results of pancreato-gastrointestinal anastomosis in our hospital. The 116th Annual Meeting of the Japan Surgical Society, Osaka, April 14-16, 2016
  12. Yukiko Kumada, et al.: Results of colonic stent SEMS placement for malignant colonic obstruction in our hospital. The 116th Annual Meeting of the Japanese Surgical Society, Osaka, April 14-16, 2016
  13. Kaihara S, et al: Treatment strategy for large HCC. 28th JHPBA annual meeting, Osaka, 2016.6.4 - 6
  14. Iwamura S, et al: Pancreatoduodenectomy with portal vein resection for locally advanced pancreatic head cancer. 28th JHPBA annual meeting, Osaka, 2016.6.4 - 6
  15. Kita R, et al: Evaluation of clinical outcome of our procedure in biliary reconstruction. 28th JHPBA annual meeting, Osaka, 2016.6.4 - 6
  16. Masui H, et al: Standardization of distal pancreatectomy for prevention of pancreatic fistula. 28th JHPBA annual meeting, Osaka, 2016.6.4 - 6
  17. Takeshi Uriuhara, et al.: A study of pancreatojejunostomy by the modified Blumgart method in our hospital. The 28th Annual Meeting of the Japanese Society of Hepato-Biliary-Pancreatic Surgery Surgery, Osaka, 2016.6.4 - 6
  18. Hashida, H. et al.: Technique and usefulness of laparoscopic rectal fixation for complete rectal prolapse. The 18th Annual Meeting of the Japanese Society of Women's Pelvic Floor Medicine, Kitakyushu, June 11-12, 2016
  19. Kobayashi H, et al: Prevention of Recurrent Laryngeal Nerve Paralysis after Esophagectomy using NIM-Response System. EAES 2016, Amsterdam, 2016.6.15-18
  20. Mizumoto M, et al: A new method of laparoscopic endoscopic cooperative surgery for gastric submucosal tumor. EAES 2016, Amsterdam, 2016.6.15-18
  21. Hiroyuki Kobayashi, et al.: Ingenuity of creating a gastric fistula for nutrition after surgery for esophageal cancer and treatment results. The 70th Annual Meeting of the The Japan Esophageal Society, Tokyo, 2016.7.4 - 6
  22. Kaihara, S. et al.: Our strategies to achieve safety in major hepatectomy. The 71st Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  23. Junji Komori, et al.: Organ regeneration by orthotopic hepatocyte sheet transplantation. The 71st Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  24. Hashida, H. et al.: Laparoscopic repair using the Sandwich technique for parastomal hernia. The 71st Annual Meeting of the Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  25. Kenji Uryuhara, et al.: Problems of long-term follow-up patients after living-donor liver transplantation in our hospital. The 71st Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  26. Motoko Mizumoto, et al.: Experience of joint laparoscopic-endoscopic surgery for duodenal tumor in our hospital. The 71st Annual Meeting of the Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  27. Hiromitsu Kinoshita, et al.: A study of colorectal cancer surgery cases aged 80 and over at our hospital. The 71st Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  28. Yukiko Kumada, et al.: Surgical outcome and long-term prognosis of liver resection in elderly patients aged 80 years and over. The 71st Annual Meeting of the Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  29. Kita, R., et al.: Surgery for dialysis patients. The 71st Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  30. Yusuke Sakamoto, et al.: Examination and countermeasures for suture failure cases in rectal cancer surgery. The 71st Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  31. Shoichi Kitano, et al.: Measures to reduce pancreatic fistula after pancreaticoduodenectomy in our hospital. The 71st Annual Meeting of the Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  32. Ayaka Omori, et al.: A resected case of a small NET G2 associated with early rectal cancer. The 71st Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Tokushima, 2016.7.14-16
  33. Kaihara S, et al: Long term follow up after surgical resection for pancreas cancer smaller than 2 cm in diameter. The 20th meeting of IAP, Sendai, 2016.8.4-7
  34. Iwamura S, et al: Management of locally advanced pancreatic cancer adjacent to the celiac axis. The 20th meeting of IAP, Sendai, 2016.8.4 - 7
  35. Kita R, et al: Our Strategy for pancreaticojejunostomy. The 20th meeting of IAP, Sendai, 2016.8.4 - 7
  36. Kondo M, et al: Complete laparoscopic spleen-preserving distal pancreatectomy without splenic vessel ligation. ACS 2016, Washington DC, 2016.10.16-20
  37. Kumata M, et al: The Sandwich Method for Parastomal Hernia. ACS 2016, Washington DC, 2016.10.16-20 ― 152 ―
  38. Hashida, H. et al.: A case of unresectable transverse colon cancer with multiple metastases that was resected after chemotherapy CR. The 54th Annual Meeting of the Japan Society of Clinical Oncology of Oncology, Yokohama, 2016.10.20-22
  39. Masato Kondo, et al.: Stylization and points of dissection in laparoscopic gastric cancer surgery. Gastric cancer postoperative disorder study group, Yonago, 2016.10.27-28
  40. Hideyuki Masui, et al.: A study of patients aged 80 years or older who underwent surgery for gastric cancer. Gastric cancer postoperative disorder study group, Yonago, 2016.10.27-28
  41. Yukiko Kumada, et al.: The Sandwich Method for Parastomal Hernia. The 14th Annual Meeting of the Japanese Hernia Society, Tokyo, 2016.10.28-29
  42. Ayaka Omori, et al.: The usefulness of preoperative ultrasound scan to detect contralateral groin hernia. The 14th Annual Meeting of the Japanese Hernia Society, Tokyo, 2016.10.28-29
  43. Takaaki Matsubara, et al.: A study of laparoscopic incisional hernia repair surgery in our hospital. The 14th Annual Meeting of the Japanese Hernia Society, Tokyo, 2016.10.28-29
  44. Hashida H, et al: Infliximab therapy and surgical intervention for Crohn's disease. APDW 2016, Kobe, 2016.11.2-5
  45. Kaihara S, et al: Liver parenchymal dissection with pre-coagulation dissection technique for laparoscopic hepatectomy. ELSA 2016, Shuzo, 2016.11.9-12
  46. Masui H, et al.: Introduction of Laparoscopic Liver Resection in our hospital. ELSA 2016, Shuzo, 2016.11.9-12
  47. Yoshifumi Kitamura: Small intestinal perforation due to accidental ingestion of a foreign object that could not be diagnosed preoperatively (case report). The 44th Annual Meeting of the Japanese Association for Acute Medicine, Tokyo, November 17-18, 2016
  48. Hiroki Hashida: Efforts to prevent SSI after emergency colostomy for perforation of the lower gastrointestinal tract. The 71st Annual Meeting of the Japanese Society of Coloproctology, Ise, 2016.11.18-19
  49. Nobua Iwamoto: Efforts toward the introduction of laparoscopic systematic liver resection in our department - Gleason's individual prior treatment method in lateral segmentectomy -. 10th Liver Endoscopic Surgery Conference, Tokyo, 2016.11.23
  50. Hideyuki Masui: Approach to highly difficult tumors at our hospital - Efforts at community hospitals -. 10th Liver Endoscopic Surgery Research Meeting, Tokyo, 2016.11.23
  51. Masato Kondo: Laparoscopic caudal pancreatic resection applying the expansion of the surgical field of gastric cancer surgery. 8th Annual Meeting of Pancreatic Endoscopic Surgery, Tokyo, 2016.11.23
  52. Ayaka Omori: A resected case of IPMC with marked swelling of the pancreas due to tumor progression. 78th Congress of Clinical Surgery, Tokyo, 2016.11.24-26
  53. Takaaki Matsubara: A case of gastric glomus tumor with gastrointestinal hemorrhage who underwent laparoscopic local gastrectomy. The 78th Congress of Clinical Surgery, Tokyo, 2016.11.24-26
  54. Motoko Mizumoto: A study using the clinical pathway for laparoscopic colectomy. The 17th Annual Meeting of the Japanese Society of Clinical Pathway, Kanazawa, 2016.11.24-26
  55. Satoshi Kaihara, et al.: Liver parenchyma dissection without bleeding: pre-coagulation dissection technique using soft coagulation. 29th Annual Meeting of the Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  56. Hiroyuki Kobayashi, et al.: Prevention of recurrent laryngeal nerve paralysis after esophageal cancer surgery by mesenterization and intra-operative nerve monitoring. 29th Annual Meeting of the Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  57. Hashida, H. et al.: Laparoscopic left-sided colectomy focusing on medial approach for splenic flexure colon cancer. 29th Annual Meeting of the Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  58. Masato Kondo, et al.: Stylization of gastrectomy on the pylorus side in a general public hospital: preparation, actual operation, and place replacement. 29th Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  59. Masato Kondo, et al.: Stylization of function-preserving caudal pancreatectomy in which the surgical method is selected based on the positional relationship between the tumor, vessels, and spleen. 29th Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  60. Yoshifumi Kitamura, et al.: A step-by-step improvement of the Glisson processing method for laparoscopic lateral segment resection of the liver in our department. The 29th Annual Meeting of the Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  61. Motoko Mizumoto, et al.: Laparoscopic total gastrectomy anastomosis using a linear stapler in our hospital. 29th Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  62. Nobua Iwamura, et al.: Ingenuity in expanding the surgical field in laparoscopic caudal pancreatic resection Is gastric taping necessary in laparoscopic caudal pancreatic resection? The 29th Annual Meeting of the Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  63. Masui, H., et al.: Trial of laparoscopic liver resection at a city hospital. The 29th Annual Meeting of the Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  64. Kita, R., et al.: Stylization of surgical technique by medial approach for left-sided advanced colon cancer. 29th Annual Meeting of Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  65. Shoichi Kitano, et al.: A device for reducing the amount of bleeding in laparoscopic-assisted right colectomy in our hospital. 29th Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  66. Yukiko Kumada, et al.: Hemostasis technique in laparoscopic gastrectomy-a device to keep a dry visual field without spreading bleeding. The 29th Annual Meeting of the Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  67. Ayaka Omori, et al.: Actual practice of TAPP and groin incision in our hospital. The 29th Annual Meeting of the Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  68. Takaaki Matsubara, et al.: Efforts toward the standardization of laparoscopic incisional hernia repair. 29th Endoscopic Surgery Society, Yokohama, December 8-10, 2016
  69. Hashida, H. et al.: Laparoscopic repair of parastomal hernia. 34th Annual Meeting of the Japanese Society of Ostomy and Excretion Rehabilitation, Nagoya, February 17-18, 2017 70. Masato Kondo, et al.: Results of preoperative SOX therapy for locally advanced gastric cancer. The 89th Annual Meeting of the Japanese Gastric Cancer Society, Hiroshima, 2017.3.8 - 9

  1. Kondo M, Kita R, Masui H, Sakamoto Y, Kinoshita H, Komori J, Uryuhara K, Kobayashi H, Hashida H, Kaihara S, Hosotani R: Total Medial Approach for Complete Mesoscopic Excision of Advanced Transverse Colon Cancer How to Approach Easily Ensuring Oncological safety. SAGES2015, Nashville, 2015.4.15-20
  2. Kinoshita H, Kondo M, Kita R, Masui H, Sakamoto Y, Okada K, Yamamoto T, Miki A, Yagi S, Uryuhara K, Kobayashi H, Hashida H, Kaihara S, Hosotani R: Thoracoscopic intrathoracic esophagogastric anastomosis following minimally invasive esophagectomy for the patient after total laryngectomy, report of a case. SAGES2015, Nashville, 2015.4.15-20
  3. Hiroyuki Kobayashi, Masato Kondo, Kazuyuki Okada, Kento Yamamoto, Hiromitsu Kinoshita, Yusuke Sakamoto, Ryosuke Kita, Hideyuki Masui, Takeshi Uryuhara, Hiroki Hashida, Shintaro Yagi, Akira Miki, Ryo Hosoya, Satoshi Kaihara: prone position thoracoscopy Stylized left upper mediastinal dissection in lower esophagectomy. The 116th Surgical Society, Nagoya, 2015.4.16-18
  4. Uryuhara K, Masui H, Kita R, Kita Y, Sakamoto Y, Kinoshita H, Yamamoto T, Okada K, Miki A, Kondo M, Yagi S, Hashida Y, Kobayashi H, Satoshi Kaihara, Hosoya R: Abdominal trauma in our hospital Treatment Practices - A Collaborative and Cooperative Practice System Led by the Emergency Department. The 116th Surgical Society, Nagoya, 2015.4.16-18
  5. Hashida, Y., Kita, R., Masui, H., Sakamoto, Y., Kinoshita, K., Okada, K., Yamamoto, K., Miki, A., Kondo, M., Uryuhara, K., Kenji Uryuhara, H., Kaibara, Satoshi Kaihara, Hosoya, R.: Posterior laparoscopic procedure for complete rectal prolapse. Fusion surgery - a study based on the surgical method and pelvic organ function -. The 116th Surgical Society, Nagoya, 2015.4.16-18
  6. S. Yagi, Satoshi Kaihara, R. Kita, Y. Sakamoto, H. Kinoshita, K. Okada, K. Yamamoto, A. Miki, M. Kondo, J. Komori, K. Uryuhara, Y. Hashida, H. Kobayashi, R. Hosoya: R0 for locally advanced pancreatic cancer A surgical technique aimed at The 116th Surgical Society, Nagoya, 2015.4.16-18
  7. Kazuyuki Okada, Masato Kondo, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yusuke Sakamoto, Nobua Iwamura, Motoko Mizumoto, Junji Komori, Kenji Uryuhara, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya: Surgical technique for esophagogastric junction cancer. The 116th Surgical Society, Nagoya, 2015.4.16-18
  8. Kento Yamamoto, Masato Kondo, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yusuke Sakamoto, Nobua Iwamura, Motoko Mizumoto, Junji Komori, Kenji Uryuhara, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya : Treatment results and preoperative diagnosis of laparoscopic pyloric gastrectomy. The 116th Surgical Society, Nagoya, 2015.4.16-18
  9. R. Kita, S. Yagi, H. Masui, H. Kinoshita, Y. Sakamoto, K. Okada, K. Yamamoto, A. Miki, M. Kondo, Kenji Uryuhara, H. Kobayashi, H. Hashida, Satoshi Kaihara Kaibara, R. Hosoya: Results of resectable pancreatic cancer . The 116th Surgical Society, Nagoya, 2015.4.16-18
  10. H. Masui, Satoshi Kaihara Kaihara, R. Kita, Y. Sakamoto, H. Kinoshita, K. Okada, K. Yamamoto, A. Miki, M. Kondo, J. Komori, K. Uryuhara, Y. Hashida, H. Kobayashi, R. Hosoya: 99mTc-GSA-SPECT and the safety of the KICG-based hepatic resection method. The 116th Surgical Society, Nagoya, 2015.4.16-18
  11. Nobori Y, Hashida Y, Kita R, Masui H, Sakamoto Y, Kinoshita H, Okada K, Yamamoto K, Miki A, Kondo M, Uryuhara K, Kobayashi H, Satoshi Kaihara, Hosoya R: Traumatic duodenal injury One case. The 116th Surgical Society, Nagoya, 2015.4.16-18
  12. Motoko Mizumoto, Hiroshi Okabe, Eiji Tanaka, Shigeru Tsunoda, Shigeo Hisamori, Katsuhiro Murakami, Yoshiharu Sakai: Study on usefulness of staging method for advanced gastric cancer by screening laparoscopy. The 116th Surgical Society, Nagoya, 2015.4.16-18
  13. Nobua Iwamura, Taku Iida, Hiroaki Terashima, Hiroyuki Matsubara, Toru Goto, Yoshikage Inoue, Mami Yoshitomi, Yoichiro Uchida, Shugo Ueda, Akinobu Kanazawa: Preoperative Biliary Drainage and Perioperative Complications for Pancreatic Head Tumors relevance to. The 116th Surgical Society, Nagoya, 2015.4.16-18
  14. H. Masui, T. Uryuhara, R. Kita, Y. Sakamoto, H. Kinoshita, K. Okada, T. Yamamoto, A. Miki, M. Kondo, J. Komori, K. Uryuhara, Y. Hashida, H. Kobayashi, Satoshi Kaihara, R. Hosoya: Treatment strategy for laparoscopic inguinal hernia repair for patients taking coagulation/antiplatelet drugs. The 13th Annual Meeting of the Japanese Hernia Society, Nagoya, 2015.5.22-23
  15. Uriuhara K, Satoshi Kaihara, Masui H, Kita R, Sakamoto Y, Kinoshita H, Okada K, Yamamoto T, Miki A, Kondo M, Masato Kondo J, Hashida Y, Kobayashi H, Hosoya R: Alcoholism in our hospital. Live-donor liver transplantation for liver cirrhosis. 33rd Liver Transplantation Study Group, Kobe, 2015.5.28-29
  16. Junji Komori: In vivo liver tissue and organ generation by ectopic hepatocyte transplantation. 22nd Hepatocyte Research Meeting, Yonago, 2015.6.4-5
  17. Uryuhara K, Masui H, Kita R, Sakamoto Y, Kinoshita H, Yamamoto T, Okada K, Miki A, Kondo M, Komori J, Hashida H, Kobayashi H, Kaihara S, Hosotani R: Analysis of secondary resection for incidental gallbladder cancer. . The 27th Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Tokyo, 2015. 6. 11-13
  18. Kinoshita H, Kaihara S, Kitano S, Kumata Y, Kita R, Masui H, Sakamoto Y, Iwamura S, Mizumoto M, Kondo M, Komori J, Uryuhara K, Kobayashi H, Hashida H, Hosotani R: Current status of central hepatectomy in our hospital. The 27th Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Tokyo, 2015. 6. 11-13
  19. Sakamoto Y, Kaihara S, Kita R, Masui H, Kinoshita H, Okada K, Yamamoto T, Miki A, Kondo M, Komori J, Uryuhara K, Kobayashi H, Hashida H, Hosotani R: Feasibility of standardization of distal pancreatectomy for prevention of pancreatic fistula. The 27th Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Tokyo, 2015. 6. 11-13
  20. Komori J, Uryuhara K, Hashida H, Kaihara S, Hosotani R: A strategy for the leakage from pancreaticojejunostomy in soft pancreas cases using the modified Blumgart method. The 27th Hepato-Biliary-Pancreatic Surgery Society, Tokyo, 2015.6.11-13
  21. Kaihara S, Yagi S, Hashida H, Uryuhara K, Hosotani R: Treatment strategy for multiple liver metastasis from colo-rectal cancer. The 27th Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Tokyo, 2015. 6. 11-13
  22. Kento Yamamoto, Hiroyuki Kobayashi, Masato Kondo, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yusuke Sakamoto, Nobua Iwamura, Motoko Mizumoto, Junji Komori, Kenji Uryuhara, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara, Hosoya R.: A study of laparoscopic cholecystectomy for acute cholecystitis. The 27th Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Tokyo, 2015. 6. 11-13
  23. Nobua Iwamura, Taku Iida, Hiroaki Terashima, Hiroyuki Matsubara, Toru Goto, Yoshikage Inoue, Mami Yoshitomi, Yoichiro Uchida, Shugo Ueda, Akinobu Kanazawa: Preoperative Biliary Drainage and Perioperative Complications for Pancreatic Head Tumors impact on The 27th Annual Meeting of the Hepato-Biliary-Pancreatic Surgery Society, Tokyo, 2015.6.11-13
  24. Uryuhara, T., Shigehira, K., Sakuma, M., Mizumoto, M., Hirata, T., Oku, S., Katayama, T., Ishida, M.: Current status and issues regarding the auxiliary role of pre-hospital examination centers for doctor practice. 17th Medical Management Conference, Osaka, 2015. 6. 12-13
  25. Y. Sakamoto, Satoshi Kaihara, R. Kita, H. Masui, H. Kinoshita, K. Okada, K. Yamamoto, A. Miki, M. Kondo, J. Komori, K. Uryuhara, H. Hashida, H. Kobayashi, R. Hosoya: Preoperative radiation chemotherapy A case of locally advanced pancreatic cancer with R0 after caudal pancreatectomy with celiac artery. The 46th Annual Meeting Japan Pancreas Society, Nagoya, 2015.6.19-20
  26. Hiromitsu Kinoshita, Masato Kondo, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yusuke Sakamoto, Nobua Iwamura, Motoko Mizumoto, Junji Komori, Kenji Uryuhara, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya: Introduction and results of laparoscopic pancreatectomy in our hospital. The 46th Annual Meeting Japan Pancreas Society, Nagoya, 2015.6.19-20
  27. Komori J, Fontes P, Lagasse E: Liver tissue engineering in swine lymph nodes by cell transplantation. ISCCR2015, Stockholm, 2015. 6. 24-27
  28. Kobayashi, H., Kondo, M., Okada, K., Yamamoto, K., Kinoshita, H., Sakamoto, Y., Kita, R., Masui, H., Hosoya, R., Satoshi Kaihara.: Video-assisted esophagectomy and intrathoracic anastomosis for thoracic esophageal cancer after laryngectomy. The 69th Annual Meeting The Japan Esophageal Society, Yokohama, 2015. 7. 2-3
  29. Masato Kondo, Ryosuke Kita, Hideyuki Masui, Hiromitsu Kinoshita, Yusuke Sakamoto, Kenji Uryuhara, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya: Preoperative chemotherapy using DCF for esophageal cancer. The 69th Annual Meeting The Japan Esophageal Society, Yokohama, 2015. 7. 2-3
  30. Satoshi Kaihara, Okada K, Kita R, Kita H, Kinoshita Y, Sakamoto Y, Yamamoto K, Komori J, Uryuhara K, Hosoya R: Ingenuity to improve the safety of liver resection and attempts to standardize the surgical procedure. The 70th Annual Meeting The Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015. 7. 15-17
  31. Kobayashi, H., Kondo, M., Okada, K., Yamamoto, K., Kinoshita, H., Sakamoto, Y., Kita, R., Masui, H., Hosoya, R., Satoshi Kaihara Thoracoscopic subtotal esophagectomy combined with superior sternotomy. The 70th Annual Meeting The Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015. 7. 15-17
  32. Hashida H, Kita R, Masui H, Kinoshita H, Sakamoto Y, Miki A, Kondo M, Kobayashi H, Hosoya R, Satoshi Kaihara: Perioperative anti-TNF-α antibody therapy for Crohn's disease. The 70th Annual Meeting The Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015. 7. 15-17
  33. Komori, J., Kita, R., Masui, H., Sakamoto, Y., Kinoshita, H., Iwamura, N., Mizumoto, M., Kondo, M., Uryuhara, K., Hiroki Hashida, H., Satoshi Kaihara, Hosoya, R.: Borderline resectable pancreatic cancer in our hospital. treatment strategy. 70th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015.7.15-17
  34. Kondo, M., Masui, H., Kita, R., Sakamoto, Y., Kinoshita, H., Yamamoto, K., Okada, K., Hashida, Y., Kaihara, Satoshi Kaihara, Hosoya, R.: Laparoscopic Complete Mesocolic Excision through Total Medial Approach for Advanced Colon Cancer. The 70th Annual Meeting The Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015.7.15-17
  35. Motoko Mizumoto, Hiroshi Okabe, Eiji Tanaka, Shigeru Tsunoda, Kenjiro Hirai, Tetsuya Shioda, Yoshiharu Sakai: Reconstruction using a linear stapler in total laparoscopic gastrectomy. The 70th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015. 7. 15-17
  36. Miki, A., Komori, J., Kita, R., Masui, H., Sakamoto, Y., Kinoshita, H., Iwamura, N., Mizumoto, M., Kondo, M., Uryuhara, K., Kenji Uryuhara, Y., Kobayashi, H., Kaihara, Satoshi Kaihara, Hosoya, R.: Gastric Surgery Improvement of surgical technique. The 70th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015.7.15-17
  37. Kazuyuki Okada, Akira Miki, Junji Komori, Ryosuke Kita, Hideyuki Masui, Yusuke Sakamoto, Hiromitsu Kinoshita, Nobua Iwamura, Motoko Mizumoto, Masato Kondo, Kenji Uryuhara, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya: Inside Ingenuity and precautions for endoscopic and laparoscopic surgical treatment. The 70th Annual Meeting The Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015. 7. 15-17
  38. Yamamoto, T., Hashida, Y., Kita, R., Masui, H., Kinoshita, H., Sakamoto, Y., Okada, K., Kondo, M., Hosoya, R., Satoshi Kaihara.: Safe and Optimal Dissection by Scissors-inside Dissection Mainly Using Medial Approach. Laparoscopic transverse colectomy. The 70th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015.7.15-17
  39. Kinoshita H, Miki A, Kita R, Masui H, Sakamoto Y, Kaihara S, Hosotani R: Current status of No.13 lymph node dissection in our hospital. The 70th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015. 7. 15-17
  40. Ryosuke Kita, Junji Komori, Shoichi Kitano, Yukiko Kumada, Hideyuki Masui, Hiromitsu Kinoshita, Yusuke Sakamoto, Motoko Mizumoto, Masato Kondo, Kenji Kenji Uryuhara, Hiroyuki Kobayashi, Hiroki Hashida, Satoshi Kaihara Kaihara, Ryo Hosoya: Our Strategy for pancreaticojejunostomy . 70th Annual Meeting of the Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015.7.15-17
  41. H. Masui, Satoshi Kaihara, R. Kita, Y. Sakamoto, H. Kinoshita, K. Okada, T. Yamamoto, A. Miki, M. Kondo, J. Komori, K. Uryuhara, H. Hashida, H. Kobayashi, R. Hosoya: Using Monopolar Electrodes Investigation of usefulness of hepatic parenchymal resection by radiofrequency precoagulation. The 70th Annual Meeting The Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015. 7. 15-17
  42. A. Omori, Y. Hashida, R. Kita, H. Masui, H. Kinoshita, Y. Sakamoto, K. Okada, M. Kondo, R. Hosoya, Satoshi Kaihara: A case of osteogenic colon cancer. The 70th Annual Meeting The Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015. 7. 15-17
  43. Nobua Iwamura, Akinobu Kanazawa, Hiroyuki Matsubara, Toru Goto, Yoshikage Inoue, Mami Yoshitomi, Taku Iida, Shugo Ueda, Hiroaki Terashima: Treatment strategy for colorectal cancer ileus in our department - Self-Expanding Metal Stent: SEMS Changes in short-term performance before and after introduction. The 70th Annual Meeting of the The Japanese Society of Gastroenterological Surgery, Hamamatsu, 2015. 7. 15-17
  44. Nobua Iwamura, Yoichiro Uchida, Hiroaki Terashima, Toru Goto: A Case of Hepatocellular Carcinoma with Rapid Progression of Portal Vein Tumor Thrombi after Frequent Local Treatment-Validity of Surgery and Appropriate Control of Residual Liver Recurrence. Ha~. The 51st Annual Meeting of the Japanese Society for Liver Cancer, Kobe, 2015. 7. 23-24
  45. Mizumoto M, Tsunoda S, Tanaka E, Hirai K, Shiota T, Sakai Y: Esophagojejunostomy using linear stapler in laparoscopic total gastrectomy. World Congress of Surgery,Thailand,2015.8.22-27
  46. Mizumoto M, Shinohara H, Okabe H, Tsunoda S, Hisamori S, Kaihara S, Sakai Y: The usefulness of staging laparoscopy for advanced gastric cancer. ELSA2015, Daegu, Korea, 2015.9.2-5
  47. Uryuhara K, Kaihara S. Successful protocol with rituximab in adult living donor liver transplantation across ABO barrier. European Society for Organ Transplantation (ESOT), Brussels, Belgium, 2015.9.13-16
  48. Hiromitsu Kinoshita, Masato Kondo: Dissection technique in laparoscopic-assisted pyloric gastrectomy. Kyoto Clinical Surgery Seminar, Kyoto, 2015.9.26
  49. Kenji Uriuhara, Satoshi Kaihara, Hiroyuki Ueda: A case of hemorrhagic shock caused by duodenal ulcer perforating the hepatic artery after a living-donor liver transplant and being saved by IVR and surgery. The 51st Annual Meeting The Japan Society for Transplantation, Kumamoto, 2015.10.1-3
  50. Kobayashi H, Kondo M, Kaihara S: Lifting Technique in the Thoracoscopic Esophagectomy Makes Lymphadenectomy Along the Left Recurrent Laryngeal Nerve Easier. ACS2015, Chicago, 2015.10.4-8
  51. Kondo M, Hashida H, Kaihara S. Total Medial Approach with Pincers Movement for Laparoscopic Complete Mesocolic Excision of Advanced Transverse Colon Cancer. ACS2015, Chicago, 2015.10.4-8
  52. Masui H, Kaihara S: Usefulness of remnant liver function using 99m-Tc SPECT CT to estimate the future liver function after hepatectomy. ACS2015, Chicago, 2015.10.4-8
  53. H. Masui, T. Uryuhara, R. Kita, Y. Sakamoto, H. Kinoshita, K. Okada, K. Yamamoto, A. Miki, M. Kondo, J. Komori, Y. Hashida, H. Kobayashi, Satoshi Kaihara Kaihara, R. Hosoya: 1 of the accessory gallbladder duct example. 13th Annual Meeting The Japanese Society of Gastroenterological Surgery, Tokyo, 2015.10.8-11
  54. Sakamoto Y, Kondo M, Yamamoto T, Kinoshita H, Kita R, Masui H, Komori J, Hashida H, Kobayashi H, Uryuhara K, Kaihara S, Hosotani R: Efficacy of a Modified Fletcher classification for Gastrointestinal Stromal Tumors. ACG2015, Waikiki, 2015. 10. 16-21
  55. Kinoshita H, Sakamoto Y, Kaihara S, Hosotani R: Clinical Outcomes for Interval Appendectomy in the Treatment of Acute Appendicitis with an appendiceal abscess or mass. ACG2015, Waikiki, 2015. 10. 16-21
  56. Kita R, Hashida H, Kaihara S, Hosotani R: Clinical Outcome of Colonic Neuroendocrine Neoplasms. ACG2015, Waikiki, 2015. 10. 16-21
  57. Yukiko Kumada, Masato Kondo, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Hiromitsu Kinoshita, Yusuke Sakamoto, Nobua Iwamura, Satoshi Kaihara, Ryo Hosoya: Indications and results of interval appendectomy including fecal stone cases. 43rd Annual Meeting of the Japanese Association for Emergency Medicine, Tokyo, 2015.10.21-23
  58. Yuki Hashida, Shoichi Kitano, Yukiko Kumada, Hideyuki Masui, Ryosuke Kita, Hiromitsu Kinoshita, Yusuke Sakamoto, Nobua Iwamoto, Motoko Mizumoto, Junji Komori, Masato Kondo, Kenji Uryuhara, Hiroyuki Kobayashi, Ryo Hosoya, Satoshi Kaihara: Current status and prospects of surgical treatment for colorectal neuroendocrine tumors. The 53rd Japanese Society of Cancer Therapy, Kyoto, 2015. 10. 29-31
  59. Shoichi Kitano, Yuki Hashida, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yusuke Sakamoto, Hiromitsu Kinoshita, Nobua Iwamoto, Masato Kondo Kondo, Junji Komori, Kenji Uryuhara, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya: A case of HER2-positive advanced gastric cancer treated with trastuzumab and XP therapy underwent adjuvant surgery. The 53rd Japanese Society of Cancer Therapy, Kyoto, 2015. 10. 29-31
  60. Hashida H, Kumata Y, Kitano S, Masui H, Kita R, Sakamoto Y, Kinoshita H, Iwamura S, Kondo M, Hosotani R, Kaihara S: Standardization of laparoscopic Left Colectomy by 4 Directional approach to Mobilize Splenic Flexure. 10th ISLCRS,Singapore,2015.11.5-6
  61. Hashida H, Kumata Y, Kitano S, Masui H, Kita R, Sakamoto Y, Kinoshita H, Iwamura S, Mizumoto M, Kondo M, Kobayashi H, Hosotani R, Kaihara S: Laparoscopic Rectopexy for Rectal prolapse and Pelvic Organ Dysfunction. 10th ISLCRS,Singapore,2015.11.5-6
  62. Yusuke Sakamoto, Masato Kondo, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Hiromitsu Kinoshita, Nobua Iwamoto, Motoko Mizumoto, Junji Komori, Kenji Uryuhara, Hiroyuki Kobayashi, Hiroki Hashida, Satoshi Kaihara, Ryo Hosoya: Effect of laparoscopic pyloric side gastrectomy and pylorus-preserving gastrectomy on nutritional disorders in our hospital. The 45th Gastric Surgery and Postoperative Disorders Study Group, Niigata, 2015.11.7
  63. Masato Kondo, Shoichi Kitano, Yukiko Kumada, Hideyuki Masui, Ryosuke Kita, Yusuke Sakamoto, Hiromitsu Kinoshita, Nobua Iwamoto, Satoshi Kaihara, Ryo Hosoya: Usefulness of electrocautery in dissection in laparoscopic gastrectomy. The 45th Gastric Surgery and Postoperative Disorders Study Group, Niigata, 2015.11.7
  64. Hashida, Y., Ishiguro, M., Takiguchi, N., Ojima, H., Sugihara, K. Postoperative adjuvant chemotherapy for colon cancer in the elderly: ACTS-CC trial age-specific analysis. The 70th Society of Coloproctology, Nagoya, 2015. 11. 13-14
  65. Nobua Iwamura, Satoshi Kaihara: Liver parenchymal dissection without bleeding: pre-coagulation dissection technique using soft coagulation. 9th Liver Endoscopic Surgery Research Meeting, Fukuoka, 2015.11.25
  66. Yuki Hashida, Shoichi Kitano, Yukiko Kumada, Hideyuki Masui, Ryosuke Kita, Yusuke Sakamoto, Hiromitsu Kinoshita, Nobua Iwamoto, Masato Kondo Kondo, Junji Komori, Kenji Uryuhara, Hiroyuki Kobayashi, Ryo Hosoya, Satoshi Kaihara: Investigation of the effect of reinforcing anastomotic sutures to prevent suture failure in laparoscopic rectal resection. 77th Congress of Clinical Surgery, Fukuoka, 2015. 11. 26-28
  67. Shoichi Kitano, Satoshi Kaihara Kaihara, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yusuke Sakamoto, Hiromitsu Kinoshita, Nobua Iwamoto, Motoko Masato Kondo, Junji Komori, Kenji Uryuhara, Hiroyuki Kobayashi, Hiroki Hashida, Ryo Hosoya: Two cases of incarcerated inguinal hernia underwent emergency surgery. 77th Congress of Clinical Surgery, Fukuoka, 2015. 11. 26-28
  68. Yukiko Kumada, Hiroyuki Kobayashi, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Hiromitsu Kinoshita, Yusuke Sakamoto, Nobua Iwamura, Satoshi Kaihara, Ryo Hosoya: A case of gallbladder malignant lymphoma. 77th Congress of Clinical Surgery, Fukuoka, 2015. 11. 26-28
  69. Hiromitsu Kinoshita, Masato Kondo: Investigation of usefulness of interval appendectomy for abscess-tumor-forming appendicitis. 2015 Kyoto University Surgery Winter Research Meeting, Kyoto, 2015.12.5
  70. Satoshi Kaihara, Kenji Uryuhara, Junji Komori, Nobua Iwamura, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Hiromitsu Kinoshita, Yusuke Sakamoto, Motoko Mizumoto, Masato Kondo, Hiroyuki Kobayashi, Hiroki Hashida, Ryo Hosoya: Nonbleeding liver parenchymal dissection: pre-coagulation dissection technique with soft coagulation. 28th Endoscopic Surgery Society, Osaka, 2015. 12. 10-12
  71. Kobayashi, H., Kondo, M., Iwamura, N., Kinoshita, H., Sakamoto, Y., Kita, R., Kitano, S., Kumada, Y., Hashida, Y., Komori, J., Mizumoto, S., Kaibara, Satoshi Kaihara, Hosoya, R.: Thinking about the upper left vertical from the view of esophageal feeding vessels Separable dissection procedure. 28th Annual Meeting of Endoscopic Surgery Society, Osaka, 2015. 12. 10-12
  72. Yuki Hashida, Masato Kondo, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yusuke Sakamoto, Hiromitsu Kinoshita, Nobua Iwamoto, Motoko Mizumoto, Junji Komori, Kenji Uryuhara, Hiroyuki Kobayashi, Ryo Hosoya, Satoshi Kaihara: Stylization of laparoscopic surgery centered on medial approach for transverse colon cancer. 28th Endoscopic Surgery Society, Osaka, 2015. 12. 10-12
  73. M. Kondo, S. Kitano, Y. Kumada, H. Masui, R. Kita, H. Kinoshita, H. Sakamoto, M. Mizumoto, J. Komori, Kenji Uryuhara, H. Kobayashi, H. Hashida, Satoshi Kaihara, R. Hosoya: Development during gastrectomy dissection leading to D2 dissection: A safe and reliable procedure for residents. The 28th Annual Meeting of the Japanese Society for Endoscopic Surgery, Osaka, 2015. 12. 10-12
  74. Motoko Mizumoto, Masato Kondo, Hiromitsu Kinoshita, Nobua Iwamura, Junji Komori, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya: Joint laparoscopic surgery and laparoscopic endoscopy for gastric submucosal tumor in our hospital surgical experience. The 28th Annual Meeting of the Endoscopic Surgery Society, Osaka, 2015. 12. 10-12
  75. Nobua Iwamura, Satoshi Kaihara Kaihara, Shoichi Kitano, Yukiko Kumada, Hideyuki Masui, Ryosuke Kita, Hiromitsu Kinoshita, Yusuke Sakamoto, Motoko Mizumoto, Junji Komori, Kenji Uryuhara, Hiroyuki Kobayashi, Hiroki Hashida, Ryo Hosoya. Approach to laparoscopic partial hepatectomy - Aiming for safe and reliable resection -. 28th Endoscopic Surgery Society, Osaka, 2015. 12. 10-12
  76. Hiromitsu Kinoshita, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yusuke Sakamoto, Nobuaki Iwamoto, Motoko Mizumoto, Masato Kondo, Junji Komori, Kenji Uryuhara, Hiroyuki Kobayashi, Hiroki Hashida, Satoshi Kaihara, Ryo Hosoya: Difficulty of lymphadenectomy in laparoscopic gastrectomy by Senior Resident. 28th Endoscopic Surgery Society, Osaka, 2015. 12. 10-12
  77. Yusuke Sakamoto, Masato Kondo, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Hiromitsu Kinoshita, Nobua Iwamoto, Motoko Mizumoto, Junji Komori, Kenji Uryuhara, Hiroyuki Kobayashi, Hiroki Hashida, Satoshi Kaihara, Ryo Hosoya: A standardization of laparoscopic pancreatic body and tail resection. 28th Endoscopic Surgery Society, Osaka, 2015. 12. 10-12
  78. R. Kita, Y. Hashida, S. Kitano, Y. Kumada, H. Masui, H. Kinoshita, Y. Sakamoto, M. Mizumoto, M. Kondo, J. Komori, K. Uryuhara, H. Kobayashi, Satoshi Kaihara, R. Hosoya: Under laparoscopic assistance 203 lymph node dissection in right-sided colectomy. 28th Endoscopic Surgery Society, Osaka, 2015. 12. 10-12
  79. Shoichi Kitano, Kenji Uryuhara, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Yusuke Sakamoto, Hiromitsu Kinoshita, Nobua Iwamoto, Masato Kondo, Junji Komori, Hiroyuki Kobayashi, Hiroki Hashida, Satoshi Kaihara, Ryo Hosoya: Efforts toward standardization of laparoscopic hernia repair (TAPP) at our hospital. 28th Endoscopic Surgery Society, Osaka, 2015. 12. 10-12
  80. Yukiko Kumada, Hiroyuki Kobayashi, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Hiromitsu Kinoshita, Yusuke Sakamoto, Nobua Iwamura, Satoshi Kaihara, Ryo Hosoya: Present status of laparoscopic cholecystectomy for acute cholecystitis at our hospital Validity of TG13 sex. 28th Annual Meeting of Endoscopic Surgery Society, Osaka, 2015. 12. 10-12
  81. Masato Kondo, Hideyuki Masui, Ryosuke Kita, Yusuke Sakamoto, Hiromitsu Kinoshita, Nobua Iwamoto, Yukiko Kumada, Shoichi Kitano, Satoshi Kaihara, Ryo Hosoya: Laparoscopic distal pancreatic resection in pursuit of functional preservation. Pancreatic Endoscopic Surgery Study Group, Kyoto, 2015. 12. 13
  82. Yusuke Sakamoto, Masato Kondo, Shoichi Kitano, Yukiko Kumada, Ryosuke Kita, Hideyuki Masui, Hiromitsu Kinoshita, Nobua Iwamoto, Motoko Mizumoto, Junji Komori, Kenji Uryuhara, Hiroyuki Kobayashi, Hiroki Hashida, Satoshi Kaihara, Ryo Hosoya: Efforts to prevent pancreatic fistula in laparoscopic pancreatectomy. Pancreatic Endoscopic Surgery Study Group, Kyoto, 2015. 12. 13
  83. Nobua Iwamura, Satoshi Kaihara: Pancreatoduodenectomy with portal vein resection for locally advanced pancreatic head cancer. 13th Hyogo Surgical Technique Video Conference, Kobe, 2016.1.23
  84. Hashida Y, Satoshi Kaihara, Kondo M, Miki A, Komori J, Uryuhara K, Kobayashi H, Hosoya R: Current status of colorectal cancer surgery at our hospital. The 15th Kobe City Higashinada-ku doctor Association Hospital-clinic Collaborative Academic Meeting, Kobe, 2016.2.21
  85. Yuki Hashida, Yukiko Kumada, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Hiromitsu Kinoshita, Yusuke Sakamoto, Nobua Iwamoto, Masato Kondo Kondo, Junji Komori, Kenji Uryuhara, Hiroyuki Kobayashi, Ryo Hosoya, Satoshi Kaihara: Current status and prospects of treatment for colorectal neuroendocrine tumors. The 12th Annual Meeting The Japanese Gastroenterological Association, Tokyo, 2016. 2. 26-27
  86. Kaihara S, Iwamura S, Kumata Y, Kitano S, Masui H, Kita R, Sakamoto Y, Kinoshita H, Mizumoto M, Kondo M, Komori J, Uryuhara K, Kobayashi H, Hashida H, Hosotani R: Parenchymal dissection technique in laparoscopic hepatectomy. SAGES2016, Boston, 2016.3.16-19
  87. Iwamura S, Kaihara S, Kumata Y, Kitano S, Masui H, Kita R, Sakamoto Y, Kinoshita H, Mizumoto M, Kondo M, Komori J, Uryuhara K, Kobayashi H, Hashida H, Hosotani R: Management of laparoscopic partial hepatectomy for cranial and dorsal lesions in our department. SAGES2016, Boston, 2016.3.16-19
  88. Motoko Mizumoto, Masato Kondo, Hiromitsu Kinoshita, Nobua Iwamura, Junji Komori, Hiroki Hashida, Hiroyuki Kobayashi, Satoshi Kaihara, Ryo Hosoya: Techniques for joint laparoscopic endoscopic surgery for GIST with Delle. The 86th Annual Meeting of the Japanese Gastric Cancer Society, Tokyo, 2016. 3. 17-19

  1. Resection strategy for colorectal liver metastasis focusing on intrahepatic vessels and resection margins. Iwaki K, Kaihara S, Kitamura K, Uryuhara K. Surg Today. 2021 Mar 6.
  2. A Case of Extensive Traumatic Duodenal Injury Saved by Jejunal Serosal Patch and Duodenal Diverticular Formation Masato Kondo (Department of Surgery, Kobe City Medical Center General Hospital), Satoshi Kaihara. Journal Japanese Association for Acute Medicine (0915-924X) Vol.32 No.2 Page116-119(2021.02)
  3. Usefulness and Cost-effectiveness of Interval appendectomy for Complicated Appendicitis. Ryosuke Kita, Hiroki Hashida, Daisuke Yamashita, Hiromitsu Kinoshita, Masato Kondo, Satoshi Kaihara. Journal of Surgery 2021; 9(3): 109-113
  4. A case report of intersigmoid hernia treated using laparoscopic surgery. Hiroyuki Kambe, Koji Kitamura, Satoshi Kaihara. Int J Surg Case Rep. 2021 Apr;81:105822.
  5. Resection strategy for colorectal liver metastasis focusing on intrahepatic vessels and resection margins. Kentaro Iwaki, Satoshi Kaihara, Koji Kitamura, Kenji Uryuhara .Surg Today. 2021 Mar 6. doi: 10.1007/s00595-021-02254-0.
  6. QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study. , Makoto Yamada , Jun Hihara , Ryoji Fukushima , Yasuhiro Choda , Yasuhiro Kodera , Shin Teshima, Hisashi Shinohara, Masato Kondo. Gastric Cancer.
  7. Appendicitis Surgery Elective laparoscopic appendectomy for abscess-forming appendicitis. Ryosuke Mizuno, Satoshi Kaihara: Surgery (0037-4423) Vol.75 No.4 Page417-423 (2021.04)

  1. Cause of recurrent laryngeal nerve paralysis following esophageal cancer surgery and preventive surgical technique along the left recurrent laryngeal nerve. Kobayashi, H., Kondo, M., Kita, R., Hashida, H., Shiokawa, K., Iwaki, K. , Kambe, H., Mizuno, R., Kawarabayashi, T., Sumi, T., Kaihara, S., Hosotani, R. Mini-invasive Surg 30 (4) 2020
  2. Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by incurable advanced gastric cancer. Terashima M, Fujitani K, Ando M, Sakamaki K, Kawabata R, Ito Y, Yoshikawa T, Kondo M , Kodera Y, Kaji M, Oka Y, Imamura H, Kawada J, Takagane A, Shimada H, Tanizawa Y, Yamanaka T, Morita S, Ninomiya M, Yoshida K. Gastric Cancer. 231.
  3. Changes in the sexual function of male patients with rectal cancer over a 2-year period from diagnosis to 24-month follow-up: A prospective, multicenter, cohort study. Sakamoto T, Hida K, Hoshino N, Yamaguchi T, Manaka D, Yamada M, Kadokawa Y, Yamanokuchi S, Kondo M, Kanazawa A, Abe H, Okada T, Morita S, Sakai YJ Surg Oncol. 2020 Dec;122(8):1647-1654.
  4. Diagnosis and treatment of parastomal hernia. Hiroki Hashida. Gastroenterological Surgery Vol.43 No.7 Page1151-1160(2020.06)
  5. Laparoscopic Surgery for Colorectal Cancer in Super-Elderly Patients: A Single-Center Analysis. Hashida H, Mizuno R, Iwaki K, Kanbe H, Sumi T, Kawarabayashi T, Kondo M, Kobayashi H, Kaihara S. Surg Laparosc Endosc Percutan Tech. 2020 Nov 23;31(3):337-341.
  6. Laparoscopic Colectomy for Splenic Flexure Cancer Approached from Four Directions. Hashida H, Kondo M, Kita R, Kitamura K, Uryuhara K, Kobayashi H, Kaihara S. J Laparoendosc Adv Surg Tech A. 2020 Nov 23. doi: 10.1089/lap.2020.0709 .Online ahead of print.
  7. Internal hernia of the stomach associated with colostomy after laparoscopic surgery for rectal cancer: a case report. Hashida H, Kita R, Kondo M, Mizuno R, Kobayashi H, Kaihara S. Surg Case Rep. 2020 Dec; 6: 127.
  8. Diaphragm disease associated with nonsteroidal anti-inflammatory drugs mimicking intestinal tumor: A case report. Mori A, Hashida H, Kitamura K, Matsui J, Mizuno R, Tanigawa Y, Izumi A, Ishida S, Yamashita D, Yamaguchi T, Kaihara S. Int J Surg Case Rep. 2020;76:121-124.
  9. Analysis of the Outcome of Laparoscopic Repair for Parastomal Hernia Using the Sandwich Technique. Hiroki Hashida, Yukiko Kumata, Masato Kondo, Hiroyuki Kobayashi, Satoshi Kaihara. Indian Journal of Surgery. 83, pages542–546 (2021) Published: 27 May 2020
  10. Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin. Kondo M, Nishino S, Yamashita D, Kaihara S. Case Rep Oncol. 2020 Jun 24;13(2):716 -720. doi: 10.1159/000507983. eCollection 2020 May-Aug.
  11. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival. Okuno M, Hatano E, Toda R, Nishino H, Nakamura K, Ishii T , Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokuka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S. J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):496-509. doi: 10.1002/jhbp.747. Epub 2020 Jun 9.
  12. Successful Treatment of a Mixed Neuroendocrine-Nonneuroendocrine Neoplasm of the Colon with Metastases to the Thyroid Gland and Liver. Kanazawa Y, Kikuchi M, Imai Y, Katakami N, Kaihara S, Shinohara S. Case Rep Otolaryngol. 2020 Feb 13;2020:5927610 doi: 10.1155/2020/5927610. eCollection 2020.
  13. Surgery for lower gastrointestinal perforation. Keiichi Shiokawa, Satoshi Kaihara: Digestive Surgery (0387-2645) Vol.43 No.5 Page664-668 (2020.04)

  1. Transperineal abdominoperineal resection for anorectal melanoma: A case report. Hiroki Hashida, Masato Kondo, Daisuke Yamashita, Shigeo Hara, Ryosuke Mizuno, Motoko Mizumoto, Hiroyuki Kobayashi, Satoshi Kaihara. Int J Surg Case Rep 61:214-217,2019
  2. Usefulness of laparoscopic posterior rectopexy for complete rectal prolapse: A cohort study. Hiroki Hashida, Masato Sato, Yukiko Kumata, Motoko Mizumoto, Masato Kondo, Hiroyuki Kobayashi, Takehito Yamamoto, Hiroaki Terajima, Satoshi Kaihara. Int J Surg 72:109-114,2019
  3. Hepatic Anisakiasis Mimicking Metastatic Liver Tumor. Ryosuke Kita, Hiroki Hashida, Kenji Uryuhara, Satoshi Kaihara. Int J Surg Case Rep 60:209-212,2019
  4. Chronic rejection after intestinal transplantation: A systematic review of experimental models. Koji Kitamura, Bettina M Buchholz, Kareem Abu-Elmagd, Joerg C Kalff, Nico Schafer, Martin W von Websky. Transplant Rev (Orlando) 33:173-181,2019
  5. Two cases of diaphragmatic hernia after radiofrequency ablation in our hospital. Hideyuki Masui, Kenji Uryuhara, Ryosuke Kita, Masato Kondo, Satoshi Kaihara. Japanese Journal of Hernia Society 5: 17-25, 2019
  6. A case of laparoscopic surgery for cecal cancer with abscess-forming appendicitis. Hideyuki Masui, Hiroyuki Kobayashi, Kenji Uryuhara, Satoshi Kaihara, Ryo Hosoya. Surgery 81: 155-161, 2019
  7. Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial. Muro K, Itabashi M, Hashida H, Masuishi T, Bando H, Denda T, Yamanaka T, Ohashi Y, Sugihara K. Jpn J Clin Oncol 2019 Apr 1;49(4):339-346.
  8. Linear or circular stapler? A propensity score-matched, multicenter analysis of intracorporeal esophagojejunostomy following totally laparoscopic total gastrectomy. Murakami K, Obama K, Tsunoda S, Hisamori S, Nishigori T, Hida K, Kanaya S, Satoh S, Manaka D, Yamamoto M, Kadokawa Y, Itami A, Okabe H, Hata H, Tanaka E, Yamashita Y, Kondo M, Hosogi H, Hoshino N, Tanaka S, Sakai Y. Surg Endosc. 2020 Dec;34(12):5265-5273.
  9. Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study.Ogata T, Satake H, Ogata M, Hatachi Y, Maruoka H, Yamashita D, Hashida H, Hamada M, Yasui H. Oncotarget. 2019 Feb 1;10(10):1070-1084.
  10. Investigation of usefulness of interval appendectomy protocol for mass-forming appendicitis in our hospital. Hiromitsu Kinoshita, Masato Kondo, Kento Yamamoto, Satoshi Kaihara. Japan Society for endoscopic Surgery (1344-6703) Vol.24 No.3 Page206-213(2019.05)
  11. ALPlat criterion for the resection of hepatocellular carcinoma based on a predictive model of posthepatectomy liver failure. Yamamoto G, Taura K, Ikai I, Fujikawa T, Nishitai R, Kaihara S, Zaima M, Terajima H, Yoshimura T, Koyama Y, Tanabe K 2020 Feb;167(2):410-416. doi: 10.1016/j.surg.2019.09.021 Epub 2019 Nov 11.

  1. Laparoscopic appendectomy for appendicitis in pregnant women. Yukiko Kumada, Satoshi Kaihara, Ryo Hosoya. Surgery 72: 1241-1247, 2018
  2. Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection. Kotake T, Satake H, Okita Y, Hatachi Y, Hamada M, Omiya M, Yasui H, Hashida T, Kaihara S, Inokuma T, Tsuji A. Asia Pac J Clin Oncol. 15: 63-68, 2018
  3. Technique and surgical outcomes of mesenterization and intraoperative neural monitoring to reduce recurrent laryngeal nerve paralysis after thoracoscopic esophagectomy: A cohort study. Kobayashi H, Kondo M, Mizumoto M, Hashida H, Kaihara S, Hosotani R. Int J Surg. 56: 301-306, 2018
  4. Laparoscopic appendectomy during the third trimester: Case presentation and literature review. Iwamura S, Hashida H, Yoh T, Kitano S, Mizumoto M, Kitamura K, Kondo M, Kobayashi H, Kaihara S, Hosotani R. Asian J Endosc Surg. 11: 413-416, 2018
  5. Updated 5-year survival and exploratory T x N subset analyzes of ACTS-CC trial: a randomized controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer. Kusumoto T, Ishiguro M, Nakatani E, Yoshida M, Inoue T, Nakamoto Y, Shiomi A, Takagane A, Sunami E, Shinozaki H, Takii Y, Maeda A, Ojima H, Hashida H, Mukaiya M, Yokoyama T, Nakamura M, Munemoto Y, Sugihara K. ESMO Open 3: e000428, 2018
  6. Esophageal/stomach arthroscopic surgery Laparoscopic omental filling. Masato Kondo. Digestive surgery. Vol.41 No.5 Page576-582 (2018.04)
  7. Treatment of rectal prolapse. Hiroki Hashida. Gastroenterological Surgery Vol.41 No.8 Page1201-1210(2018.07)
  8. A Case of Cecal Cancer with Heterotopic Ossification. Ayaka Omori, Hiroki Hashida, Satoshi Kaihara. J Med Cases. 2018;9(5):131-134
  9. Fistula Formation Secondary to Mucinous Appendiceal Adenocarcinoma May Be Related to a Favorable Prognosis: A Case Report and Literature Review. Yokode M, Ikeda E, Matsui Y, Iwamura S, Mikami S, Kobayashi H, Imai Y, Kaihara S, Yamashita Y. Intern Med. 2018 Oct 15;57(20):2945-2949. doi: 10.2169/internalmedicine.0694-17. Epub 2018 Jun 6.

  1. Clinical factors that affect the outcomes after anatomical versus non-anatomical resection for hepatocellular carcinoma. Yamamoto T, Yagi S, Uryuhara K, Kaihara S, Hosotani R. Surg Today. 2017 Feb;47(2):193-201.
  2. Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer. Satake H, Kondo M, Mizumoto M, Kotake T, Okita Y, Ogata T, Hatachi Y, Yasui H, Miki A, Imai Y, Ichikawa C, Murotani K, Kotaka M, Kato T, Kaihara S, Tsuji A. Anticancer Res. 2017 Jul;37(7):3703-3710.
  3. Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI). Satake H, Miki A, Kondo M, Kotake T, Okita Y, Hatachi Y, Yasui H, Imai Y, Ichikawa C, Murotani K, Hashida H, Kobayashi H, Kotaka M, Kato T, Kaihara S, Tsuji A. ESMO Open. 2017 Mar 9;2(1):e000130.
  4. A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy. Hashida H, Satake H, Kaihara S. Case Rep Oncol. 2017 Jan 17;10(1):81-85.
  5. Technique and usefulness of laparoscopic rectal fixation for complete rectal prolapse. Yuki Hashida, Yukiko Kumada, Motoko Mizumoto, Keiichi Shiokawa, Takaaki Matsubara, Shoichi Kitano, Ryosuke Kita, Hideyuki Masui, Yoshifumi Kitamura, Masato Kondo, Kenji Uryuhara, Hiroyuki Kobayashi, Ryo Hosoya, Satoshi Kaihara. Japanese Journal of Women's Pelvic Floor Medicine (2187-5669) Vol.14 No.1 Page84-87(2017.12)
  6. A case of acute appendicitis associated with threatened premature labor at 32 weeks of gestation underwent laparoscopic appendectomy. N. Iwamura, Y. Hashida, M. Mizumoto, R. Hosoya, S. Kaihara. Japan Society for endoscopic Surgery (1344-6703) Vol.22 No.4 Page539-544(2017.07)
  7. Significance of Proper Graft Selection in Adult Living-Donor Liver Transplant Recipients with Preoperative Deteriorated Condition. Iida T, Masuda K, Matsuyama T, Harada S, Nakamura T, Koshino K, Suzuki T, Nobori S, Ushogome H, Ito T, Sakamoto S , Uryuhara K, Okajima H, Kaihara S, Uemoto S, Yoshimura N. Ann Transplant. 2017 Sep 8;22:541-549. doi: 10.12659/aot.904575.
  8. Biliary Pneumonia due to the Presence of a Bronchobiliary Fistula. Matsumoto T, Otsuka K, Kaihara S, Tomii K. Intern Med. 2017;56(11):1451-1452. doi: 10.2169/internalmedicine.56.8066. Epub 2017 Jun 1.
  9. Prospective registry for laparoscopic liver resection. Fuji H, Hatano E, Seo S, Arimoto A, Okabe M, Fujikawa T, Nishitai R, Ishii T, Kaihara S, Matsushita T, Oike F, Ichimiya M, Ohta S, Yamanaka K, Taura K, Yasuchika K, Uemoto S. Asian J Endosc Surg. 2017 May;10(2):173-178. doi: 10.1111/ases.12351. Epub 2016 Dec 14.
  10. Hepatectomy Satoshi Kaihara: Digestive Surgery (0387-2645) Vol.40 No.4 Page433-440 (2017.04)

  1. A case of double cystic duct diagnosed during surgery. Hideyuki Masui. Surgery 70: 701-706, 2016
  2. Axillobifemoral Bypass for Aortitis Syndrome in a Living-Donor Liver Transplant Patient. Fukunaga N, Uryuhara K, Koyama T. Ann Vasc Dis. 2016;9(2):114-6.

  1. A case of appendiceal mucinous carcinoma for which contrast-enhanced US was useful for diagnosis. Kaori Minami, Naoko Araki, Nobuhiro Iwasaki, Hitoshi Kazuo, Hiroshi Tei, Yoshiki Suginoshi, Yuki Hashida, Kazushi Minowa, Yukihiro Imai, Tetsuro Inokuma. Ultrasound Medicine 43:367, 201
  2. Long-term survival after resection of pancreatic cancer: A single-center retrospective analysis. Yamamoto T, Yagi S, Kinoshita H, Sakamoto Y, Okada K, Uryuhara K, Morimoto T, Kaihara S, Hosotani R. World J Gastroenterol 21: 262-268, 2015
  3. Comparison between anatomical subsegmentectomy and non-anatomical partial resection for hepatocellular carcinoma located within a single subsegment: a single-center retrospective analysis. Yamamoto T, Yagi S, Kita R, Masui H, Kinoshita H, Sakamoto Y, Okada K, Miki A, Kondo M, Hashida H, Kobayashi H, Uryuhara K, Kaihara S, Hosotani R. Hepatogastroenterology 62: 363-367, 2015
  4. Prediction of mortality in patients with colorectal perforation based on routinely available parameters: a retrospective study. Yamamoto T, Kita R, Masui H, Kinoshita H, Sakamoto Y, Okada K, Komori J, Miki A, Uryuhara K, Kobayashi H, Hashida H, Kaihara S, Hosotani R. World J Emerg Surg 10: 24, 2015
  5. The preventive surgical site infection bundle in patients with colorectal perforation. Yamamoto T, Morimoto T, Kita R, Masui H, Kinoshita H, Sakamoto Y, Okada K, Komori J, Miki A, Kondo M, Uryuhara K, Kobayashi H, Hashida H, Kaihara S, Hosotani R. BMC Surg 15: 128 , 2015
  6. Investigation of risk factors for postoperative recurrence of gastrointestinal mesenchymal tumors and usefulness of risk classification by modified Fletcher classification. Kento Yamamoto, Akira Miki, Kazuyuki Okada, Chihiro Ichikawa, Ryosuke Matsuoka, Keiichiro Uehara, Satoshi Kaihara, Ryo Hosoya. Journal of The Japanese Society of Gastroenterological Surgery 48: 473-480, 2015

For young doctor considering training at our hospital

For those who aim for post-surgery training at our hospital

Our hospital is the flagship hospital for the specialized surgery training program (program name: Kyoto University of Hyogo Surgery Training Program). Here, we will explain the features of the training program for gastroenterological surgery at our hospital, including the "Kyoto University of Hyogo Specialized Surgery Training Program".

About Hyogo Kyoto University Surgery Training Program

(1) Features of the program

Group of educational facilities with a wide range of environments

Kobe City Medical Center General Hospital (hereinafter referred to as "Kobe City Medical Center) is the core hospital, and seven hospitals (Hyogo Prefecture Amagasaki General Medical Center, Himeji Medical Center, Nishi-Kobe Medical Center, Shinko Memorial Hospital, Toyooka Public Hospital, Kobe City Municipal Medical Center Nishi Municipal Hospital, Ako Municipal Hospital) are arranged as cooperative facilities to form a group of hospitals that consider regional medical care.

number of surgeries

The group as a whole performs approximately 12,000 surgeries a year, including highly difficult surgeries (approximately 5,000 endoscopic surgeries a year), providing an extremely favorable environment for experiencing a large number of surgeries and deepening understanding of surgical diseases. is in

Highly specialized leadership team

There are 80 specialized training instructors, including not only gastrointestinal surgery, Cardiovascular Surgery, Respiratory Sugery, pediatric surgery, and Breast Surgery, but also highly specialized Technology Certified Physician such as Instructor for Advanced Skills in hepato-biliary-pancreatic surgery and endoscopic surgery technicians. We have a team of instructors.

(2) Recruitment

The number of recruits for the "Kyoto University of Hyogo Surgery Training Program" is 17 people per year (total of 51 people in 3 years). We do not set hiring quotas for each subspecialty. Hiring will be based on document review and interview. Those who wish to train at hospitals in this group will be recruited and assigned to the "Kyoto University of Hyogo Surgery Training Program" and will not be recruited at each hospital.

③Training hospital, training period

A main training facility will be established, where at least two consecutive years of specialized surgical training will be provided. Of the remaining one year, half of the training will be at a core hospital (Kobe City Medical Center) and half of the training will be at a partner facility. In addition, during these three years, subjects other than the desired sub-specialty (for example, if a request for gastrointestinal surgery is desired, other cardiac, respiratory, pediatric, and mammary gland surgeries) will also be rotated, and the number of cases required for specialists will be increased. experience.

The selection of the main facility is based on the request of the trainee doctor, but the final decision will be made by the Program Management Committee after considering the situation of each hospital.

(4) Career path after completion of specialized training in surgery

After completing the Hyogo Kyoto University Surgical Training Program, you can freely choose if you wish doctor the training ends. If you are considering a career path at Kyoto University, please contact the Kyoto University Surgery Exchange Center (Gastroenterological Surgery, Breast Surgery), Kyoto University Respiratory Sugery, Kyoto UniversityCardiovascular Surgery We collaborate with and share information, and have established a generous support system even after the training is completed. In addition, it is also possible to work at specialized disease hospitals such as cancer centers, cardiovascular centers, and children's hospitals. Taking the current Kobe City Medical Center General Hospital surgery as an example, about 2% of people who have completed their three-year residency period 3 have chosen the career path of the Kyoto University affiliate, but the remaining 1/3 have chosen various other career paths.

(Reference) Specific examples of career paths for doctor who wish to undergo training in gastrointestinal surgery at our hospital

  • Applied for the "Kyoto University of Hyogo Surgery Training Program" and was hired after an interview.
  • Kobe City Medical Center General Hospital Gastroenterological Surgery, which is the desired facility, was decided as the main facility.
  • A total of two years from the first year to the end of the second year, training mainly in gastrointestinal surgery at the main facility, and the first half and second half of the third year are rotated for six months each at partner facilities. Other subspecialties are also trained during the training period. Acquired as a Board Certified Surgeon in the year following completion of training.
  • After completing the three-year training, a career path affiliated with Kyoto University was set. At the Kyoto University Surgery Exchange Center, we selected a Kyoto University-affiliated training hospital and received another two years of clinical training. Acquired Gastroenterological Surgeon certification in the year following the completion of training, endoscope Technology Certified Physician acquisition is also possible.
  • After completing two years of training, he entered the graduate school of Kyoto University University.

About the training at Kobe City Medical Center General Hospital Surgery

(1) Clinical training

Surgical training at our hospital is characterized by a much higher percentage of involvement in actual surgery than at other hospitals. Specifically, in addition to routine surgeries, mainly numerous cancer surgeries, we actively perform emergency surgeries, maintaining a total of approximately 1,300 to 1,400 surgeries per year (see "Surgery Statistics" for details). These surgeries are always performed in pairs by a staff member doctor and a late-career resident, who provides direct one-on-one instruction in preoperative diagnosis and evaluation, surgery, postoperative management, and organization of surgical records. In addition, we have adopted our originally developed surgical technique evaluation system as a measure of surgical technique proficiency, and provide guidance based on this system. On the other hand, we do not have a system to provide adequate training in areas other than surgery and the perioperative period. For example, if a cancer patient unfortunately relapses, chemotherapy is provided by Oncology. For patients in the terminal stages of cancer, the palliative care department is in charge. Thus, our surgical training is specialized in surgery and perioperative care, and those areas in which we lack such training, such as chemotherapy and palliative care, will be trained at our rotation hospitals.

Under the strict guidance of the staff, young doctor residents are encouraged to actively perform surgeries in order to gain more experience. Specifically, in the first year of training, they will first learn basic surgical techniques, focusing on cholecystectomy, hernia, and laparotomy. In the second year, they are more likely to be in charge of gastrointestinal surgery and have more opportunities to perform surgeries for these diseases. In the second year, they are more likely to be in charge of gastrointestinal tract surgeries and have more opportunities to perform these procedures. They will also be assigned to hepatobiliary and pancreatic diseases after a certain stage, and will have more opportunities to perform these procedures on their own. The staff doctor will always be responsible for teaching these procedures, but laparoscopic surgery will be taught by the endoscopist Technology Certified Physician, and hepatobiliary surgery will be taught by the advanced hepatobiliary surgeons Technical Supervisor and Certified Physician.

In addition, I have extensive experience in emergency situations. Patients with surgical diseases who are hospitalized on duty about four times a month become attending physicians, and if surgery is necessary, they become operating surgeons under the guidance of the staff in charge.

By accumulating these clinical experiences, the required number of Board Certified Surgeon and Gastroenterological Surgeon can be easily achieved.

(2) Robotic surgery is possibleNEW

Robotic surgery in the field of gastrointestinal surgery was limited to Gastroenterological Surgeon and doctor with endoscopic technology certification, so it was not possible for late-stage trainees to perform surgery. However, in 2022, the conditions were greatly relaxed, and even late-stage trainees can now perform robotic surgery under certain conditions.
However, in reality, most facilities have many restrictions for late-stage trainees to perform robotic surgery. First of all, since robots are jointly used not only in gastroenterological surgery but also in Urology, Respiratory Sugery, obstetrics and Obstetrics and Gynecology, etc., the number of surgical cases that can be performed in gastroenterological surgery is limited. In addition, post-career trainees can only operate on organs with robotic surgery proctors. In addition, the training required for robotic surgery costs hundreds of thousands of yen, which is a heavy burden for late-stage trainees.
However, our hospital has been focusing on robotic surgery for some time, and has taken various measures to address the above problems.

1) Our hospital has three surgical assistance robots.
Compared to other facilities, it is possible to perform more robotic surgeries, and from 2023, post-doctoral trainees are also performing robotic surgeries.
2) We have full-time proctors for all organs where robotic surgery can be performed in gastrointestinal surgery.
Post-doctoral trainees can perform robotic surgery on all organs (esophagus, stomach, large intestine, rectum, liver, pancreas).
3) The cost of training in robotic surgery will be borne by the hospital.
You can acquire qualifications without any burden on individual trainees.

In this way, it is noteworthy that our hospital's gastroenterological surgery has an environment in place that allows late-stage trainees to perform robotic surgery as soon as possible.

Robotic Surgery Center Page

③Off site training environment is in place

In addition to actual clinical practice, we also conduct off-site training by editing Dry Lab and surgical videos and conducting clinics. Specifically, the Dry Lab is jointly used by multiple surgical departments, providing an environment that allows practice 24 hours a day. In addition, surgical videos are collectively managed and saved at the surgeon's office, and previous surgical videos can be viewed at any time. In addition, we hold monthly "Video Clinics" as a place for discussion based on surgical videos edited by young doctor. We are preparing an environment where we can receive

④ Actively participating in academic activities

There are still many clinical issues to be clarified. Clinical research is one of the means to solve these problems, and we actively participate in clinical research and launch our own projects. In addition to staff doctor, each project is always handled by a post-doctoral trainee. In addition, there is a possibility that new knowledge can be obtained by compiling and analyzing the data of diseases experienced at our hospital. In that sense, database management is extremely important, and staff members and junior doctor are in charge in pairs, similar to clinical research.

We also actively participate in conference presentations as a forum for presenting our research. At first, the content of the presentations was case reports, but eventually it became a summary presentation of the data analysis, and not only the staff but also the late-stage trainees made presentations on advanced topics at national-scale academic conferences. In addition, I actively participate in overseas academic conferences because I believe that they are a good opportunity not only to experience overseas medical care firsthand, but also to reconsider the current state of medical care in Japan. We aim to present four times at national conferences in Japan and one time at overseas conferences during our stay at our hospital. It has been adopted and presented at external academic societies (excluding regional meetings).

⑤ Efforts toward work style reform

The training at our hospital is very busy, including pre-operative preparation, surgery, post-operative management, organization of surgery records, etc. for patients who have been in charge of scheduled surgery. However, on the other hand, as an initiative for work style reform, we are adding a sharpness to the on/off duty. Specifically, there is no duty for the next day after the shift, so we return home in the morning to reduce the burden on the day after the shift. In addition, we have a complete shift system on weekends, so there is no need to go to work if it is not your turn. It is also a big feature of our clinic to do a very sharp training like this.

At the end

For surgical training at our hospital, it is possible to receive specialized training specialized in surgery and the perioperative period. Other features include one-on-one guidance by staff with specialized qualifications, robotic surgery by post-doctoral trainees, construction of an off-site voluntary training system, and active academic activities. The three-year training period is very busy, but two in each grade, a total of six trainees in the three years, enjoy the training while stimulating and helping each other.

If you are interested in clinical training at our hospital or have any questions, please contact the Director of Surgery: Kaihara (skaihara@kcho.jp). And I hope you will take a look at the surgical training at our clinic.

Written by: Satoshi Kaihara, Director of Surgery

news

Introduction of our department for doctor and those who aspire to become doctor

* This content is intended for doctor people to deepen their understanding of this medical institution, and is not intended for advertising or advertising for the general public. Nice to meet you Kobe City Medical Center General HospitalSurgery and Transplant Surgery My name is Satoshi Kaihara (Satoshi Kaihara) of Director.
As a core hospital in the region, our department handles all kinds of digestive diseases, from benign diseases such as gallstone disease and inguinal hernia to malignant diseases such as gastric cancer, colorectal cancer, and liver cancer. In addition, we respond to emergency illnesses 24 hours a day, 365 days a year. With 8 staff members and 7 Senior Resident staff, we provide medical care with experts in general surgery, upper gastrointestinal surgery, lower gastrointestinal surgery, and hepatobiliary and pancreatic surgery in a wide range of fields such as gastrointestinal surgery, emergency surgery, and transplant surgery, and cooperation with each department is quick and strong. The ability to provide intensive treatment is also a major strength of our hospital.
The annual incidence of colorectal cancer in Japan currently exceeds 150,000, and the opportunities for treatment are increasing. Today, I would like to introduce some of our efforts for surgical treatment and anticancer drug treatment for colorectal cancer. Surgical M.D. Hiroki Hashida (Hiroki Hashida) for minimally invasive surgery of the large intestine, and Yoshifumi Kitamura (Koji Kitamura of the surgical M.D. for liver metastasis. However, for chemical chemotherapy, OncologyDirector Hisaaki Yasui will be in charge.

Satoshi Kaihara
Assistant to Hospitl Director
Surgery and Transplant Surgery Director

Wide range of indications for minimally invasive surgery for colorectal cancer and strengths in postoperative complications

Surgery and Transplant Surgery M.D.
Yuki Hashida
(Hiroki Hashida)
Specialized field
Gastroenterological Surgery, Colon Surgery, Endoscopic Surgery
Academic specialist/ Certified Physician
Japan Surgical Society Specialist/Preceptor
The Japanese Society of Gastroenterological Surgery Specialist / Preceptor
Endoscopic Surgery Society Technology Certified Physician, etc.

The most distinctive feature of our Department of Surgery for colorectal cancer is that we aim to combine a minimally invasive approach with an oncologic approach. We have been actively adopting laparoscopic surgery for some time now, and the number of laparoscopic surgeries has been increasing, reaching nearly 90% of all surgeries.

We are working to provide minimally invasive and high quality surgeries. In addition, elderly and obese patients are not excluded from laparoscopic surgeries, and laparoscopic surgeries are performed with care for adhesions even in patients who have previously undergone open abdominal surgery. Even patients in poor general condition (heart, lung, liver, kidney function, etc.) are eligible for laparoscopic surgery if they can receive general anesthesia, and laparoscopic surgery is also indicated for all but a few cases such as large tumors and invasion of other organs. Japan Society for endoscopic Surgery Technology Certified Physician We have performed nearly 2,000 colorectal cancer surgeries in the past 10 years.

The complications of Clavien-Dindo classification Grade IV or higher in the postoperative complication criteria are extremely low at less than 1%, leaving stable results. The average postoperative hospital stay was 7.3 days.

Robotic surgery is performed in almost all cases of rectal cancer. Improving curability and prognosis

Robotic surgery is performed by a doctor who is certified as a robotic surgeon. Robot-assisted surgery for rectal cancer is thought to be able to further improve the advantages of conventional laparoscopic surgery, and currently almost all cases of rectal cancer are treated with robot-assisted surgery.

The robot has multi-joint forceps, and it is possible to operate the pelvic floor, which is difficult with conventional laparoscopic surgery, and to perform complicated and delicate surgical techniques.
The Firefly Imaging System enables real-time tissue evaluation using near-infrared rays and visible light, which can be used as a countermeasure against suture insufficiency. Early recovery is expected, and minimally invasive surgery with few sequelae becomes possible.

In addition, in robotic surgery, even in a narrow pelvis, by fully demonstrating the characteristics of the robot, it is possible to operate deep into the pelvis, making it possible to preserve the anus and avoid permanent colostomy.

Multidisciplinary treatment aiming for complete cure even in stage 4

Surgery and Transplant Surgery M.D.
Yoshifumi Kitamura
(Koji Kitamura)
Specialized field
Gastroenterological Surgery, Hepato-Biliary-Pancreatic Surgery, Emergency Surgery
Academic specialist/ Certified Physician
Japanese Gastroenterological Society Specialist / Preceptor
Japanese Society of Hepato-Biliary-Pancreatic Surgery Advanced Technical Specialist
Japanese Association for Acute Medicine Emergency Medicine Specialist Medicine, etc.

In Stage 4, which is metastatic recurrent colorectal cancer, we are aiming for a radical cure through a multidisciplinary approach, including colorectal surgeons, liver surgeons, and medical Oncology.
In our surgery, we perform about 20 operations for metastatic liver tumors every year. Based on past performance, we decide indications for liver resection.

Liver metastases with 4 or more tumors or 5 cm or more in size are defined as resectable borderline liver metastases, and patients with these resectable borderline liver metastases are treated with preoperative chemotherapy before resection. We have a policy of
About half of the patients who have relapsed have recurrence only in the liver, and if resectable, the recurrence site can be aggressively repeatedly resected to improve the prognosis and cure.

Aggressive surgical resection for liver metastases

The number of cases is increasing, and the number of resections by laparoscopic surgery is also increasing rapidly. Liver resection is often very difficult due to its anatomical characteristics. We aim at radical resection led by highly skilled hepato-biliary-pancreatic surgery specialists. Compared to conventional open surgery, laparoscopic surgery has advantages such as faster recovery after surgery and less bleeding as well as aesthetics. surgery is limited. Currently, about 80% of liver resections are performed laparoscopically.

Combined chemotherapy for difficult-to-remove cases

If the liver reserve is less than the limit, we have no choice but to judge that it is unresectable, but sometimes resection becomes possible as the tumor becomes smaller due to chemotherapy. In some cases, liver tumors that are difficult to resect can be resected by selecting a procedure to increase the residual liver by portal vein embolization before surgery or a method of resecting the surgery in two stages (stage hepatectomy). I have.

By constructing a 3D image based on images taken before surgery, it is possible to set the resection range and surgical method, estimate the degree of difficulty of surgery and the expected remaining liver capacity, and select the optimal surgical method that is neither excessive nor deficient. Decide
In addition, intraoperative ICG fluorescence imaging is used to visualize the tumor and the liver region to be resected in real time, which is used as navigation for liver resection to provide higher quality and safer surgery.

Small lesions under the liver capsule can be difficult to visualize with intraoperative ultrasound, so ICG fluorescence imaging is used to identify tumors.

Ever-advancing chemotherapy

Director Oncology
Hisaaki
Hisateru Yasui
Specialized field
Drug therapy for solid tumors, supportive care, cancer genomic medicine
Academic specialist/ Certified Physician
The Japanese Society of Internal Medicine Board Certified Member of the Japanese Society of Internal Medicine /Preceptor
Japanese Society of Medical Oncology Oncology Pharmacotherapist, Preceptor, etc.

(1) Adjuvant chemotherapy after resection of liver metastases

In a multicenter joint clinical trial conducted mainly by our hospital, favorable results were obtained by adding adjuvant chemotherapy after liver resection. One cycle of capecitabine and four cycles of capecitabine plus oxaliplatin (CAPOX) were administered as adjuvant chemotherapy after curative resection of liver metastases, and the 5-year recurrence-free and overall survival rates were 65.2% and 87.2%, respectively. , the most common grade ≥3 toxicity was neutropenia (29%)¹⁾. Chemotherapy after hepatectomy is said to have strong side effects, but under the management of the Oncology, sufficient treatment is continued and a good survival rate is obtained.
1) Satake, et al. The Oncologist 2021;25:1–8

Adjuvant chemotherapy with CAPOX for 3 months is well tolerated and is considered one of the promising strategies for curative resection of liver metastases. Based on this, we believe that it is necessary to promote personalized medicine based on genetic characteristics.

(2) Preoperative chemotherapy for unresectable liver metastases

With the introduction of molecular-targeted drugs, even seemingly unresectable multiple liver metastases may become resectable if tumor shrinkage is achieved with chemotherapy. After examining tumor cell biomarkers (RAS/BRAF gene mutation, microsatellite instability, UGT1A1 gene polymorphism), the optimal chemotherapy regimen will be selected and a medical Oncology will perform thorough treatment. Approximately 60% to 70% of responses can be obtained with the first treatment, and 20% to 30% can be expected to undergo radical resection. The therapeutic effect is evaluated every 6 to 8 weeks, and the appropriate timing of surgery is considered in cooperation with the surgical department.
Recently, new treatment options that are expected to be effective, such as new treatments (trials) using immune checkpoint inhibitors, are increasing. Even after second-line treatment, resection may be possible due to tumor shrinkage.
Even stage 4 colorectal Oncology can be cured by radical resection.

Method of referral to surgery and medical Oncology and treatment flow

For introductions to our department, please use the FAX reservation or web reservation described on our website. For online reservations, a special ID and password will be distributed from here, so you can access the dedicated site from there and make a reservation directly to the vacant slot. New patient outpatient appointments are available from 9:00 to 11:00 on all days of the week. After your visit to our hospital, we will contact you as soon as a treatment policy is decided. You will usually be admitted to the hospital one day before the surgery, and you will usually be discharged from the hospital around one week after the surgery. Through regional cooperation, we introduce patients to doctors who have been introduced at the request of patients.

Click here for details on how to refer a patient to our hospital
message to teachers

In colorectal cancer, even highly advanced cancer can be expected to have a long-term prognosis through multidisciplinary treatment including surgery and chemotherapy. Some patients hesitate to undergo surgery because of their advanced age, but at our hospital, we have a track record of safely performing minimally invasive surgery on patients over the age of 80, and in some cases over the age of 90. It doesn't matter if the indication for surgery is uncertain, so please introduce me first. We can handle any case.

If you need medical Oncology treatment, we will refer you to our hospital. Our motto is to provide high-quality medical care as a general hospital surgery department. It is important to enhance hospital-clinic collaboration and hospital-patient collaboration, and to have local doctors use our hospital's medical functions.